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Abstract 
The Eri1 (enhanced RNAi) gene is conserved from fission yeast to humans and 
codes for a protein consisting of an amino-terminal SAP domain and a carboxy-
terminal 3’ exonuclease domain. In this study mouse Eri1 protein was analyzed for its 
impact on three RNA target molecules: ribosomal RNA, histone mRNA and miRNA. 
The Eri1 protein was found to be enriched in nucleoli, the sites of ribosome 
biogenesis. Consistent with this finding, RNA-immunoprecipitations revealed binding 
of Eri1 to 5.8S rRNA as well as its precursor and it could be demonstrated that Eri1 
performs in 5.8S rRNA 3’ end processing. Furthermore, histone mRNA could be co-
immunoprecipitated with Eri1 in living cells and functional data demonstrate that the 
exonuclease activity of Eri1 is crucial for the initiation of cell cycle-dependent histone 
mRNA degradation. Detailed analyses using Eri1 point mutants identified critical 
amino acids for binding of the RNA target molecules in the nucleic acid-binding SAP 
domain as well as in the linker sequence between the SAP and exonuclease domain. 
Together, these results suggest an impact of Eri1 on fundamental cellular processes 
such as protein biogenesis, DNA replication and cell division.  
Systematic analysis of Eri1-knockout mice uncovered a number of phenotypes. The 
most prominent ones were growth retardation, postnatal death and male sterility. 
Further, a skeletal dysmorphology phenotype was found, revealing an additional pair 
of ribs in Eri1-knockout mice. To investigate the underlying molecular mechanism 
analyses were performed on various levels. First, a detailed description of the 
skeleton showed a duplication of the thoracic vertebra T7 and an extension of the 
homeotic transformation to the first sacral vertebra. Second, literature and database 
research revealed a high degree of similarity between Hoxc8-knockout mice and 
Eri1-knockout mice. Third, molecular analysis of the Hoxc8 mRNA expression pattern 
indicated a shift of the anterior expression border of Hoxc8 comparing Eri1-knockout 
and wildtype embryos. Finally, Eri1 could be shown to reduce miR-196a levels in 
MEF cells, and luciferase reporter assays demonstrated an inhibition of miR-196a-
mediated Hoxc8 3’ UTR silencing by Eri1. These data led to the current model in 
which Eri1 regulates Hoxc8 silencing by miR-196a in embryos and thus controls 
skeletal patterning during mouse development.  
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Zusammenfassung 
Das Eri1 (enhanced RNAi) Gen ist von der Spalthefe bis zum Menschen konserviert 
und kodiert für ein Protein mit einer amino-terminalen SAP-Domäne und einer 
carboxy-terminalen 3’ Exonuklease-Domäne. In dieser Studie wurde der Einfluss von 
dem Eri1-Protein der Maus auf drei RNA-Zielmoleküle analysiert: ribosomale RNA, 
Histon-mRNA und miRNA. Eine Anreicherung des Eri1-Proteins wurde in Nukleoli, 
den Orten der Ribosombiogenese, gefunden. In Übereinstimmung mit diesem 
Ergebnis zeigten RNA-Immunpräzipitationen eine Bindung von Eri1 an 5.8S rRNA 
sowie an die ribosomale Vorläufer-RNA und es konnte nachgewiesen werden, dass 
Eri1 5.8S rRNA am 3’ Ende prozessiert. Des Weiteren konnte Histon-mRNA mit Eri1 
in lebenden Zellen ko-immunpräzipitiert werden und funktionelle Daten beweisen, 
dass die Exonuklease-Aktivität von Eri1 für die Initiierung der Degradation Zellzyklus-
abhängiger Histon-mRNAs notwendig ist. Detaillierte Analysen mit Eri1-
Punktmutanten identifizierten kritische Aminosäuren für die Bindung von RNA-
Zielmolekülen in der Nukleinsäure-bindenden SAP-Domäne sowie in der Region 
zwischen SAP- und Exonuklease-Domäne. Zusammengefasst machen diese 
Ergebnisse deutlich, dass ein Einfluss von Eri1 auf elementare zelluläre Prozesse 
wie Proteinbiogenese, DNA-Replikation und Zellteilung besteht. 
Bei der systematischen Analyse von Eri1-„Knockout“-Mäusen wurde eine Reihe von 
Phänotypen entdeckt. Die markantesten waren Wachstumsverzögerung, postnataler 
Tod und Sterilität bei männlichen Mäusen. Weiterhin wurde eine Skelettfehlbildung 
mit einem zusätzlichem Rippenpaar in Eri1-„Knockout“-Mäusen gefunden. Zur 
Erforschung des zugrundeliegenden molekularen Mechanismus wurden Analysen 
auf verschiedenen Ebenen durchgeführt. Erstens zeigte eine detaillierte 
Beschreibung des Skeletts eine Duplikation des 7. Brustwirbels und eine 
Ausdehnung der homeotischen Transformation bis zum ersten sakralen Wirbel. 
Zweitens machten Literatur- und Datenbanknachforschungen eine hohe Ähnlichkeit 
zwischen Hoxc8-„Knockout“-Mäusen und Eri1-„Knockout“-Mäusen deutlich. Drittens 
kennzeichnete die molekulare Analyse der Hoxc8 mRNA-Expression eine 
Verschiebung der anterioren Expressionsgrenze von Hoxc8 in Eri1-„Knockout“-
Mäusen  im Vergleich zu Wildtyp-Mäusen. Letztlich konnte gezeigt werden, dass Eri1 
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miR-196a-Level in MEF-Zellen reduziert und Luziferase-Reporter Experimente 
bewiesen eine Inhibierung der miR-196a-vermittelten Hoxc8 3’ UTR-Stilllegung durch 
Eri1. Diese Daten führten zu dem aktuellen Modell, in dem Eri1 die Hoxc8-Stilllegung 
durch miR-196a im Embryo reguliert und folglich die Skelettmusterung während der 
Mausentwicklung kontrolliert. 
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1 Introduction 
1.1 The eukaryotic transcriptome 
All living cells store their hereditary information in the same genetic code in the form 
of deoxyribonucleic acid (DNA), a long, double-stranded winding molecule that 
contains the instructions needed to build and maintain cells. For these instructions to 
be carried out, DNA must be transcribed into corresponding molecules of ribonucleic 
acid (RNA), referred to as transcripts. The transcriptome comprises the entire set of 
transcripts in a cell. For a long time the description of the transcriptome was limited to 
the transcription products of known annotated genes: These products were mainly 
messenger RNAs (mRNAs) as well as stable non-coding RNAs (ncRNAs), such as 
ribosomal RNAs (rRNAs), transfer RNAs (tRNAs), small nuclear RNAs (snRNAs) and 
small nucleolar RNAs (snoRNAs). However, the catalogue of transcribed sequences 
became more complex, first with the discovery of naturally occurring interfering 
RNAs, such as small interfering RNAs (siRNAs) and microRNAs (miRNAs). Lately, 
new technologies revealed that the transcription landscape in higher eukaryotes was 
found to imply high portions of transcripts originating from intergenic regions. This 
widespread genomic transcription is often called ‘pervasive transcription’, because 
contrary to genes, the transcripts are not restricted to well-defined functional features 
(Jacquier, 2009). 
Additionally to the complexity in sequence, recent findings have revealed that 
enormous diversity can be generated on the RNA level. Regulatory networks control 
RNA transcription as well as post-transcriptional events (Figure 1). For example, 
ribosomal RNAs are further modified by pseudouridylation (Ψ) and ribose methylation 
(CH3) at specific residues. In alternative splicing, exonic sequences are removed as 
part of an intron to generate alternative mRNAs that direct the synthesis of distinct 
protein isoforms. Interfering RNAs might inhibit protein synthesis or even lead to 
mRNA degradation (Mendes Soares and Valcarcel, 2006). Consequently, numerous 
proteins tightly regulate gene expression to ensure spatio-temporal expression, 
meaning that the correct complement of RNA and proteins is present in the right cell 
at the correct time.  
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Accordingly, in contrast to the clear description of genomes, transcriptomes are 
entities as diverse as the cell types, developmental stages and environmental 
conditions that the organism harbors or faces. 
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Figure 1: An overview of the eukaryotic transcriptome. miRNA, microRNA; mRNA, messenger 
RNA; rasiRNA, repeat associated small interfering RNA; RISC, RNAi-induced silencing complex; 
miRITS, miRNA-induced transcriptional silencing; rRNA, ribosomal RNA; shRNA, small hairpin RNA; 
snRNP, small nuclear ribonucleoprotein; snoRNA, small nucleolar RNA. (Adapted from Mendes 
Soares and Valcarcel, 2006)  
1.2 Coding and structural RNAs  
1.2.1 Messenger RNAs  
Protein coding genes represent only a small fraction of eukaryotic genomes. New 
insights indicate that the generation of organismal complexity from the relative small 
number of genes is mainly achieved through the regulation of RNA complexity. The 
primary products of transcription of eukaryotic protein-coding genes are subject to 
extensive processing. A single primary transcript can lead to the generation of 
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multiple mRNAs, proteins and functions due to post-transcriptional events; for 
example, through alternative splicing, alternative polyadenylation and RNA editing. 
Protein-coding genes are transcribed exclusively by RNA polymerase II (RNA-Pol II) 
to synthesize mRNA precursors (pre-mRNAs). The processing of the pre-mRNAs to 
their mature form often occurs co-transcriptionally. The standard modifications 
involve capping, splicing and cleavage/polyadenylation (Figure 1). In brief, the 7-
methyl G5’ppp5’N cap is an identifying mark on all RNA-Pol II transcripts. Three 
enzymes contribute to the capping of mRNAs: RNA triphosphatase, 
guanylyltransferase and 7-methyltransferase. The cap is added when the RNA is 
about 25 bp long, soon after its 5’ end emerges from the RNA exit channel of the 
polymerase (Shuman, 1997). Introns can be removed by the spliceosome, a large, 
dynamic complex comprising five uridine-rich small nuclear ribonucleoproteins 
(snRNPs) and a number of additional proteins. Splicing can occur either co-
transcriptionally or post-transcriptionally (Wetterberg et al., 1996). At the end of the 
gene, the pre-mRNA is cleaved at the poly(A) motive and a poly(A) tail is added to 
the exposed 3’ end. Finally, the mature mRNA will be transported to the cytoplasm to 
be translated into proteins. 
1.2.2 Canonical histone mRNAs  
Histones are the primary protein component of chromatin. The canonical histone 
mRNAs encode the four core histones – H2A, H2B, H3 and H4 – which make up the 
nucleosome, and the linker H1 histones, which are found between nucleosomes. 
Two of each core histones form a heterooctamer, which is used to wrap the DNA 
around twice. In 1974 it has already been discovered that histones are involved in 
chromosomal DNA packaging (Kornberg, 1974; Kornberg and Thomas, 1974; Olins 
and Olins, 1974), but only recently a crucial role for histones in regulating gene 
expression was recognized. In this process extensive modification of the histone 
proteins plays an important role. Furthermore, the accurate positioning of 
nucleosomes within chromatin is essential for proper transcriptional regulation, the 
demarcation of heterochromatic boundaries and the epigenetic inheritance of gene 
expression patterns. Thus the cell must carefully coordinate the replication of DNA, 
the synthesis of estimated 108 molecules of each histone type per mammalian cell 
and the rapid deposition of new and old histones to reform chromatin during each 
relatively short S-phase (Marzluff et al., 2008). 
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In mouse there are 65 distinct canonical histone mRNAs, which code for the five 
types of histone proteins. These canonical histone mRNAs are the only metazoan 
mRNAs, which are not polyadenylated but contain a unique 3’ end structure. They 
are encoded by replication-dependent histone genes and must rapidly reach high 
levels of expression during S-phase. In contrast, the replication-independent histone 
variants are polyadenylated and their synthesis persists also outside S-phase. 
Transcription of the canonical histone genes and processing of the resulting pre-
mRNA occur in association with the Cajal body in the nucleus. The genes are 
transcribed by RNA-Pol II and their rate of transcription increases as cells approach 
S-phase (DeLisle et al., 1983). Additionally, the formation of histone mRNAs by 3’ 
end processing is most effective during S-phase, coupling histone synthesis with 
DNA replication (Harris et al., 1991). 
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Figure 2: Global view of histone mRNA metabolism in mammalian cells. DCP, mRNA decapping 
enzyme; EIF4G, eukaryotic translation initiation factor 4-γ; LSM, Sm-like protein; Pol, polymerase; 
SLBP, stem-loop binding protein; SLIP1, SLBP-interacting protein 1; snRNP, small nuclear 
ribonucleoprotein; TUTase, terminal uridylyltransferase; XRN1, 5’–3’ exoribonuclease 1. (Adapted 
from Marzluff et al. 2008)  
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The genes encoding metazoan canonical histones lack introns, and thus one 
endonucleolytic cleavage reaction is the only processing event necessary to form 
mature histone mRNA (Figure 2). Cleavage requires binding of the stem-loop binding 
protein (SLBP) and is carried out by a multi-component machinery containing U7 
snRNP (Mowry and Steitz, 1987). SLBP remains bound to the histone mRNA as it 
relocates to the cytoplasm, where histone mRNA is circularized through a complex of 
proteins including at least SLBP, SLBP-interacting protein 1 (SLIP1) and eukaryotic 
translation initiation factor 4-γ (EIF4G). Subsequently, translation of histone mRNA 
takes place. At the end of S-phase, a short U-tail is added to histone mRNA in the 
cytoplasm. The LSM1–7 ring binds the oligo(U) to cooperate in the recruitment of the 
decapping complex and a conserved complex of 3’ to 5’ exonucleases, termed the 
exosome to degrade the mRNA. In addition, the cyclin A/cyclin-dependent kinase 1 
complex (CycA/CDK1) phosphorylates SLBP to trigger its degradation by the 
proteasome preventing further accumulation of histone mRNAs and eventually 
histone proteins (Marzluff et al., 2008). 
1.2.3 Ribosomal RNAs 
One of the most important tasks of any cell is to synthesize ribosomes. There are 
about 106 ribosomes in a growing cell, so the cell has to synthesize 106 copies of 
each type of ribosomal RNA (rRNA) in each cell generation; these represent about 
80% of the total RNA. In eukaryotes, the process of rRNA transcription, processing 
and assembly occurs sequentially in the nucleolus, the nucleoplasm and the 
cytoplasm. The nucleolus is a distinct subnuclear compartment with over 700 
proteins identified in the proteome of human nucleoli (Andersen et al., 2005; 
Andersen et al., 2002; Scherl et al., 2002). The primary function of the nucleolus is 
ribosome subunit biogenesis, but besides pre-mRNA processing factors also other 
proteins have been identified that are involved in cell-cycle control as well as DNA 
replication and repair (Boisvert et al., 2007). 
The ribosomal DNA (rDNA) genes are encoded in so-called nucleolar organizer 
regions, which are located on acrocentric chromosomes. Nucleoli form at the end of 
mitosis around the rDNA genes and result in a subnuclear compartment that locally 
concentrates the transcription and processing machineries that are responsible for 
generating ribosome subunits. The rDNA genes are arranged in long tandem arrays 
separated by non-transcribed spacer regions. The transcription of rDNA genes 
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requires a specialized RNA polymerase, RNA-Pol I, which produces uncapped and 
unpolyadenylated rRNA transcripts. The primary pre-rRNA most likely starts to fold 
spontaneously and to interact with small RNAs and proteins during transcription. 
Indeed proper transcriptional elongation by RNA-Pol I is required for efficient pre-
rRNA processing and pre-ribosome assembly (Schneider et al., 2007). 
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Figure 3: Synthesis and processing of rRNA for ribosome biogenesis in mammals. ETS, 
external transcribed spacer; ITS, internal transcribed spacer; rDNA, ribosomal DNA; rRNA, ribosomal 
RNA. 
The primary transcript (47S pre-rRNA) of ∼14 kb in size is processed into 18S, 5.8S, 
and 28S mature rRNAs (Figure 3). About half of the primary rRNA transcript is 
comprised of regions termed external transcribed spacers (5’ETS and 3’ETS) and 
internal transcribed spacers (ITS-1 and ITS-2). The latter are removed and rapidly 
degraded during rRNA maturation (Eichler and Craig, 1994). Processing of pre-rRNA 
requires more than 150 non-ribosomal factors that transiently associate with the 
developing pre-ribosomes (Henras et al., 2008; Tschochner and Hurt, 2003). For 
example, the exosome is involved in multiple steps in pre-rRNA maturation 
(Houseley et al., 2006; Mitchell et al., 1997; Raijmakers et al., 2004). The most 
Introduction 
 
 7 
common covalent modifications found in rRNA are methylation and 2’-O-ribose 
pseudouridylation (Figure 1). Both of these modifications are catalyzed in the 
nucleolus by small nucleolar ribonucleoproteins (snoRNPs) that act on the pre-rRNA 
substrate (Kiss, 2002). Contrary to the long precursor RNA, which is transcribed by 
RNA-Pol I and has to be processed further, the 5S rRNA is transcribed from a 
separate cluster of genes by RNA-Pol III. The 5.8S and 28S rRNAs assemble with 
the 5S rRNA transcript to form the large 60S subunit, whereas the 18S rRNA alone 
assembles into the small 40S ribosome subunit. The pre-40S and pre-60S ribosome 
subunits are both exported into the cytoplasm, where final assembly and maturation 
steps occur. As a last step, the mature ribosomal subunits bind to mRNA to form 
functional ribosomes (Boisvert et al., 2007). 
1.3 Regulatory RNAs 
RNA interference (RNAi) was discovered by Andrew Fire and Craig Mello in 1998. 
This finding was awarded with the Nobel Prize for Medicine in 2006. The discovery 
that sequence-specific gene silencing occurs in response to the presence of double-
stranded RNAs in the worm (Fire et al., 1998) and the subsequent demonstration that 
RNAi operates also in mammalian cells (Elbashir et al., 2001) has had an enormous 
impact on biology, uncovering an unsuspected level of regulation of gene expression. 
During the last decade, remarkable progress has been made towards understanding 
the underlying mechanisms of RNAi. These small RNAs are able to regulate the fine-
tuning and networking of complex suites of gene activity, thereby specifying cellular 
physiology, differentiation and development. Additionally, RNAi has become a 
powerful experimental tool for biological research as well as drug discovery and is 
currently being developed for human gene therapy. 
1.3.1 Mechanisms of RNA interference 
During RNAi, dsRNAs are processed into small RNAs of approximately 21 
nucleotides, termed small interfering RNAs (siRNAs), which guide the destruction of 
complementary target mRNAs (Mello and Conte, 2004). Natural mechanisms related 
to RNAi are involved in developmental gene regulation mediated by microRNAs 
(miRNAs) and in transcriptional silencing and heterochromatin formation (Ambros, 
2004; Lippman and Martienssen, 2004).  
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Figure 4: Mechanism of RNA interference in mammalian cells. Ago2, Argonaute-2; ds, double-
stranded RNA; mRNA, messenger RNA; Pre-miRNA, precursor miRNA; Pri-miRNA, primary miRNA; 
RISC, RNAi-induced silencing complex; siRNA, small interfering RNA. (Adapted from Fougerolles et 
al., 2007) 
Two main categories of small RNAs have been defined on the basis of their 
precursors: The cleavage of exogenous long dsRNA precursors in response to viral 
infection or after artificial introduction generates siRNAs, whereas the processing of 
genome-encoded stem–loop structures generates miRNAs (Figure 4). The synthesis 
of mature miRNAs begins with endogenously encoded primary miRNA transcripts 
(pri-miRNAs) that are mostly transcribed by RNA Pol II (Kim, 2005) and are 
processed by the nuclear-localized RNase III Drosha enzyme complex, which defines 
one end of the duplex and releases a precursor miRNA (pre-miRNA) of ~65–70 
nucleotides. The pre-miRNA hairpin is exported to the cytoplasm by exportin 5, 
where Dicer completes the processing for loading onto the Argonaute 2/RNAi-
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induced silencing complex (Ago2/RISC). When the RNA duplex loaded onto RISC 
has imperfect sequence complementarity, the passenger strand is unwound leaving 
a mature miRNA bound to active RISC. The mature miRNA recognizes target sites, 
typically in the 3’ UTR of the mRNA, leading to direct translational inhibition. Binding 
of a miRNA to its target mRNA may also lead to mRNA target degradation in 
processing (P)-bodies. In the siRNA pathway the RNA duplex loaded onto the RISC 
has perfect sequence complementarity. AGO2 cleaves the passenger strand, so that 
active RISC containing the guide strand is produced. The guide strand recognizes 
target sites to direct mRNA cleavage, again carried out by the catalytic domain of 
AGO2 (de Fougerolles et al., 2007; Siomi and Siomi, 2009). 
1.3.2 MicroRNAs in development and cell differentiation 
The first miRNA, lin-4, was discovered in C. elegans and was shown to be essential 
for the normal temporal control of diverse postembryonic developmental events. 
Lin-4 transcripts were found to contain sequences complementary to a repeated 
sequence element in the 3' UTR of lin-14 mRNA. This suggested the post-
transcriptional regulation of the heterochronic gene lin-14 expression via an 
antisense RNA-RNA interaction (Lee et al., 1993; Wightman et al., 1993). In 2000, 
another C. elegans miRNA, let-7, was identified and shown to regulate 
developmental timing in the nematode (Reinhart et al., 2000). It was proposed that 
the sequential stage-specific expression of the lin-4 and let-7 regulatory RNAs 
triggers transitions in the complement of heterochronic regulatory proteins to 
coordinate developmental timing in C. elegans. However, unlike lin-4, which is 
conserved only in closely related species, let-7 RNAs were detected and found to 
exhibit temporally controlled expression in samples from a wide range of animal 
species, including vertebrates (Pasquinelli et al., 2000). Since then, numerous 
regulatory small RNAs have been cloned from several species, and many of these 
exhibit spatially and/or temporally regulated patterns of gene expression (Aravin et 
al., 2006; Aravin et al., 2003; Lagos-Quintana et al., 2002; Landgraf et al., 2007; Lau 
et al., 2001; Lee and Ambros, 2001). The abundance of these tiny RNAs, their 
expression patterns, and their evolutionary conservation implied that, as a class, 
miRNAs have broad regulatory functions in animals. For example, while the two 
founding members of this class of regulatory RNAs both were found to control 
developmental timing, other miRNAs were shown to function in the neuronal 
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patterning in nematodes (Johnston and Hobert, 2003) or the modulation of 
hematopoietic lineage differentiation in mammels (Chen et al., 2004). Drosophila 
miRNAs, bantam and miR-14, have been implicated in the control of cellular 
proliferation and in the reduction of programmed cell death (Brennecke et al., 2003; 
Johnston and Hobert, 2003; Xu et al., 2003) and the muscle-specific miR-1 was 
found to control cardiac differentiation (Kwon et al., 2005a). Microarray based 
analysis of mouse miRNAs demonstrated tissue specific expression of many miRNAs 
(Liu et al., 2004). These observations led to the notion that a principal function of 
miRNAs is to control cell differentiation and development.  
1.4 Embryonic development in vertebrates 
Animal development begins with fertilization of the ovum, which initiates rapid cell 
division and a cascade of gene expression changes. The final pattern of a 
differentiated cell type is the outcome of a specific program for cell specialization.  
Although every cell contains the same genetic information, selective gene expression 
will produce many diverse cells in a final pattern of great complexity and precision.  
During development, many cell movements occur to shape the vertebrate body. In 
gastrulation the cells from the exterior of the early embryo tuck into the interior to 
form a gut cavity and create the three germ layers: endoderm, mesoderm, and 
ectoderm. In vertebrates, the movements of gastrulation are organized by signals 
from the organizer, called node in a mouse embryo. This specifies the dorso-ventral 
(from back to belly) axis and gives shape to the anterior-posterior (from head to tail) 
axis, which has already been defined by the animal-vegetal asymmetry of the egg. 
The segmentation of the mesoderm into somites depends on a periodic pattern of 
gene expression, which is laid by a biochemical oscillator in the mesoderm and 
dictates the way the mass of cells will break up into separate blocks. The vertebral 
bodies and ribs evolve from somatic mesoderm, only the sternum is formed by the 
lateral plate mesoderm. In all vertebrates the axial skeleton is composed of similar 
components that extend from anterior to posterior along the body axis: the occipital 
skull bones and cervical, thoracic, lumbar, sacral, and caudal vertebrae. During 
evolution significant changes in the number and size of these elements occurred, but 
the basic character and the order in which they appear in vertebrate skeletons have 
remained remarkably similar. 
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1.4.1 Skeletal patterning and the organization of Hox clusters 
An important mechanism during embryonic development is the correct patterning of 
the axial skeleton. The definition of the anterior to posterior (A-P) animal body axis is 
probably the ancestral role of Hox genes (Duboule and Dolle, 1989; Graham et al., 
1989; Gruss and Kessel, 1991; Krumlauf, 1994). Hox proteins are transcription 
factors that contain a homeodomain and were first described in Drosophila for their 
ability to cause segmental homeotic transformations of the body plan (Lewis, 1978). 
In mammals there are four Hox gene clusters (Hoxa -d) containing 39 Hox genes that 
can be classified in 13 paralogous subgroups. The size of the Hox clusters is 
between 100 and 200 kb. In the Hox gene nomenclature, the numbers of the 
paralogous genes descend in the direction of transcription with Hox1 paralogues 
mapping to the 3’ end of each cluster. The temporal and spatial colinearity is a 
striking phenomenon of Hox gene expression: Hox genes located at the 3’ end of the 
cluster are expressed earlier, whereas genes more 5’ are expressed at later stages 
of development. In addition, genes at the 3’ end of the clusters are expressed more 
anterior, while genes at the 5’ end are expressed in more posterior parts of the 
embryo. Thus the gene order in the cluster is collinear to the relative position of their 
distinct expression domains along the A-P axis of the embryo (Pearson et al., 2005) 
(Figure 5).  
Hoxa1 Hoxa2 Hoxa3 Hoxa4 Hoxa5 Hoxa6 Hoxa7 
Hoxb1 Hoxb2 Hoxb3 Hoxb4 Hoxb5 Hoxb6 Hoxb7 Hoxb8 Hoxb9 Hoxb13 
Hoxc4 Hoxc5 Hoxc6 Hoxc8 Hoxc9 Hoxc10 Hoxc11 Hoxc12 
Hoxb13 
Hoxb13 Hoxd1 Hoxd3 Hoxd4 Hoxd8 Hoxd9 Hoxd10 Hoxd11 Hoxd12 
Hoxd9 Hoxd10 Hoxd11 
Hoxb13 
3’ 5’ 
Fi  5 
 
 
Figure 5: Hox expression and genomic organization. Mouse embryo with approximate Hox 
expression domains at embryonic day E12.5. The colors that denote the expression patterns of the 
Hox transcripts are color-coded to the genes in the Hox cluster diagrams. (Adapted from Pearson et 
al., 2005)  
A specific combination of Hox gene transcription factor activity assigns the 
morphology of each vertebra (Kessel and Gruss, 1991). Because of Hox gene 
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expression in overlapping domains, a posterior prevalence model has been 
suggested, in which the pattering information at a given region relies on the more 
posterior expressed Hox gene (Duboule and Morata, 1994). Consequently, it is likely 
that particularly the establishment of the anterior boundary of Hox genes is an 
important step to accomplish an exact patterning of the embryo. Interestingly, it has 
been shown for C. elegans that after the initial boundaries are set, Hox gene 
expression patterns can still shift within the larger limits of their initial expression 
domains (Castelli-Gair and Akam, 1995; Salser and Kenyon, 1996). Several studies 
with mice also demonstrated that early Hox expression boundaries are subjected to 
both anterior and posterior changes before fixed boundaries are established at 12.5 
days post coitum (dpc) (McIntyre et al., 2007; Wellik, 2007). 
Hox mutant animals often exhibit morphological defects that involve changes in the 
A-P axial identity of the vertebrae. While for single Hox gene mutants both anterior 
and posterior homeotic transformations have been reported, loss of function of Hox 
paralogous groups always leads to anterior homeotic transformations of collinear 
regions throughout the skeleton (McIntyre et al., 2007). Additionally, data suggest 
that paralogous Hox genes show large functional redundancy, because double and 
triple mutant mice display a more severe and more penetrant phenotype (Chen and 
Capecchi, 1997; Condie and Capecchi, 1994; Davis et al., 1995; Fromental-Ramain 
et al., 1996a; Fromental-Ramain et al., 1996b; Horan et al., 1995; Manley and 
Capecchi, 1997; Manley and Capecchi, 1998).  
Tandem duplications within the ancestral Hox cluster and subsequent genome 
duplication events have resulted in a relatively fixed arrangement of four Hox clusters 
in mammals, composed of two to four paralogous members (Wellik, 2007). The use 
of several Hox paralogous might be due to smaller differences in the coding 
sequence and in the 3’ UTR. A slightly different regulatory modality has been 
observed for the single paralogous transcription factors, maybe because of diverse 
transcriptional as well as post-transcriptional regulation.  
1.4.2 Regulation of Hox gene expression 
The underlying mechanism of spatial and temporal colinearity is still elusive. An 
elaborate set of global and local transcriptional regulatory mechanisms seems to be 
involved (Deschamps, 2007; Heard and Bickmore, 2007). For example, it has been 
shown that Polycomb and Trithorax group complexes control the maintenance of Hox 
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gene expression in appropriate domains. The Polycomb complexes function as 
global enforcers of epigenetically repressed states, balanced by an antagonistic state 
that is mediated by Trithorax (Duboule and Morata, 1994; Schwartz and Pirrotta, 
2007). When cells become committed to differentiation, the epigenetic state has to be 
reprogrammed. Recently, it has been shown that a directional transition of the 
chromatin status takes place on Hox clusters. A dynamic progression of transcription-
competent modifications is employed that leads to an increase of activation marks 
and a decrease of repressive marks (Soshnikova and Duboule, 2009a; Soshnikova 
and Duboule, 2009b). 
For regulation of Hox expression on the post-transcriptional level, miRNAs have been 
proposed. It has been suggested that miRNAs are fine-tuners of developmental gene 
expression programs (Stark et al., 2005). At least 30 of the 39 mammalian Hox 3’ 
UTRs have one or more binding sites for vertebrate miRNAs. Hoxa7, Hoxb8, Hoxc8 
and Hoxd8 have already been demonstrated experimentally as conserved targets of 
miR-196 (Mansfield et al., 2004; Yekta et al., 2004). Hoxc8, Hoxd8 and Hoxa7 have 
complementary sequences with canonical seed matches for miR-196 that mediate 
translational repression. Although Hoxb8 lacks perfect seed pairing, it has extensive 
complementarity to miR-196 making it a substrate for cleavage. Furthermore, it could 
be shown that miR-196 acts upstream of Hoxb8 in vivo in the context of hindlimb 
development. The presented data indicated that the miRNA functions in a fail-safe 
mechanism acting as an inhibitor of Hoxb8 preventing its induction by ectopic retinoic 
acid (Hornstein et al., 2005). This supports the idea that many miRNAs in vertebrates 
may function as a secondary level of gene regulation. 
The Hox miRNAs, miR-10 and miR-196a, are encoded at two or three paralogous 
locations in the Hox clusters (Figure 6). 
 
 
Figure 6: Predicted repression of Hox genes by miR-196. Depiction of the mouse Hox clusters 
including the Hox miRNAs miR-10 and miR-196. (Adapted from Yekta et al., 2008) 
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The miRNAs are regulated spatially and temporally like the adjacent Hox genes as 
has been shown for miR-10a and Hoxb4 or miR-196a and Hoxb8 for mouse 
embryonic day E10.0 (Mansfield et al., 2004). Interestingly, the members of the miR-
196 family have been predicted to target only Hox genes that are located more 3’ in 
the cluster, while leaving unaffected the activity of Hox genes located more 5’ in the 
cluster (Yekta et al., 2008). Thus the genomic organization, the collinear expression 
and the conserved miRNA-recognition motifs in 3’ genomically encoded Hox mRNAs 
make it likely that these miRNAs shape the boundaries of those Hox proteins. 
Recently it has been shown that during chick development antagomir-mediated 
neutralization of miR-196 led to an expansion of the anterior limit of Hoxb8 and 
thereby induced a cervical to thoracic homeotic transformation (McGlinn et al., 2009). 
1.5 Functional protein-RNA interactions 
RNA regulatory proteins induce changes in tissue and developmental mRNA profiles. 
It is challenging to investigate, how these regulatory proteins work in complexes to 
control the fate of transcribed RNA. New biochemical strategies to map RNA binding 
protein (RNABP)-RNA interactions in vivo are yielding transcriptome-wide insights 
into mechanisms of RNA processing. In general, researchers wish to distinguish 
between the primary (direct) and secondary (indirect) effects of RNA regulatory 
factors. However, it is often hard to distinguish between the direct and indirect 
consequences of cellular manipulation, because any perturbation in a cell is likely to 
disrupt the RNA profile. Several approaches have emerged for the biochemical 
identification of functional RNABP-RNA interactions in vivo. These include 
immunoprecipitation (IP) of the RNA-binding protein followed by purification of the co-
precipitating RNA and analysis by RT-PCR or microarrays. The strategy is limited by 
the need to use relatively low stringency conditions to maintain protein-RNA 
interaction, so that discrimination between direct and indirect interaction or 
identification of the RNA-protein-binding site is impossible. Further, co-
immunoprecipitation of other RNABPs and RNABP-RNA reassociation in vitro cannot 
be controlled (Licatalosi and Darnell, 2010). An alternative method for identifying 
regulatory RNABP-RNA interactions is the RNA-immunoprecipitation (RIP) assay, 
which involves formaldehyde-mediated crosslinking as a first step (Gilbert et al., 
2004; Niranjanakumari et al., 2002) (section 2.2.18). This method yields a population 
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of RNA sequences that are directly bound by the RNABP of interest and 
consequently allows determining RNABP-RNA interactions occurring in live cells. In 
the future, the generation of transcriptome-wide maps of functional RNABP–RNA 
interactions will reveal the rules underlying RNA regulation and networks of 
biologically linked transcripts. 
1.6 The 3’ exonuclease Eri1 
The Eri1 (enhanced RNAi-1) gene is conserved from fission yeast to humans. In 
C. elegans two equally abundant splice variants of the Eri1 gene have been found, 
Eri1a (∼1.4 kb) and Eri1b (∼1.8 kb). In mice and humans only the shorter splice 
variant (∼1.0 kb) has been detected. The mouse Eri1 gene is encoded on 
chromosome 8 and is expressed as a 345 amino acid protein.   
Analyses of purified recombinant Eri1 proteins expressed from C. elegans, S. pombe, 
and human cDNAs have shown that Eri1 degrades single stranded RNA 3’ 
overhangs, but that it is not efficient in degrading RNA duplexes. Single stranded 
DNAs have also been found to be very poor substrates for Eri1 (Dominski et al., 
2003; Iida et al., 2006; Kennedy et al., 2004; Yang et al., 2006). The exonuclease 
Snipper is a homolog of Eri1 in Drosophila, which efficiently degrades structured 
RNA and DNA substrates as long as there exists a minimum 3' overhang of 2 nt to 
initiate degradation (Kupsco et al., 2006). 
1.6.1 The structure of Eri1 
The Eri1 gene encodes a protein with an amino-terminal SAP (SAF-A/B, Acinus and 
PIAS) domain and a carboxy-terminal 3’ exonuclease domain. The SAP domain, has 
been defined as sequence of 35 residues containing an invariant glycine and a 
conserved distribution of hydrophobic, polar and bulky amino acids. It is present in a 
number of eukaryotic proteins in conjunction with other domains that link these 
proteins with the RNA or DNA metabolism.  
The structure of the nuclease domain of the human Eri1 homolog, called 3’hExo or 
formerly named THEX1 (Three prime histone exonuclease-1), complexed with rAMP 
(riboadenine-5’-monophosphate) was determined in the presence of Mg2+ ions 
(Cheng and Patel, 2004) (Figure 7). Ribonucleotide 5’-monophosphates (rNMPs) are 
the products of the 3’-5’ exonuclease hydrolysis reaction and are thus believed to 
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mimic interactions associated with nuclease activity. The data revealed, that the 
nuclease domain adopts an α/β globular fold. In the active site of the nuclease 
domain two magnesium cations are coordinated to D134, E136, D234 and D298, and 
together with H293 provide a platform for hydrolytic cleavage of bound RNA in the 3’-
5’ direction. The bound rAMP is positioned within a deep active-site pocket. The 
nuclease domain is similar to 3’ exonucleases of the DEDD-family characterized by 
the presence of these four invariant acidic amino acids after which the family name 
has been originated (Zuo and Deutscher, 2001). The DEDD-family includes both 
DNA- and RNA-specific enzymes.   
 
 
 
 
 
Figure 7: Simplified structure of the mouse Eri1 protein. 
Red: nuclease domain coordinating two Mg2+ ions. Yellow: 
Exon 3, which has been targeted to create a conditional 
knockout mouse model. (Adapted from the RCSB Protein 
Data Bank) 
1.6.2 Eri1 and canonical histone mRNAs 
1.6.2.1 Eri1 binds to the stem loop of histone mRNAs 
The replication-dependent histone mRNAs end with a highly conserved 26-nucleotide 
sequence that contains a 6-nucleotide stem and a 4-nucleotide loop, followed in 
vertebrates by an ACCCA sequence (Dominski and Marzluff, 1999). The human Eri1, 
named 3’hExo, has been shown to bind oligos mimicking this 3’ stem loop of 
canonical histone mRNAs in vitro (Dominski et al., 2003). It has further been 
demonstrated that Eri1 can bind to stem loop-RNA alone or in conjunction with the 
stem-loop binding protein (SLBP), but SLBP and Eri1 do not directly interact with 
each other in the absence of stem loop-RNA. Tight binding and sequence-specific 
recognition of the RNA by SLBP requires the 5’ flank of the stem, the two invariant 
uridines at position 12 and 14 in the loop and the 5 nucleotides 5’ to the stem loop 
region (Battle and Doudna, 2001; Martin et al., 2000; Williams and Marzluff, 1995). In 
contrast, Eri1 was demonstrated to recognize the 3’ flank of the stem, the loop and 
Mg 
Fig 7 
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the 3’ single stranded ACCCA sequence (Dominski et al., 2003). Thus SLBP and 
Eri1 bind to opposite faces of the histone stem loop (Figure 8). 
Furthermore, it was suggested that Eri1 selects histone mRNA targets by sequence-
specific binding through its SAP domain. In 2006, the crystal structure of Eri1 in 
complex with stem loop RNA was solved and suggested that the SAP domain is 
indispensable for binding to histone RNA (Y. Cheng and D. Patel, submitted to the 
Protein Data Bank). Functional assays supported these data showing that a SAP 
domain deletion mutant as well as specific mutations in the SAP domain and the 
linker sequence abolished binding of Eri1 to stem loop-RNA (Yang et al., 2006). 
 
 
Figure 8: Binding of SLBP and Eri1 to the stem loop 
structure of the histone mRNAs. Consensus sequence of the 
3’ end of metazoan histone mRNAs. The absolutely conserved 
nucleotides are colored red. R and Y denote purine and 
pyrimidine, respectively. (Adapted from Dominski et al., 2003 
and the Eri1 structure at the RCSB Protein Data Bank) 
1.6.2.2 Does Eri1 regulate histone mRNAs in a cell cycle dependent manner? 
Recombinant Eri1 was shown to degrade stem loop RNA in a 3’ to 5’ direction, thus it 
was suggested that Eri1 initiates degradation of histone mRNAs (Dominski et al., 
2003). Lately the same group presented data that disproved a role for Eri1 in histone 
mRNA degradation. They introduced a 80-90% knockdown of Eri1 in Hela cells, but 
hydroxyurea-induced degradation of replication-dependent histone mRNAs failed to 
reveal any contribution of Eri1 in the degradation process (Mullen and Marzluff, 
2008). A physiological role for Eri1 binding to histone mRNAs in cells therefore 
remains unclear.  
1.6.3 Eri1 and RNA interference 
Eri1 has been shown to have an impact on different RNAi and RNAi-related 
pathways. It is involved in the regulation of exogenous (exo-) siRNAs (Kennedy et al., 
2004) as well as endogenous (endo-) siRNAs (Duchaine et al., 2006), and it has 
been demonstrated to affect heterochromatin formation (Bühler et al., 2006; Iida et 
al., 2006).  
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1.6.3.1 Eri1 is a regulator of siRNAs 
The C. elegans Eri1 gene was found in a screen for inhibitors of RNA interference in 
neurons (Kennedy et al., 2004). It had been shown before that dsRNAs vary in 
different cell types in their ability to trigger RNA interference; e.g. the nervous system 
of C. elegans is refractory to RNAi. The group of Gary Ruvkun discovered that worms 
with Eri1 mutations accumulated more siRNAs after exposure to dsRNA or siRNAs 
than did wildtype animals. Thus it was proposed that Eri1 is a negative regulator of 
RNAi, which normally functions to limit duration, cell-type specificity or endogenous 
functions of RNAi. It was further suggested, that Eri1 inhibits RNAi by degrading the 
3’ overhangs of siRNAs and thereby makes them fail to enter the RNAi-induced 
silencing complex (RISC) or alternatively that the 3’ recessed siRNAs may be 
unstable in vivo. In agreement with a decreased efficiency of RNAi in neurons, the 
Eri1b form fused to GFP was seen in a subset of neurons. In these neurons, Eri1 
predominantly localized to the cytoplasm. Eri1 was further found to be expressed in 
the developing somatic gonad and the spermatheca of adult worms (Kennedy et al., 
2004).  
In addition to down-regulating the response to exogenous siRNAs, Eri1 was shown to 
be required for the production of several endogenous siRNAs in C. elegans. The 
pathways for exo-siRNA and endo-siRNA use in part separate enzymes while 
sharing others including Dicer (DCR-1) (Lee et al., 2006). Mass spectrometry data of 
Dicer immunoprecipitations revealed that Eri1b exists in a complex with DCR-1 and 
functionally both proteins were required for the generation of endogenous siRNAs in 
C. elegans (Duchaine et al., 2006). In the new model Eri1 binds to short stem loops 
in a group of endogenous RNAs, which causes the removal of unpaired 3’ 
nucleotides. Thus a structure is generated that can prime an RNA-dependent RNA 
polymerase for the synthesis of double stranded RNA species. These RNAs will 
subsequently be cleaved by DCR-1 and introduced into the RNAi-pathway. If Eri1 is 
deleted, the proposed pathway for endogenous siRNA production cannot take place 
any more. Consequently, the Eri1 phenotype might be caused by the release of 
limiting components from the endogenous to the exogenous RNAi pathway in these 
mutants. Therefore, exogenous siRNAs show an increased effect in worms with Eri1 
mutation. 
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1.6.3.2 Regulation of heterochromatin assembly by Eri1 
Eri1 has also been shown to be an important regulatory factor in RNAi-mediated 
heterochromatin assembly. In fission yeast, heterochromatin assembly is initiated by 
siRNAs derived from heterochromatic regions and it requires the RNA-induced 
transcriptional silencing (RITS) complex (Cam and Grewal, 2004; Cam et al., 2005; 
Verdel et al., 2004; Volpe et al., 2002). Deletion of Eri1 caused an increase in 
siRNAs associated with the RITS complex and therefore enhanced heterochromatin 
silencing (Iida et al., 2006). Furthermore, it has been shown that de novo silencing 
mediated by siRNAs is under a strong negative control by Eri1. Eri1 interfered with 
heterochromatin assembly in trans. Hence, deletion of Eri1 allowed siRNAs to silence 
the expression of a second allele, which was located on another chromosome in an 
experimental RNAi-induced gene silencing in S. pombe (Bühler et al., 2006). 
1.7 Aim of the work 
The primary aim of the present work was to functionally characterize the impact of 
mouse Eri1 on RNA target molecules and to analyze the consequence of Eri1-
deletion in mice. Only two RNA target molecules have been proposed for Eri1 so far. 
It has been shown that human Eri1 binds to histone mRNA in vitro (Dominski et al., 
2003; Yang et al., 2006), but the physiological role remained unclear. Further, Eri1 
was reported to be a regulator of siRNA-mediated RNAi in C. elegans and in fission 
yeast (Bühler et al., 2006; Duchaine et al., 2006; Iida et al., 2006; Kennedy et al., 
2004). A possible function for Eri1 on miRNAs in the mammalian system has not 
been described yet. 
RIP is the method of choice to reveal functional protein-RNA interactions in vivo. 
Hence this method should be established and applied to find RNA target molecules 
of Eri1. Further, binding specificity should be analyzed employing Eri1-mutants. 
Since RNAs identified in the RIP assay directly bind to Eri1, they are possible targets 
for its exonuclease activity. This should be analyzed in functional assays. A 
systematic screen in cooperation with the German Mouse Clinic should be 
accomplished to reveal phenotypes of Eri1-knockout mice. One prominent phenotype 
should subsequently be studied for its underlying molecular mechanism.  
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2 Material and methods 
2.1 Material 
2.1.1 Chemicals and biochemicals 
Chemical Company 
Ampicillin  Roche 
Biozym DNA Agarose Biozym Scientific GmbH 
BSA (Albumin Fraktion V) Roth 
Chloroform min.  99% Sigma-Aldrich 
Deoxynucleotide (dNTP) set Fermentas 
Dimethyl sulfoxide (DMSO)  Sigma-Aldrich 
Dynabeads MyOne Tosylactivated Invitrogen 
Dynabeads Protein G Invitrogen 
Ethidium bromide 1% (w/v) Serva 
Glycogen blue Ambion 
Hydroxyurea Sigma 
Kanamycin sulfate Roth 
Milk powder Roth 
Paraformaldehyde Sigma-Aldrich 
1 kb Plus DNA Ladder Invitrogen 
Tri®Reagent Invitrogen 
0.05% Trypsin/ 0.02% EDTA in PBS  Pan biotech GmbH 
Trypton Merck 
Tween 20 Applichem 
Urea  Applichem 
Yeast extract Serva 
β-Mercaptoethanol 99% Sigma-Aldrich 
2.1.2 Enzymes 
Enzyme Company 
Gateway LR Clonase II Enzyme Mix Invitrogen 
Herculase® II Fusion DNA Polymerase  Stratagene 
Proteinase K Invitrogen 
Restriction enzymes New England Biolabs 
T4 DNA Ligase ( 10,000 U/ml) New England Biolabs 
Taq Polymerase (5,000 U /ml) Invitrogen 
Taq Polymerase (5,000 U /ml) New England Biolabs 
Topoisomerase I (E.coli) (5.000 U/ml) New England Biolabs 
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2.1.3 Kits 
Kit Company 
TOPO TA Cloning Kit Invitrogen 
pENTR/D-TOPO Cloning Kit Invitrogen 
pCR8/GW/TOPO TA Cloning Kit Invitrogen 
Nucleobond®Xtra Maxi Kit Macherey-Nagel GmbH & Co.  KG 
pENTR/D-TOPO Cloning Kit Invitrogen 
peqGOLD Plasmid Miniprep Kit I PeqLab Biotechnologie GmbH 
QIA®PCR purification Kit Qiagen 
QIA®quick gel extraction Kit Qiagen 
QuickChange Stratagene 
TaqManMicroRNA Assay Applied Biosystems 
Universal Probe Library Roche 
ViraBind Adenovirus Miniprep Kit Cell Biolabs Inc. 
2.1.4 Solutions 
Standard Solutions  Composition  
20x SSC  
3M NaCl  
0.3 M Sodium citrate, pH=7.0  
10x PBS  
137 mM NaCl  
27 mM KCl  
100 mM NaH2PO4  
17 mM KH2PO4  
dissolve in ddH2O  
5x Loading buffer  
100 mM EDTA  
30% (v/v) Glycerine  
0.25% (w/v) Bromophenolblue  
dissolve in ddH2O  
10x TE 
100 mM Tris/HCl pH 8.0 
10 mM EDTA, pH=8.0 
5x TBE  
0.445 M Tris-Borat, pH=8.0  
10 mM EDTA, pH=8.0  
20% SDS  
20% SDS (w/v)  
dissolve in ddH20  
 
 
Western blot solutions  Composition  
RIPA buffer 
20 mM Tris-HCl, pH 7.5 
250 mM NaCl 
10 mM MgCl2  
1% NP-40 
0.1% SDS 
0.5% Na-desoxycholate 
1 mM DTT 
complete protease inhibitor cocktail tablet 
(Roche)/50 ml 
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4x SDS sample buffer  
200 mM Tris/HCl pH=6.8  
8% w/v SDS  
4% Glycerol  
0.1% w/v Bromphenol blue  
10% v/v ß-Mercaptoethanol  
5x SDS-PAGE running buffer  
25 mM Tris-Base  
200 mM Glycine  
10% (w/v) SDS  
ddH2O  
1x Western blot buffer  
25 mM Tris-Base  
192 mM Glycin  
20% v/v Methanol  
pH=8.4 
1x TBS-T 
20 mM Tris-Base  
137 mM NaCl  
3.8 ml 1M HCl  
0.1% (v/v) Tween 20  
dissolve in 1l ddH20  
APS  10% APS w/v in ddH20  
2.1.5 Vectors 
For the generation of most expression constructs the Gateway system (Invitrogen) 
was used. Therefore the expression plasmids first had to be converted into gateway 
destination vectors via ligation of the gateway cassette behind the respective 
promoter. The open reading frame of the gene of interest was PCR amplified and 
cloned into one of the so-called entry-plasmids (pENTR11, pENTR-D Topo, pCR8-
GW), which contain a gateway cloning cassette. For some applications a myc- or 
eGFP-tag was added to the cloning cassette. Point mutations were introduced into 
the gene of interest via site-directed mutagenesis with the Quickchange kit 
(Stratagene) (section 2.2.1.3). Finally, recombination reactions from the entry-
plasmids into expression plasmids were performed with the LR clonase kit 
(Invitrogen) (section 2.2.1.8). 
2.1.5.1 Entry-plasmids 
Table 1: Entry-plasmids for LR reactions into expression plasmids. 
Entry plasmid Insert Tag 
pENTR11 Eri1 wildtype myc, eGFP 
pENTR11 Eri1 A176D myc, eGFP 
pENTR11 Eri1 R101A myc, eGFP 
pENTR11 Eri1 K107A K108A myc, eGFP 
pENTR11 Eri1 D130G E132G myc, eGFP 
pENTR11 Eri1 N96A K107A myc, eGFP 
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pENTR11 Eri1 delta N myc, eGFP 
pENTR11 Eri1 SAP only myc, eGFP 
pENTR11 attL sites without ccdb gene no tag 
pCR8 GW-TOPO eGFP no tag 
pENTR-D Topo pri-miR-196a no tag 
pENTR-D Topo pri-miR-150 no tag 
pENTR-D Topo Hoxc8 3’ UTR no tag 
pENTR-D Topo 
Hoxc8 3’ UTR/miR-196a 
sites mutated 
no tag 
 
Mouse Eri1 cDNA (NM_026067) was PCR amplified from IMAGE clone 5354985. 
The primers for site-directed mutagenesis are listed in section 2.1.6 and the point 
and deletion mutants are shown in figure 2-1. 
N-ter C-ter SAP 3`exo 
72 106 126 302 345 1 
Eri1 point mutants: 
Eri1 deletion mutant: 
delta N 
Fig 9 
 
Figure 9: Schematic depiction of the structure of Eri1 and the employed point and deletion mutants. 
 
The pri-miRNAs, pri-miR-196a and pri-miR-150, have been amplified from mouse 
genomic DNA (C57BL/6 mouse strain) with the primers listed in section 2.1.6, to get 
a 702 bp fragment in the case of miR-196a and a 725 bp fragment in the case of 
miR-150. 
 
Hoxc8 3’ UTR was also amplified from mouse genomic DNA (C57BL/6 mouse 
strain). For the Hoxc8 3’ UTR/miR-196a sites mutated construct, all four conserved 
miR-196a binding site sequences have been mutated (actaCCt>actaAAt) within the 
seed sequence. Primers for the amplification and the four site-directed mutagenesis 
reactions are listed in section 2.1.6. 
2.1.5.2 Expression plasmids 
pMSCV-puro and pLNCX2 are retroviral expression plasmids from Clontech, that 
were converted into gateway destination vectors via ligation of the gateway cassette. 
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Recombination reactions of Eri1 wildtype, point and deletion mutants as well as 
control sequences were performed into the pMSCV-puro, pLNCX2 and pDest12.2 
(Invitrogen) using the LR clonase kit. 
 
The adenoviral pCAGAdDu plasmid was constructed by insertion of a gateway 
cassette, an internal ribosome entry site (IRES), the open reading frame of green 
fluorescent protein (GFP) and the bovine growth hormone polyadenylation 
sequences in the context of a CMV early enhancer and chicken beta-actin (CAG) 
promoter. The sequences for Eri1 wildtype, Eri1 D130G E132G, pri-miR-196a and 
pri-miR-150 were inserted by LR reaction. 
2.1.5.3 Plasmids for dual luciferase assay 
The pAdpsiCHECK2 adenoviral plasmid for the dual luciferase activity assays was 
cloned based on the psiCHECK2 dual luciferase construct (Promega), in the context 
of an adenoviral backbone of pAd-Pl (Invitrogen). A gateway cassette was placed 
between the renilla luciferase open reading frame and the polyadenylation signal. 
The sequences for Hoxc8 3’ UTR or Hoxc8 3’ UTR/miR-196a sites mutated 
(actaCCt>actaAAt) were inserted by LR reaction. For the control reporter the 
gateway cassette was deleted. 
2.1.5.4 Plasmids for knockdown experiments 
For knockdown experiments a mouse Eri1 specific sequence (si6: 
ggatggatgtgaacttcga) was cloned into the pSUPER-puro retroviral vector from R. 
Agami (The Netherlands Cancer Institute, Amsterdam, The Netherlands) 
(Brummelkamp et al., 2002). For the control vector a scrambled DNA sequence was 
cloned. 
2.1.5.5 Additional constructs 
The large T-plasmid for the immortalization of MEF cells was kindly provided by W. 
Hammerschmidt (HelmholtzZentrum München, Germany). 
 
For the production of retroviruses, amphotropic packaging plasmids were co-
transfected with the respective expression plasmids.  
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2.1.6 Oligonucleotides 
Table 2: Oligonucleotides, synthesized by the company METABION. 
Labeling Sequence (5’-3’) Application 
MEXO A gggtggtatatcctcagttacttttg 
MEXO B gccataaccttgaacctgca 
MEXO C gcaacccgaggtaaaaggag 
Mouse genotyping of the 
Eri1 fl/fl allele 
del Cre for gaaagtcgagtaggcgtgtacg 
del Cre rev cgcataaccagtgaaacagcat 
Mouse genotyping of the 
deleter Cre allele 
eGFP NcoI for gagaccatggtgagcaagggcgagg 
eGFP SalI rev2 gagagtcgaccccttgtacagctcgtccatg 
eGFP STOP rev ttacttgtacagctcgtccatg 
eGFP tag/ eGFP control 
rfa XhoI for tgcctcgagatcacaagtttgtacaaaaaagc 
rfa PmeI rev tgcgtttaaacatcaccactttgtacaagaaagc 
Introduce gateway 
cassette into pAdpL  
BglII-ClaI-BglII oligo gatccatcgatg 
ClaI site linker to clone 
pSiCHECK2 into pAdpL 
Test-LR 
pAdpSiCHECK2 for 
cgtgctgaagaacgagcagt 
Sequence insert in 
pAdpSiCHECK2 
M13 for tgtaaaacgacggccagt 
M13 rev caggaaacagctatgacc 
Sequence insert of a 
Gateway plasmid 
mExo aa 101 for 
gtcaaggatgttctaaagaaggcactgaaaaact
attacaagaagc 
mExo aa 101 rev 
gcttcttgtaatactttttcagtgccttctttagaacatc
cttgac 
Quick change 
Eri1 R101A 
mExo aa 107/8 for 
aaactattacgcggcgcagaagttgatgctgaaa
gagagctccgc 
mExo aa 107/8 rev 
gcggagctctctttcagcatcaacttctgcgccgcg
taatagttt 
Quick change 
Eri1 K107A K108A 
 
mExo aa 176 for ggccagaagtcaatgatcagctttcagagttatgc 
mExo aa 176 rev gcagaactctgaaagctgatcattgacttctggcc 
Quick change 
Eri1 A176D 
Hoxc8UTR for caccaaaagagagagaaaatcagccc 
Hoxc8UTR rev aattcttttttttttattatgactcacg 
PCR on mouse gDNA to 
clone the Hoxc8 UTR 
Hoxc8-mut196asite1 
for 
gacactcacaactctaactaaatgtcagatagttgc
agctctg 
Hoxc8-mut196asite1 
rev 
cagagctgcaactatctgacatttagttagagttgtg
agtgtc 
Quick change on Hoxc8 
UTR to mutate miR-196a 
binding site 1 
Hoxc8-mut196asite2 
for 
ataaatctttaacatactaaataaagggaacctgc
aataatcttggggg 
Hoxc8-mut196asite2 
rev 
cccccaagattattgcaggttccctttatttagtatgtt
aaagatttat 
Quick change on Hoxc8 
UTR to mutate miR-196a 
binding site 2 
Hoxc8-mut196asite3 
for 
cctccagcgtattttatcactaaatatagaaagaaa
tcctgctttgag 
Hoxc8-mut196asite3 
rev 
ctcaaagcaggatttctttctatatttagtgataaaat
acgctggagg 
Quick change on Hoxc8 
UTR to mutate miR-196a 
binding site 3 
Hoxc8-mut196asite4 
for 
cccaacaactgagactgaatagcccgccggtct 
Hoxc8-mut196asite4 
rev 
agaccggcgggctattcagtctcagttgttggg 
Quick change on Hoxc8 
UTR to mutate miR-196a 
binding site 4 
Pri-miR-196a for cacctgctgagaggccaagtaggt PCR on mouse gDNA to 
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Pri-miR-196a rev cctacaacccaaaggcttga clone pri-miR-196a 
Pri-miR-150 for caccaggggaagtgctaggct 
Pri-miR-150 rev gttggagtgatgggaacacc 
PCR on mouse gDNA to 
clone pri-miR-150 
RT-PCR 5ETS for gagaggtgtcggagagctgt 
RT-PCR 5ETS rev ggcggagagcctcgcg 
(Semi-) quantitative PCR 
for mouse rRNA 
RT-PCR 18S for cgctgagaagacggtcgaac 
RT-PCR 18S rev cacctcgctccacacgcg 
(Semi-) quantitative PCR 
for mouse rRNA 
RT-PCR 5.8S for gtggatcactcggctcgt 
RT-PCR 5.8S rev agtgcgttcgaagtgtcgat 
(Semi-) quantitative PCR 
for mouse rRNA 
RT-PCR ITS-2 for ggagagcgagggcgagaac 
RT-PCR ITS-2 rev gggtgaaggagaagcggagac 
(Semi-) quantitative PCR 
for mouse rRNA 
RT-PCR 28S for cggctgggcgcgtgtc 
RT-PCR 28S rev gttcactcgccgttactgagg 
(Semi-) quantitative PCR 
for mouse rRNA 
RT-PCR 3ETS for gtgtgggagcctcgtgcc 
RT-PCR 3ETS rev gatcccaccgtcggtcacc 
(Semi-) quantitative PCR 
for mouse rRNA 
RT-PCR out 3ETS for ggcgggctcactctggac 
RT-PCR out 3ETS rev gacatctggtcgacctctgcg 
(Semi-) quantitative PCR 
for mouse rRNA 
RT-PCR 5S for gtctacggccataccaccctg 
RT-PCR 5S rev gcctacagcacccggtattcc 
(Semi-) quantitative PCR 
for mouse rRNA 
h5ETS for5 gttcgtgtgtgggttgactt 
h5ETS rev5 gcggtacgaggaaacacct 
(Semi-) quantitative PCR 
for human rRNA 
h18S for 1 aaacggctaccacatccaag 
h18S rev 1a cctccaatggatcctcgtta 
(Semi-) quantitative PCR 
for human rRNA 
hITS-1 for cgggtgggggctttac 
hITS-1 rev gtcggaaggtttcacaccac 
(Semi-) quantitative PCR 
for human rRNA 
h5.8S for2 gactcttagcggtggatcactc 
h5.8S rev2 gacgctcagacaggcgtag 
(Semi-) quantitative PCR 
for human rRNA 
h28S for tcagcggaggaaaagaaact 
h28S rev gcctcgatcagaaggacttg 
(Semi-) quantitative PCR 
for human rRNA 
h3ETS for2 ccttctcggctcttgagact 
h3ETS rev2 gcagacgccggctaagt 
(Semi-) quantitative PCR 
for human rRNA 
qmExos cggctcagcagactcaaaca 
qmExoas ggccgtccatcataatccat 
Light cycler qPCR 
Hist2h4 for ccagctggtgtttcagattaca 
Hist2h4 rev acccttgcctagaccctttc 
Light cycler qPCR with 
probe #6  (UPL) 
UPL-Hoxc8 for catgcccagcatacactctc 
UPL-Hoxc8 rev atagggattaaataggaactccttctc 
Light cycler qPCR with 
probe #15 (UPL) 
UPL-Hoxb8 for cagctctttccctggatgc 
UPL-Hoxb8 rev atagggattaaataggaactccttctc 
Light cycler qPCR with 
probe #1 (UPL) 
UPL-2 pri-miR196a for gcggacctctgttaggaaaa 
UPL-2 pri-miR196a rev gctaaaatggccacgcaat 
Light cycler qPCR with 
probe #6 (UPL) 
PBGD F cagtgatgaaagatgggcaac 
PBGD R aacagggacctggatggtg 
Light cycler qPCR with 
probe #22 (UPL) 
HPRT1 F tgatagatccattcctatgactgtaga 
HPRT1 R aagacattctttccagttaaagttgag 
Light cycler qPCR with 
probe #95  (UPL) 
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2.1.7 Antibodies 
Antibody Company 
Monoclonal anti-Eri1 (5G8-111, 5G8-112) HMGU monoclonal antibody facility 
Polyclonal anti-Eri1 (A28) Millbrook 
Monoclonal anti-Hoxc8 (C952-12E) Covance 
Polyclonal anti-GFP (A11122) Invitrogen 
Monoclonal anti-c-Myc (9E10) Abcam 
Monoclonal anti-alpha tubulin (5-B-1-2) Santa Cruz Biotechnology 
Monoclonal anti-rat IgG1 (Tib-170) HMGU monoclonal antibody facility 
2.1.8 Cell culture 
2.1.8.1 Cell medium 
Medium and Additive Company 
Dulbecco's Modified Eagle Medium (DMEM) Gibco, Invitrogen 
Fetal Calf Serum (FCS) BioWhittaker, Lonza 
HEPES (1 M) Gibco, Invitrogen 
PenStrep (10 000 U/ml) Gibco, Invitrogen 
2.1.8.2 Cell lines 
The human embryonic kidney cell lines (HEK293A and HEK293gag/pol) were 
purchased from ATCC as well as the human lung adenocarcinoma epithelial cell line 
(A549). 
 
Primary or immortalized mouse embryonic fibroblast cells (MEF cells) were produced 
from NMRI x C57BL/6 wildtype and Eri1-knockout embryos or C57BL/6 wildtype and 
Dicerfl/fl embryos, respectively (section 2.2.5).  
2.1.9 Mice 
BALB/c, NMRI and C57BL/6 mice were obtained from Taconic or Jackson 
Laboratories. C57BL/6 Eri1fl/fl (the exon 3 of the Eri1 gene is flanked by LoxP sites, 
‘floxed’) mice were bred with CMV-Cre transgenic mice (6.C-Tg(CMV-cre)1Cgn) to 
obtain C57BL/6 Eri1fl/fl x del Cre mice for the generation of Eri1-knockout mice. 
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2.1.10 Instruments 
Device Official name and Company 
Accuracy weighing 
machine 
KERN ABJ-220-4M (Kern und Söhne GmbH) 
KERN EW 220-3NM (Kern und Söhne GmbH) 
Agarose gel chambers Peqlab Biotechnologie GmbH 
Bacterial incubator 
Brutschrank BINDER BF 53 (Binder Labortechnik) 
Innova 4400 incubator shaker (New Brunswick Scientific GmbH) 
Blotting chamber BioRad 
Centrifuges 
and 
Rotors 
Beckman Coulter Avanti-J-26XP (Beckman Coulter) 
JS-7.5 Swinging-Bucket Rotor (Beckman Coulter) 
JA-10 Rotor, Fixed Angle (Beckman Coulter) 
Allegra®X-12R Centrifuge (Beckman Coulter) 
Rotor FX 6100 (Beckman Coulter) 
Rotor SX 4750 (Beckman Coulter) 
CO2 incubator 
Forma Direct Heat CO2 Incubator HEPA Class 100 
(Thermo Electron Corporation) 
Coasting mixer Tube Roller-Mixers, SRT1 (Stuart) (ScienceLab) 
Confocal microscope Type: 301-185.104-000 Order-No: 500277 (Leica) 
Energy supplier 
Stromgeber EC105 (Thermo Electron Corporation) 
BioRad energy supplier (BioRad) 
FACS machine BD FACS Calibur Flow Cytometer (BD Biosciences) 
Fluorescence 
microscope 
Axiovert 200M (Zeiss) 
Gel documentation (Peqlab Biotechnologie GmbH) 
Ice machine Scotsman AF 200 (Scotsman Icesystem) 
Luminometer Orion Microplate Luminometer, Berthold Detection systems 
Magnet stirrer  RCT basic safety control (IKA) 
Microscope Axiovert 40C (Zeiss) 
Microwave Bosch 
pH meter 
pH-Meter inoLab® pH 720 
(Wissenschaftlich Technische Werkstätten) 
Protein gel chamber BioRad 
Spectro photometer 
Eppendorf BioPhotometers (Eppendorf) 
Thermo Scientific NanoDropTM 1000 Spectrophotometer 
(Thermo Fisher Scientific Inc.) 
Sterile-working bench  BDK, Luft und Reinraumtechnik 
Table centrifuge 
Centrifuge 5415D (Eppendorf) 
Centrifuge 5417R (Eppendorf) 
Thermo cycler 
Biometra TGradient Thermal Cycler 96 (Biometra) 
DNA Engine 48/48 Dual Alpha Unit With Two Heated Lids 
(BioRad) 
Light Cycler 480II (Roche) 
Thermo mixer 
Thermomixer compact (Eppendorf) 
Thermomixer comfort (Eppendorf) 
UV-lamp Transilluminator model.  TS-40 (Ultra-Violet Products Ltd.) 
Vortexer Vortex Genius 3 (IKA) 
Waterbath WB7 (Memmert) 
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2.2 Methods 
2.2.1 Molecular biological standard methods 
2.2.1.1 Bacterial culture 
Chemical competent E. coli DH5alpha bacteria (Invitrogen) were used to amplify 
plasmid DNA. The transfer of plasmids into bacteria requires that the cell membrane 
is permeable for the plasmids, which is achieved by a short time heat incubation at 
42°C. 50 µl of E.coli bacteria were thawed on ice, mixed with the plasmid DNA and 
incubated for 30 min on ice. For the plasmid uptake, the bacteria were placed into a 
42°C waterbath for 45 s and briefly equilibrated on ice. 250 µl of LB medium was 
added and cells were incubated for 1 h at 37°C while shaking (600 rpm). The 
suspension was plated onto LB-agar plates containing the respective antibiotic. LB 
plates were incubated over night at 37°C. Single colonies were selected for 
downstream applications. For storage, single colonies were scraped off the LB agar 
plates and a fresh overnight bacterial culture was stored at -80°C, mixed at an 1:1 
ratio with glycerol. LB media and LB agar were prepared with ‘ready to mix’-powder 
(SERVA), supplemented with ampicillin (100 µg/ml), spectinomycin (50 µg/ml) or 
kanamycin (30 µg/ml) for selection of bacterial resistance. 
2.2.1.2 PCR reaction 
Cyclic reaction series of denaturation, reannealing of forward and reverse primer and 
polymerization with a thermostable DNA polymerase allow the in vitro amplification of 
DNA (Saiki et al., 1988). A standard PCR reaction, e. g. for the genotyping of mice, 
contained: 150 ng DNA template, 0.5 µl of 100 pmol/µl forward primer, 0.5 µl of 100 
pmol/µl reverse primer, 1 µl dNTP-mix (5 mM each), 2.5 µl 10x PCR Rxn Buffer, 1 µl 
50 mM MgCl2 and 0.5 µl (5 Units) Taq DNA polymerase (Invitrogen). The mixture 
was filled up with ddH20 to a volume of 25 µl. Cycling reactions were: 95°C for 3 min; 
31 cycles of 95°C for 15s, 58°C for 30s, 72°C for 60 s, 72° for 10 min, hold at 4°C. A 
minimum of 15 µl of the PCR reaction was analyzed on an agarose gel. 
2.2.1.3 Site-directed mutagenesis 
In vitro site-directed mutagenesis is a technique for studying protein structure-
function relationships. The Quik Change site-directed mutagenesis kit (Stratagene) is 
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used to make point mutations, switch amino acids, and delete or insert single or 
multiple amino acids. The basic procedure utilizes a dsDNA vector with the insert of 
interest and two synthetic oligonucleotide primers containing the desired mutation. 
The Quik Change primers, listed in section 2.1.6, were chosen according to the 
manufacturer’s protocol. The reaction mix was prepared and the oligonucleotide 
primers extended during temperature cycling by PfuTurbo DNA polymerase. After 
amplification, the PCR product was DpnI digested for one hour to degrade the 
methylated and hemimethylated parental template. Then 5 µl of the PCR product 
were transformed into competent DH5alpha bacteria. One of the resulting colonies 
was selected for sequencing. 
2.2.1.4 Vector restriction enzyme digests 
Digests were carried out in 20 µl volume with a DNA content of 1 µg for 1 h with 5 U 
of each enzyme. For digestions over night, a minimum volume of at least 50 µl is 
recommended. For digests of the pCAGAdDU adenoviral vector, 20 µg vector were 
digested over night at 37°C using 30 U of the restriction endonuclease PacI. 
2.2.1.5 PCR purification and gel extraction 
PCR product purification was performed using the QIAquick PCR Purification Kit 
according to the manufacturer’s protocol (Qiagen). In cloning approaches, the 
restriction digested vector was separated in a 1% agarose gel containing ethidium 
bromide. Under 254 UV nm light, vector and insert bands were carefully cutted out 
and extracted from the agarose gel using the QIAquick Gel Extraction Kit according 
to the manufacturer’s protocol (Qiagen). 
2.2.1.6 Annealing of oligonucleotides 
To obtain a double stranded DNA oligonucleotide linker for the conversion of a Bgl II 
restriction site into a Cla I restriction site in the psiCHECK2 vector, sense and 
antisense oligonucleotides were annealed. The oligonucleotides were dissolved in 
nuclease free water to a concentration of 100 pmol/µl. For annealing of the 
oligonucleotides, 25 µl of each oligonucleotide were added to 150 µl annealing buffer 
(50 mM Tris pH 8.0, 70 mM NaCl), and incubated 15 min at 95°C, then slowly cooled 
down to 4°C reducing the temperature every 30 s by 0.5°C in a PCR machine.  
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2.2.1.7 Ligation of DNA fragments 
For the ligation of the digested vector with an insert, the fragments were incubated 
with T4 DNA ligase (New England Biolabs) at RT for 1 h according to the 
manufacturer’s protocol. For the ligation of plasmids with more than 20 kb, the 
reaction was done at 16°C overnight. 
2.2.1.8 Lambda recombination reaction 
Gateway is a universal cloning technique based on the site-specific recombination 
properties of bacteriophage lambda. The Gateway LR Clonase enzyme mix contains 
a proprietary blend of Int (Integrase), IHF (Integration Host Factor) and Xis 
(Excisionase) enzymes that catalyze the in vitro recombination between an entry-
plasmid (containing a gene of interest flanked by attL sites) and a destination vector 
(containing attR sites) to generate a new expression plasmid. Only destination 
vectors that have recombined are selected. This is ensured by differences in 
antibiotic resistance between the destination and the entry vector and the expression 
of a death gene (ccdB) in clones that have not recombined. LR reactions were 
carried out according to the manufacturer´s protocol, using 150 ng entry-plasmid and 
150 ng destination vector. 
2.2.1.9 Trizol RNA extraction 
RNA was extracted from cells, immunoprecipitation samples, or embryos by mixing 
with 1 ml of Trizol (Invitrogen) according to the manufacturer’s protocol. Shortly, the 
contents were mixed with 200 µl chloroform and incubated at RT for 2 min. The 
organic and aqueous phases were separated by centrifugation at 12,000g for 15 min 
at 4°C. The aqueous phase was collected and subjected to isopropanol precipitation 
in the presence of 1 µl glycoblue-carrier (Ambion) for 10 min at RT. RNA precipitates 
were collected by centrifugation at 12,000g for 10 min at 4°C, washed with 75% 
ethanol, air-dried and resuspended in 20 µl RNase-free water. 
2.2.1.10 Reverse transcriptase reaction 
Genomic DNA elimination and reverse transcription of RNA was done according to 
the QuantiTect Reverse Transcription Kit (Qiagen). 1 µg Trizol-purified RNA was 
incubated in gDNA ‘wipeout buffer’ at 42°C for 2 min. For the reverse transcription a 
mix prepared from Quantiscript Reverse Transcriptase, Quantiscript RT Buffer, and 
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3 µg Random Primers (Invitrogen) was used. The entire reaction took place at 42°C 
for 15-20 min and was then inactivated by incubation at 95°C for 3 min.  
2.2.1.11 Acrylamide-Urea RNA gels 
RNA was extracted using Trizol reagent (Invitrogen) and resuspended in RNase free 
water (section 2.2.1.9). 5 µg RNA were vacuum dried and resuspended in 2x loading 
buffer (RNA Loading Buffer PA, BioDynamics Laboratory Inc.). Samples were 
separated on 7% acrylamide, 8 M urea gels (24.04 g Urea, 11.8 ml 30% acrylamide, 
5 ml 10x TBE, 25 µl TEMED, 250 µl 10% APS, a.d. 50 ml with water) in 1x TBE 
buffer and visualized by ethidium bromide staining. 
2.2.2 Breeding and genotyping of mice 
BALB/c, NMRI and C57BL/6 mice were housed in a specific pathogen-free barrier 
facility. For genotyping the tip of the mouse tail was lysed in 200 µl genotyping buffer 
(100 mM Tris-HCl, pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 0.2 mg/ml 
proteinase K) by incubation overnight at 800 rpm at 55°C. The Proteinase K was 
heat-inactivated at 95°C for 15 min the next day. 300 µl of water were added and 
0.4 µl were used as template for the genotyping-PCR (section 2.2.1.2). To genotype 
embryos, the yolk sac was lysed in 100 µl genotyping buffer and 0.4 µl of undiluted 
sample were taken for PCR amplification. 
2.2.3 Preparation of embryos 
For the preparation of embryos, breeding pairs were caged together in the late 
afternoon and the females were examined for the presence of vaginal plug on the 
following morning, which was defined as 0.5 day post coitum (dpc). Pregnant females 
were sacrified at the required gestational stages and embryos were dissected free of 
maternal and extraembryonic tissue in PBS. Embryo genotypes were determined by 
PCR (section 2.2.2).  
2.2.4 Generation of mouse embryonic fibroblasts 
For cell culture experiments, mouse embryonic fibroblasts (MEF) were generated 
from Eri1-knockout, Eri1-heterozygous, wildtype and Eri1fl/fl  (the exon 3 of the Eri1 
gene is flanked by LoxP sites, ‘floxed’) embryos at 12.5 dpc or 13.5 dpc. The trunk of 
the embryos excluding the head was sliced into very small pieces, incubated with 
Material and methods 
 
 33 
trypsin for 2 min and then cultivated in normal MEF cell medium (section 2.2.5). Cells 
were directly taken into experiments where primary MEF cells were required, i.e. the 
cell screen experiment. For other experiments, the cells were immortalized via 
ecotropic retroviral infection with an SV40 large T antigen plasmid followed by 
hygromycin selection at 100 µg/ml for two weeks. These MEF cells could then be 
expanded in cell culture and be infected with retroviruses and adenoviruses. 
2.2.5 Cell culture 
HEK293 cells and MEF cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM). The medium was supplemented with 10% fetal calf serum (FCS), 10 mM 
HEPES and 100 mg/ml penicillin/streptomycin. Cells were cultured at 37°C in a 5% 
CO2 humidified incubator. Stocks from cell lines were stored in liquid nitrogen in a 
mixture of 90% FCS and 10% DMSO in NUNC-freezing tubes. The cells were first 
placed into a -80°C freezer to slowly cool down. The next day, the cells were 
transferred into a liquid nitrogen container for long-time storage. 
2.2.6 Transfection of cells 
HEK293A or HEK293gag/pol cells were split to about 60-80% confluency at least 6 
hours prior to transfection. For one cell culture dish (92 x 17 mm) a mixture of 10 µg 
virus construct and 50 µl cold 2 M CaCl2 was filled up with sterile water to 500 µl total 
volume and then added drop-wise to 500 µl 2 x HBS (For 500 ml: 8.0 g NaCl, 6.5 g 
HEPES, 10 ml Na2HPO4 (Na2HPO4 stock solution: 5.25 g Na2HPO4 in 500 ml water), 
pH 7.0) on a vortexer. For retrovirus production amphotropic packaging vectors (1 µg 
ampho-env construct and 1 µg gag/pol construct) were added to the transfection 
mixture. After 15 min incubation time at RT the co-precipitates of DNA and calcium 
phosphate were added to the HEK293 cells. The next day the medium was replaced 
with fresh medium. Transfected cells were analyzed or kept in culture if used for 
adenovirus- or retrovirus-production.   
2.2.7 Infection of cells with adeno- and retroviruses 
Type 5 replication-deficient adenoviruses were produced from PacI-digested 
adenoviral vectors. The vectors were transfected into HEK293A cells using the 
calcium phosphate method (section 2.2.6). In a second round of infection the viruses 
were amplified in HEK293A cells and viral stocks were purified using mini columns 
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according to the manufacturer’s instructions (Cell Biolabs). Titers were determined in 
A549 cells by FACS approximately 40 h after infection. MEF cells were infected with 
adenoviruses at a multiplicity of infection (MOI) of 10-1000. Importantly, an MOI of 50 
of the pCAGAdDU-virus was needed to reconstitute MEF cells to about endogenous 
levels of Eri1 expression. 
 
Retroviral supernatants were produced by calcium phosphate transfection of 
amphotropic packaging vectors and retroviral expression vectors in HEK293gag/pol 
cells. Supernatants were collected 48-72 h post transfection, passed through 0.45 
µm filters, mixed with polybrene at a final concentration of 5 µg/ml and added to the 
MEF cells. The medium was replaced the next day and infected MEF cells were 
analyzed two or three days after.  
2.2.8 Flow cytometry analysis  
Flow cytometry (FCM) analysis is a method that can be used for measuring the 
number of virus-infected cells in a cell sample and the level of infection. Therefore a 
fluorescent marker, i.e. GFP, is co-expressed with the gene of interest either as a tag 
or after an IRES sequence. For FCM infected MEF or A549 cells were scraped off 
the plates and analyzed in a 1:4 dilution of trypsin in PBS. FCM was performed on a 
FACS Calibur device (Becton Dickinson) and raw data were analyzed with Flow Jo 
(Treestar) software. 
2.2.9 Hydroxyurea treatment of cells 
Hydroxyurea (HU) is used for cell cycle related studies, because it is a potent 
inhibitor of DNA synthesis and depletes the cellular deoxyribonucleotide pool through 
inhibition of ribonucleotide reductase. Through this pharmacological treatment the 
situation in the cell at the end of S-phase is simulated. MEF cells were incubated for 
45 min in DMEM supplied with 5 mM Hydroxyurea (1 M Hydroxyurea stock solution: 
0.76 g Hydroxyurea, 10 ml PBS). After the HU-treatment, the cells were directly 
harvested in 1 ml Trizol for RNA extraction, followed by the analysis on an 
acrylamide-urea gel (section 2.2.1.11) and qRT-PCR (section 2.2.19.1). 
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2.2.10 Measurement of cell growth 
MEF cells from wildtype and Eri1-knockout embryos at 13.5 dpc were taken into 
culture (section 2.2.3, 2.2.4) to measure the doubling time. The primary MEF cells 
were seeded in 96 well plates, 5000 cells in 200 µl DMEM. The Cellscreen 
(Innovatis) was used according to the manufacturer’s instructions to take pictures of 
exactly the same cells and their progeny over a culture period of 24 h or 48 h, 
respectively. Percentages of the surface area covered with cells were determined by 
automated analysis of each picture using the PA adhesion software (Innovatis). At 
least eight replicates of each culture were used to calculate the cell-doubling time. 
2.2.11 Confocal microscopy 
Cells were transfected and split the next day to seed 3x 105 cells on a glass cover 
slip. The day after, the cells were fixed with 4% PFA for 20 min at RT with agitation, 
washed three times for 5 min each in wash buffer WB (PBS + 0.5% Nonidet P-40, 
0,01% NaN3) and blocked by incubation in WB/FCS (WB,10% FCS) for 30 min at RT. 
Staining was performed by incubation with the primary Pes1 antibody in WB/FCS 
(1:10 dilution) for 1h at RT. After three washing steps, the cells were stained with the 
secondary Cy5 antibody in WB/FCS (1:200 dilution) for 45 min at RT. Finally, after 
two more washing steps, the cells were stained for 1 min in DAPI solution (15 µg 
DAPI (Sigma D8417)/100 ml 2xSSC buffer) and then put in PBS/0.01% NaN3 before 
mounting. 
2.2.12 Western blot analysis 
For SDS-PAGE, gel solutions with 8-12% acrylamide in the resolving part and 5% in 
the stacking part were prepared. 30% ammonium persulphate (APS) and 0.001% 
N,N,N’,N’-tetramethylethylendiamine (TEMED) were added to the gel solution to 
induce polymerization. MEF cells or embryo parts were washed in PBS and lysed in 
20-300 µl RIPA-buffer. Lysates were incubated for 30 min on ice and then 
centrifuged at 14,000g, 4°C for 15 min. Protein samples were boiled in 4x SDS 
sample buffer for 5 min at 95°C and subsequently loaded into the slots of the gel. In 
addition, a protein size maker (Precision Plus Protein All Blue Standards, Biorad) 
was loaded into one slot of the gel. Electrophoresis was applied for 50 minutes at 
130 V. The electrophoretic transfer of polypeptides from polyacrylamide (PAA) gel to 
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a polyvinylidene fluoride (PVDF) membrane was performed by using a wet gel 
transfer apparatus (Biorad). The PVDF membrane was briefly activated in 100% 
methanol and soaked for 5 min in Western blot buffer (25 mM Tris-Base, 192 mM 
glycine, 20% v/v methanol) for 10 min. The PAA gels were carefully removed from 
the electrophoresis chamber and the Western blot ‘sandwich’ was assembled. The 
transfer was carried out for 2 h at 100 V and 250 mA in ice-cold buffer. For protein 
detection with antibodies, the membranes containing the separated polypeptides 
were blocked in TBS/5% milk for 1 h at RT. After blocking, the membrane was 
washed with TBS/0.05% Tween (3 x 5 min) and the diluted primary antibody was 
added 1 h at RT or over night at 4°C. After washing (3 x 5 min) the membrane was 
incubated with the secondary antibody conjugated with horse radish peroxidase 
(HRP) for 1 h at RT. While washing (3 x 10 min) the membrane, the ECL 
chemiluminescent substrate was prepared (ECL Western Blot Detection Kit). 
Following incubation of the membrane with the ECL solution for 5 min at RT, the 
solution was drained off. The membrane was placed in a plastic foil to prevent drying 
and then placed in a dark developing cassette and exposed to an ECL film. The 
exposure time of the film was between 2 s and 2 h. 
2.2.13 Immunohistochemistry stain on embryos 
For immunohistochemistry (IHC) stains embryos were taken from pregnant females 
at 11.5 dpc or 12.5 dpc (section 2.2.3). The embryos were washed in PBS, then fixed 
in 4% neutral buffered formalin or 4% buffered paraformaldehyd for 24 h, embedded 
in paraffin and 1 µm serial slides were cut for immunohistochemistry. Eri1-
immunohistochemistry was performed using the discovery immunohistochemistry 
autostainer (Discovery®XT Instrument, Ventana medical systems, Illkirch CEDEX, 
France) and affinity-purified rabbit anti mouse Eri1-antibodies (A28), which were 
diluted 1:100. Image capturing was done using the dotslide virtual microscopy 
system (2.0; Olympus GmbH, Hamburg, Germany). 
2.2.14 Whole mount in situ hybridization of embryos 
Embryos were obtained from timed pregnancies (section 2.2.3), dissected in 
phosphate buffered saline (PBS) and fixed in 4% paraformaldehyde (PFA) in PBS at 
4°C overnight.  In situ hybridizations were performed as previously described 
(Kloosterman et al., 2006; Sweetman et al., 2008). All embryos were stained using 
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BM Purple (Roche) according to the manufacturer’s instructions. The double DIG 
labeled probe for miR-196a was purchased directly from Exiqon. The in situ 
hybridizations were performed using an Intavis In Situ Pro robot. The pictures of 
embryos from whole mount in situ hybridizations were taken using a Leica MZ16F 
microscope and a Leica DFC320 camera.  
2.2.15 Methods employed in German Mouse Clinic  
Table 3: Methods employed in the screen at the German Mouse Clinic. 
Screen Goal Method 
Dysmorphology, 
Bone and Cartilage 
morphological analysis of body, 
skeleton, bone, and cartilage 
morphological observation, bone 
densitometry, X-ray 
Behavior 
locomotion and anxiety-related 
behavior sensory motor gaiting 
open field Acoustic startle & PPI 
Neurology 
assessment of muscle, 
spinocerebellar, sensory, and 
autonomic function 
modified SHIRPA protocol grip 
strength Rotarod 
Eye 
assessment of morphological 
alterations of the eye 
funduscopy laser interference 
biometry slit lamp biomicroscopy 
Nociception 
detection of altered pain 
response 
hot plate assay 
Energy Metabolism 
measurement of altered body 
weight regulation, body 
temperature and energy 
balance 
bomb calorimetry 
Clinical Chemistry 
and Hematology 
determination of clinical- 
chemical and hematological 
parameters in blood 
glucose tolerance 
blood autoanalyzer, ABC-animal 
blood counter  
 
simplified IpGTT 
Steroid Metabolism 
analysis of steroid hormones in 
blood plasma: testosterone and 
DHEA 
ELISA 
Immunology 
analysis of peripheral blood 
samples for immunological 
parameters 
flow cytometry, Multiplex Bead 
Array 
Allergy analysis of total plasma IgE ELISA 
Cardiovascular 
function 
assessment of functional 
cardio-vascular parameters, 
analysis of plasma ANP 
non-invasive tail-cuff blood 
pressure measurement, sur- face 
limb ECG / Echo, heart weight, 
ELISA 
Lung Function 
assessment of alterations in 
breathing patterns 
whole body plethysmography 
(Buxco") 
Molecular 
Phenotyping 
RNA expression profiling DNA-chip technology 
Pathology 
microscopic and macroscopic 
examination 
histology, immunochemistry 
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2.2.16 Skeletal analysis 
2.2.16.1 X-ray and computed tomography (CT) scanner 
For x-ray analysis the Faxitron X-ray Model MX-20 (Specimen Radiography System, 
Illinois, USA) and the NTB Digital X-ray Scanner EZ 40 (NTB GmbH, Diepholz, 
Germany) were used. The anesthetized mouse was fixed on an X-ray-permeable 
plate, placed in the machine and scanned with a voltage of 25 kV and an integration 
time of 40 ms. Using iX-Pect software the image was taken. Analysis was done 
qualitatively by visual inspection of the images as well as quantitatively by using the 
ruler tool of iX-Pect software. For micro-computed tomography (µCT) a VAMP 
Tomoscope 10010 m, version 1.2 (VAMP GmbH, Erlangen, Germany) was used. CT 
images were captured according to the manufacturer’s instructions and reconstructed 
using the ImpactView 3.0 software supplied by the manufacturer. More CT analyses 
were performed with a LaTheta LCT-100A (Bruker) and the corresponding LaTheta 
2.1 Software. Mice were imaged with a 0.2 mm slice thickness. 3D reconstruction 
was performed with the 3D Doctor software.  
2.2.16.2 Skeletal stain 
Skeletal preparations were generated as previously described (Fuchs et al., 
Screening for bone an cartilage phenotypes in mice (2006), In: Standards of mouse 
model phenotyping, 1st edition, Wiley-VCH Verlag GmbH. pp. 35–86). For analysis, 
vertebrae were dissected and photographed with Leica DFC320 and the 
corresponding software for image acquisition. 
2.2.17 Molecular phenotyping of embryos 
Isolation of total RNA 
The 4 wildtype and 4 Eri1-knockout embryo littermates were taken from pregnant 
females at 12.5 dpc (section 2.2.3). The embryos, exclusive heads, were thawed in 
buffer containing chaotropic salt (RLT buffer, Qiagen) and homogenized using a 
Polytron homogenizer. Total RNA from individual samples was obtained according to 
the manufacturer’s protocols using RNeasy Midi kits (Qiagen). The concentration 
was calculated from OD260/280 measurements and 2-µg-RNA aliquots were run on a 
formaldehyde agarose gel to check for RNA integrity. The RNA was stored at -80°C 
in RNase free water (Qiagen). 
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Chip hybridization 
Two chip hybridizations were performed with RNA from each individual mutant 
embryo. Each chip hybridization was performed against a pool of reference RNAs. 
For each individual mutant embryo the chip experiments include a colorflip 
experiment (in total eight hybridizations). 
 
Reverse transcription and fluorescent labeling 
For labeling 15 µg of total RNA were used for reverse transcription and indirectly 
labeled with Cy3 or Cy5 fluorescent dye according to the TIGR protocol (Hegde et 
al., 2000). Labeled cDNA was dissolved in 50 µl hybridization buffer (6x SSC, 0.5% 
SDS, 5x Denhardt’s solution and 50% formamide) and mixed with 50 µl of reference 
cDNA solution (pool from six control animals) labeled with the second dye. This 
hybridization mixture was subjected to a prehybridized microarray in a HS4800 
Hybstation (Tecan) and incubated at 42°C for 16 h. After hybridization slides were 
washed with 3x SSC, 1x SSC, 0.5x SSC and 0.1x SSC at room temperature. Slides 
were dried with nitrogen. Dried slides were scanned with a GenePix 4000A 
microarray scanner and the images were analyzed using the GenePix Pro6.0 image 
processing software (Axon Instruments, USA). 
 
Significance of regulation 
The TIGR software package for Microarray analysis (TM4; Chu et al., 2002, Saeed et 
al., 2003) was used for normalization (MIDAS: Microarray Data Analysis System; 
Quackenbush 2002) and identification of genes with significant differential regulation 
(SAM, Significance Analysis of Microarrays; Tusher et al., 2001). Expression data 
were normalized performing a total intensity normalization to transform the mean log2 
ratio to zero. To eliminate low-quality array elements several filtering methods were 
applied. They include: background checking for both channel with a signal/noise 
threshold of 2.0, one bad tolerance policy parameter and flip dye consistency 
checking (Yang et al., 2002). SAM was used to identify genes with statistically 
significant changes in expression. Genes were ranked according to their relative 
difference value d(i), a score assigned to each gene on the basis of change in gene 
expression levels relative to the standard deviation. Genes with d(i) values greater 
than the threshold were selected as significantly differentially expressed. The 
percentage of such genes identified by chance is the false discovery rate (FDR). To 
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estimate the FDR, nonsense genes were identified by calculating permutations of the 
measurements. The selection of the top differentially expressed genes with 
reproducible up- or down-regulation includes less than 10% false positives (FDR). 
 
Functional classification of regulated genes 
For in silico analysis of differentially expressed genes EASE, a module of the DAVID 
database assigning genes to Gene Ontology (GO) functional categories was 
employed. EASE analysis including a Bonferroni multiplicity correlation evaluated the 
set of differentially expressed genes for over- representation of two categories of GO 
terms: Biological processes and molecular functions (Dennis et al, 2003). 
2.2.18 RNA-immunoprecipitation (RIP) 
In vivo formaldehyde fixation of cells  
Actively dividing mouse embryonic fibroblasts (1.7 x 107 cells) were first washed with 
PBS, treated with trypsin, and then washed twice with PBS. The cells were fixed in 
20 ml 1% formaldehyde/PBS buffer, prepared from a 36.5-38% aqueous solution 
(Sigma), for 10 min at room temperature with rotation. Crosslinking reactions were 
quenched with glycine (pH 7.0) at a final concentration of 0.25 M, followed by 
incubation at room temperature for 5 min with rotation. The cells were harvested by 
centrifugation at 280g for 4 min followed by a PBS wash.  
 
Solubilization of crosslinked complexes by sonication 
Fixed cells were resuspended in 2 ml RIPA buffer (50 mM Tris, pH 7.5, 1% Nonidet 
P-40 (NP-40), 0.5% sodium deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM NaCl) 
containing complete protease inhibitors mix (Roche) and 1 mM dithiothreitol (DTT). 
The cells were then lysed by three rounds of sonication, 30 s each, at an amplitude 
setting of 15% (Branson Digital Sonifier) in an ice-water bath. Insoluble material was 
removed by centrifugation at 16,000 g for 10 min at 4°C.  
 
Preclearing lysates 
Cell lysates were precleared by mixing with 20 µl MyOne Tosylactivated Dynabeads 
(Invitrogen) that have been covalently coupled to a monoclonal anti-rat IgG1 
(TIB170) according to the manufacturer’s protocol. The mixure was rotated for 1 h at 
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4°C. The precleared lysate was removed and used for immunoprecipitation. An 
aliquot was saved for RNA extraction (100 µl input).  
 
Immunoprecipitation of crosslinked RNA-protein complexes 
TIB170 antibody coated Dynabeads (20 µl) were coated with 3 ml supernatant of 
5G8-111 hybridoma containing anti-Eri1 antibody for 1 h at 4°C, followed by three 
wash steps with RIPA buffer. The precleared lysate was mixed with the antibody-
coated beads, 20 U of RNasin (Promega) was added and incubated with rotation at 
RT for 2 h. The beads were washed five times with 1 ml of high-stringency RIPA 
buffer (50 mM Tris, pH 7.5, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS,1 mM 
EDTA, 1 M NaCl, 2 M urea, and 0.2 mM phenylmethylsulfonyl fluoride (PMSF)) for 10 
min rotation at RT. 
 
Reversal of crosslinks and RNA purification 
The beads containing the immunoprecipitated samples were collected and 
resuspended in 100 µl of 50 mM Tris, pH 7.0, 5 mM EDTA, 10 mM DTT and 1% 
SDS. Samples (resuspended beads) were incubated at 70°C for 45 min to reverse 
the crosslinks. The RNA was extracted from 100 µl by mixing with 1 ml Trizol 
(Invitrogen) following the standard protocol (section 2.2.1.9).  
 
Analysis of immunoprecipitated RNA by semiquantitative RT-PCR 
RNA (1/5 of the total sample) was subjected to genomic DNA elimination and reverse 
transcription of RNA according to the QuantiTect Reverse Transcription Kit (Qiagen) 
(section 2.2.1.10). PCR was performed in 50 µl volume containing 1× Taq buffer 
(20 mM Tris, pH 8.4, 50 mM KCl,) 1.5 mM MgCl2, 0.2 mM dNTP, 1 pmol of each 
specific primer, 5 U of Taq DNA polymerase, and 1 µl of RT product. After an initial 
incubation at 95°C for 3 min, the reaction mixtures were subjected to 28–32 cycles of 
amplification using the following sequence: 95°C for 15 s, 55°C for 30 s, and 72°C for 
30 s. 15 µl of each reaction mixture were run on a 2% agarose gel and visualized by 
ethidium bromide staining. The primers for semiquantitative PCR amplification are 
listed in section 2.1.6. 
 
RIP assays on HEK293 cells expressing GFP or GFP-tagged Eri1 constructs were 
performed with the following modifications: extracts containing 2 mg of protein were 
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immunoprecipitated in 1 ml volume with 10 µg polyclonal anti-GFP (A11122) 
antibody. The anti-GFP antibody was coupled to 25 µl Protein G Dynabeads 
(Invitrogen) according to the manufacturer’s protocol. 
2.2.19 Quantitative PCR 
2.2.19.1 qRT-PCR using the universal probe library 
For an accurate qualitative and quantitative detection of RNAs the universal probe 
library system (UPL, Roche) was used. It is based on short hydrolysis probes that are 
labeled at the 5’ end with fluorescein and at the 3’ end with a dark quencher dye. The 
sequences of the 165 UPL probes have been selected to detect 8- and 9-mer motifs 
that are very prevalent in the transcriptomes ensuring optimal coverage of all 
transcripts in a given transcriptome. PCR primers for the quantitative real-time PCR 
experiments were designed with the Primer design tool from Roche Applied Science: 
‘universal probe library’ (https://www.roche-applied-science.com/sis/rtpcr/upl/ 
index.jsp?id=UP030000) listed in section 2.1.6. All primer/UPL-probe sets were 
tested for an efficiency of close to 2. For qRT-PCR measurements, the cDNA 
template was synthesized by a reverse transcription reaction including a gDNA 
wipeout step using the QuantiTect Reverse Transcription Kit (Qiagen) as previously 
described (section 2.2.1.10). The qPCR reaction mixture consisted of 10 µl MM (Light 
Cycler 480 Probes Master 2x conc., Roche), 1 µl forward Primer (4 pmol/µl), 1 µl 
reverse Primer (4 pmol/µl), 0.2 µl UPL probe (Roche), 2.8 µl H2O (Roche) and 5 µl 
cDNA template (about 1:30 diluted in H2O). The qPCRs were run in 96-well-plates on 
a Light Cycler 480 (Table 4). Calculations of relative RNA levels were performed in 
correlation to a housekeeping gene (pbgd). Individual samples were always 
measured in duplicates to ensure reliability.  
Table 4: PCR program on the Light Cycler 480 for real-time PCR using the UPL library (Roche). 
Program step Cycles Target (°C) Hold 
Ramp rate 
(°C/s) 
Pre-incubation 1 95°C 10 min 4.4 
95°C 10 sec 4.4 
60°C 30 sec 2.2 Amplification 45 
72°C 1 sec 4.4 
Cooling 1 40°C 30 sec 2.2 
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2.2.19.2 qRT-PCR of miRNAs 
For the measurement of miRNAs the TaqMan MicroRNA assays kit (Applied 
Biosystems) was used. The two-step protocol requires a reverse transcription step 
with a miRNA-specific primer, followed by a qPCR step with TaqMan probes. The 
assays target only mature microRNAs, not their precursors. To convert a specific 
miRNA to cDNA, first strand synthesis was carried out using the TaqMan microRNA 
reverse transcription kit (Applied Biosystems) and stem-loop primers, specific for 
miR-196a, miR-196b, miR-181a and U6 snRNA as reference (Applied Biosystems) 
according to the manufacturer’s protocol. The qPCR reaction mixture consisted of 10 
µl MM (Light Cycler 480 Probes Master 2x conc., Roche), 1.3 µl specific forward and 
reverse Primer + TaqMan probe (Applied Biosystems), 7.67 µl H2O (Roche) and 1.33 
µl cDNA template. The qPCRs were performed on the LightCycler 480 (Table 5). U6 
snRNA was taken as a reference for relative quantification. 
Table 5: PCR program on the Light Cycler 480 for real-time PCR using miRNA Taqman primers 
(Applied Biosystems). 
Program step Cycles Target (°C) Hold 
Ramp rate 
(°C/s) 
Pre-incubation 1 95°C 10 min 4.4 
95°C 15 sec 4.4 
Amplification 45 
60°C 1 min 2.2 
Cooling 1 40°C 30 min 2 
 
2.2.20 Dual-luciferase reporter assay 
Genetic reporter systems are widely used to study the regulation of eukaryotic gene 
expression. The term ‘dual’ refers to the simultaneous expression and measurement 
of two individual reporter enzymes within a single system. The experimental reporter 
is correlated with specific experimental conditions, while the activity of the second 
‘control’ reporter provides an internal control that serves as a baseline for infection 
efficiency. The psiCHECK2 (Promega) encodes for both reporter genes on the very 
same plasmid. Because of low transfection efficiency of MEF cells, first the 
commercial psiCHECK2 plasmid had to be converted to an adenoviral expression 
plasmid (pAdpsiCHECK2) (section 2.1.5.3). Then the sequences for Hoxc8 3’ UTR 
and Hoxc8 3’ UTR/miR-196a sites mutated (actaCCt>actaAAt) were fused to the 
Renilla luciferase gene. For the dual-luciferase assays MEF cells were plated onto 
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12-well plates at 1-2 x 105 cells per well and cells were co-infected with the indicated 
adenoviruses in triplicates. Two days after infection, Renilla and Firefly luciferase 
activities were assayed using a Dual-Luciferase Reporter System (Promega) and a 
luminometer (Orion Microplate Luminometer, Berthold Detection Systems). Infected 
cells were washed once with PBS and lysed in 150 µl of 1x passive lysis buffer 
(Promega) for 20-30 min at RT on a shaker. Then cells were subjected to one freeze 
and thaw cycle followed by centrifugation at 20,000 g for 5 min. 20 µl of each lysate 
was pipetted into the reader plate of the luminometer.  
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3 Results 
3.1 Characterization of mouse Eri1: the knockout 
phenotypes, the expression patterns and the binding 
and processing of target RNAs 
In order to understand the molecular function of Eri1 in mice (section 3.2), the 
phenotypes of the Eri1-knockout mouse were first systematically analyzed (section 
3.1.1). Then organs and tissues were examined for Eri1 expression in adult mice 
(section 3.1.2) and the intracellular localization of the Eri1 protein was determined 
(section 3.1.3). Protein-intrinsic binding specificity and the processing activity of Eri1 
towards two of its target RNAs, namely the ribosomal RNA and the histone mRNA, 
was analyzed (section 3.1.4 and 3.1.6). Additionally, the growth rate of primary Eri1-
deficient MEF cells was measured (section 3.1.5). 
3.1.1 Description of the Eri1-knockout mouse 
Eri1-knockout mice were analyzed on two different genetic backgrounds, on a 
C57BL/6 inbred background and on an NMRI x C57BL/6 mixed background that was 
generated by crossing in an NMRI outbred strain. An inbred strain is defined by at 
least 20 consecutive generations of sister x brother or parent x offspring matings and 
the strain has to be traceable to a single ancestral pair in the 20th or subsequent 
generation. Except for the sex difference, mice of an inbred strain are genetically as 
alike as possible by being homozygous at virtually all of their loci. 
In contrast, the mice of an outbred strain are genetically undefined; no two wildtype 
individuals from an outbred strain are the same. Outbred mice are intentionally not 
bred with siblings or close relatives. Hence unlike fully inbred strains, outbred mice 
have normal levels of heterozygosity for polymorphisms, recapitulating the genetic 
situation in humans. An advantage of using outbred strains is, amongst others, the 
better resistance to diseases, this applies also for intentionally caused conditions by 
genetic modifications. 
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3.1.1.1 Growth defects in Eri1-knockout mice  
Eri1-knockout mice were smaller in body size than wildtype littermates. This was 
especially pronounced when littermates on the C57BL/6 inbred strain background 
were compared (Figure 10a), but the difference was also penetrant after crossing in 
an NMRI outbred strain to generate mice on a NMRI x C57BL/6 mixed background. 
The growth defect was similarly reflected by the body weight, comparing Eri1-
knockout, Eri1-heterozygous and wildtype mice from one litter. Comprising the 
differences in weight among males or females, the wildtype and Eri1-heterozygous 
littermates were heavier than the Eri1-knockout mice of the same sex (Figure 10b). 
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Figure 10: Reduced body size and weight of Eri1-knockout mice. (a) Picture of a C57BL/6 
wildtype mouse (7.4 cm) and its Eri1-knockout littermate (4.6 cm) 6.5 weeks after birth. (b) Weight of 
male and female littermates from one litter on a C57BL/6 inbred strain background. wildtype (black), 
Eri1-heterozygous (gray) and Eri1-knockout (white) 6 weeks after birth.  
3.1.1.2 Postnatal death and male sterility of Eri1-knockout mice  
On the C57BL/6 inbred background about 90% of Eri1-knockout mice died during the 
first days after birth, so that the p-value for an Eri1-knockout to survive till weaning 
age was calculated to be only p = 1.1x10-10 (Table 6).  
Table 6: Effect of strain background on the reduced viability of Eri1-knockout mice. 
Genotype representation, Actual (Expected) *1 
Strain 
Eri1+/+ Eri1+/- Eri1-/- 
p *2 
C57BL/6 55 (42) 109 (84) 4 (42) 1.1x10-10 
(NMRI x C57BL/6) F2 197 (180) 410 (360) 116 (180) 1.6x10
-7 
 
*1 The number of animals with the indicated Eri1 genotype. Expected numbers assuming Mendelian 
inheritance of Eri1 alleles are shown in parentheses. 
*2 Chi-squared test for deviation from the expected Mendelian distribution. 
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In contrast Eri1-heterozygous mice had similar chances for survival as wildtype mice 
(Figure 11). Standard analyses did not reveal the cause for the neonatal mortality, 
but the postnatal death of the Eri1-knockout mice could partly be rescued by crossing 
in mice from the NMRI outbred strain (Table 6). 
 
 
 
 
 
Figure 11: Postnatal death of Eri1-knockout 
mice. Survival curve of C57BL/6 Eri1-knockout 
mice (open circles), Eri1-heterozygous (grey 
circles), and wildtype (black circles) littermates. (In 
collaboration with K. Mark Ansel.) 
On a mixed NMRI x C57BL/6 background Eri1-knockout mice were viable, but the 
male mice showed the phenotype of sterility that was likely to be caused by the 
underdeveloped testes that were observed for this genotype (Figure 12). 
Consequently, only Eri1-heterozygous male mice on C57BL/6 inbred background or 
NMRI x C57BL/6 mixed background could be used for further breeding. 
 
 
 
 
Figure 12: Smaller testis in Eri1-deficient mice. Picture 
of testis and kidney from NMRI x C57BL/6 Eri1-knockout 
and wildtype littermates. 
3.1.1.3 Summary of the phenotypes of Eri1-knockout mice found in the 
screens of the German Mouse Clinic  
For a detailed description of the Eri1-knockout mouse phenotype a large scale 
breeding strategy was planned and realized to generate 25 Eri1-knockout and 25 
wildtype littermates, males and females each, for a first systematic screen in the 
German Mouse Clinic. The analyzed mice were an F2 generation on a mixed 
background: Eri1-heterozygous mice on a C57BL/6 background were mated with 
wildtype mice on an NMRI background. The progeny (F1 Eri1-heterozygous males 
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and F1 Eri1-heterozygous females) was intercrossed to generate the cohort for the 
analyses in the German Mouse Clinic. Subsequently, a secondary systematic screen 
with 12 Eri1-knockout, 12 Eri1-heterozygous and 12 wildtype littermates, males and 
females each, was performed to provide further information about the uncovered 
phenotypes. Out of the 14 different categories that have been analyzed, an Eri1-
specific phenotype was observed in nine of them (Table 7).  
Table 7: Summary of the results from primary and secondary screens on Eri1-knockout, Eri1-
heterozygous and wildtype mice in the German Mouse Clinic.  
Screen Eri1-knockout mouse specific phenotype 
Allergy No. 
Behavior 
Slight decrease in locomotion activity, increased anxiety in the open 
field and light/dark box test. 
Cardiovascular 
malfunction 
No. 
Clinical chemistry 
and hematology 
Homozygous Eri1-knockout mice develop a macrocytic blood cell 
count with slightly reduced hemoglobin values, increased ferritin and 
transferrin levels as well as an increased alkaline phosphatase 
activity, while heterozygous mice share the wild-type phenotype 
concerning these parameters. 
Dysmorphology 
An additional thoracic vertebra and/or an extra pair of ribs in most of 
the mutants. 
Energy metabolism 
Only small significant differences were revealed. For the metabolic 
parameter 'efficiency in energy turnover' an increase was seen in 
Eri1-knockout mice. 
Eye malfunction No. 
Immunology 
The analysis of Eri1-mutant mice in the primary immunology screen 
showed statistically significant lower frequencies of NK1.1+ cells in 
mutant mice compared to controls. Furthermore, in female mice a 
higher proportion of CD44 expressing cells within the CD4+ T cell 
cluster has been found. The analysis of the blood plasma revealed 
statistically higher levels of IgG1 and IgG2b in mutants compared to 
controls. 
Lung dysfunction No. 
Molecular 
phenotyping 
Embryos (E12.5) on pure C57BL/6 background were chosen for this 
secondary screen. The data analysis of the microarray experiments 
including various statistical methods detected several genes 
differentially regulated between mutant and reference tissues in the 
embryo. Several of the regulated genes have known expression 
during embryogenesis. 
Neurology 
Reduction of grip force that could be a consequence of the reduced 
body weight. 
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Nociception No. 
Pathology 
Compared to the control mice, the Eri1-mutant mice showed a 
reduction of the body weight and body length, which was however not 
statistically significant. The presence of testicular hypoplasia could be 
confirmed in 5 of 6 mutants and an arrest of spermatogenesis was 
found in all male mice. In the femurs, we observed a tendency to a 
reduction in the amount of metaphyseal trabeculae, mainly in male 
mutant mice. 
Steroid metabolism 
For dehydroepiandrosterone (DHEA) significantly reduced levels were 
found in mutant females. In case of testosterone, mutants did not 
display sex-specific differences and mutant male mice presented very 
low concentrations of testosterone, even below the limit of 
quantification. Unfortunately these findings could not be confirmed in 
a second cohort of mice. 
 
3.1.2 Eri1 is ubiquitously expressed in mice  
The expression pattern of Eri1 in mice was analyzed to get a hint for Eri1’s function in 
mammals. Western blot analysis of a panel of tissues indicated that Eri1 is 
ubiquitously expressed, and it was represented highly in total tissue protein extracts 
from the spleen, thymus and testis (Figure 13).  
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Figure 13: Ubiquitous expression of Eri1 protein in various organs of adult mice. Tissue protein 
extracts from one Eri1-knockout, Eri1-heterozygous and wildtype mouse of the NMRI x C57BL/6 F2 
generation were examined with the monoclonal 5G8 rat-anti Eri1 antibody by Western blotting. 
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Together, the increased expression of Eri1 in the testis, the male sterility phenotype 
and the smaller testis size upon absence of Eri1 (3.1.1.2) supported Eri1’s function in 
testis development. The ubiquitous expression pattern gave a hint for the 
involvement of Eri1 in a general processing pathway or even in several pathways that 
occur in all cell types. There was only half the amount of Eri1 protein expressed in all 
tissues from the Eri1-heterozygous mouse and no Eri1 protein could be detected in 
the Eri1-knockout mouse (Figure 13). Hence, this Western blot result also assured 
that the conditional Eri1-knockout mouse model worked outright and showed that 
Eri1 is expressed in a dose dependent manner when one allele is expressed 
compared to two alleles. 
3.1.3 The SAP domain and linker sequence of Eri1 determine its 
localization to the nucleolus  
Microscopic analysis was performed to determine the subcellular localization of Eri1 
in HEK293A cells. For this experiment an N-terminal eGFP-tag was fused to wildtype 
and mutant sequences of Eri1. Localization of the fusion protein was found in both, 
the cytoplasm and nucleus, and within the nuclear compartment Eri1 was enriched in 
the nucleolus (Figure 14a). The presence of Eri1 in the nucleolus was confirmed by 
colocalization with the nucleolar marker Pes-1.  
To determine whether the RNA/DNA-binding SAP domain or the adjacent linker 
sequences influence localization, two mutant Eri1 proteins were tested, which had 
been shown, in the context of human Eri1, to impair histone mRNA stem-loop binding 
in vitro (Yang et al., 2006) (Figure 14a,b). Murine Eri1 harboring orthologous 
mutations in conserved residues in either the SAP domain (R101A) or the adjacent 
linker sequence (K107A/K108A) localized more diffusely throughout the nucleus, and 
were not as enriched in the nucleoli as compared to the wildtype protein (Figure 
14a,b). These observations showed that nuclear import remains intact after 
inactivation of residues critical for RNA binding, but that accumulation in the nucleoli 
is driven by the ability of the Eri1 protein to bind to RNA and/or DNA. A naturally 
occurring polymorphism found in C57BL/6 mice was also analyzed, which results in 
an amino acid substitution (A176D) in the catalytic domain of Eri1. The increased 
negative charge of the protein by this additional residue did not affect the subcellular 
localization (Figure 14a,b). 
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Figure 14: Eri1 accumulation in the nucleolus is driven by the function of the RNA/DNA-binding 
SAP domain and the linker sequence. (a) HEK293A cells were transiently transfected with eGFP-
tagged Eri1 using pDEST12.2. Eri1 wildtype and Eri1 proteins with point mutations within the SAP 
domain (R101A) or linker sequence (K107A K108A) or in the exonuclease domain (A176D) were 
analyzed for colocalization with endogenous Pes-1. (In collaboration with Elke Glasmacher.) (b) 
Schematic depiction of the structure of Eri1 and the employed point and deletion mutants. 
3.1.4 Eri1 binds 5.8S rRNA as well as its rRNA precursor and 
catalyses 5.8S rRNA processing 
The finding that Eri1 localized to the nucleolus dependent on its SAP domain and 
linker sequence and that specific residues are important for interaction with nucleic 
acids suggested an interaction of Eri1 with rRNA, which is transcribed in the 
nucleolus. 
3.1.4.1 Eri1 is associated with 5.8S rRNA in vivo 
RIP assays were established to show direct binding of the Eri1 protein to RNAs and 
to analyze the impact of SAP domain deletion or the exchange of critical amino acids 
on RNA binding. In IP assays the protein of interest is pulled out of the cell lysate by 
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an antibody – either directly specific for the protein itself or indirectly for a protein-
tag – and the co-immunoprecipitated RNAs are purified and subsequently analyzed, 
i.e. by RT-PCR. Other than in the classical IP assay, the RIP protocol starts with a 
formaldehyde-mediated protein-RNA crosslinking step, which allows washing at more 
stringent conditions during the following precipitation steps. This reduces the co-
immunoprecipitation of unspecific background RNA and prevents in vitro 
reassociation of protein-RNA complexes. Additionally, the lysate containing the 
crosslinked protein-RNA complexes is subjected to sonification to shear the RNA and 
to avoid the co-immunoprecipitation of unspecifically bound RNAs. These 
modifications to the classical protocol allowed the co-immunoprecipitation of only 
those RNAs, which are directly associated to Eri1 in living cells.  
 
RIP assays using a monoclonal anti-Eri1 antibody revealed that 5.8S rRNA 
specifically co-immunoprecipitated with Eri1 in wildtype MEF cells, whereas no 5.8S 
rRNA could be amplified by semi-quantitative RT-PCR in the RIP-sample from Eri1-
knockout MEF cells (Figure 15a). This result could be reconfirmed by an RIP 
experiment on HEK293 cells that had been transfected with a GFP-Eri1 or a GFP-
control expression construct. Performing the assay with a polyclonal anti-GFP 
antibody, 5.8S rRNA could again only be co-immunoprecipitated in the sample 
expressing GFP-Eri1 (Figure 15b). 
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Figure 15: RNA-immunoprecipitation of Eri1 reveals association with 5.8S rRNA. (a) The RIP 
assay was preformed on Eri1-knockout and wildtype MEF cells using an anti-Eri1 monoclonal 
antibody. Subsequently, the co-immunoprecipitated RNA was Trizol-purified, reverse transcribed and 
amplified by semi-quantitative PCR with primers specific for 5.8S rRNA. For visualization the PCR-
product was run on a 2% agarose gel and stained with ethidium bromide. (b) RIP experiment with anti-
GFP polyclonal antibody on HEK293 cells transfected with LNCX2-GFP or LNCX2-GFP-Eri1, 
respectively. 
The input samples were harvested prior to the immunoprecipitation steps, thus 
before the samples were incubated with the respective antibodies. The RT-PCR 
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results for this inputs showed only marginal differences in the amount of 5.8S rRNA 
in cells with or without Eri1 protein expression (Figure 15a,b). These results assured 
that equal quantities of 5.8S rRNA were present in all immunoprecipitations. It could 
further be concluded that the absence of Eri1 does not have an obvious impact on 
upstream ribosomal RNA maturation steps. If Eri1 would affect earlier ribosomal RNA 
processing, less mature 5.8S rRNA would be expected in the Eri1-knockout input 
sample. 
3.1.4.2 Eri1 interacts with 5.8S rRNA and rRNA precursors 
Although Eri1 might not be important for early ribosomal maturation steps, it could be 
shown that Eri1 interacts with ribosomal RNA precursors. This association is 
consistent with its nucleolar localization (section 3.1.3). 
For the RIP assay immortalized Eri1fl/fl MEF cells were produced from an embryo that 
has the Eri1 exon 3 flanked by loxP sites, ‘floxed’ (fl/fl). Excision of the exon 3 by a 
recombination event prevents the production of Eri1 proteins. Eri1fl/fl MEF cells were 
stably transduced with retroviruses (1) to create Eri1 overexpression situation (GFP-
Eri1) or (2) to keep endogenous Eri1 levels (GFP) or (3) to generate an Eri1-
knockout situation (Cre recombinase).  
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Figure 16: Eri1 binds directly to 5.8S rRNA and rRNA 
precursors. (a,b) MEF Eri fl/fl were stably transduced with 
pMSCV encoding GFP-Eri1 (Eri1 overexpression), GFP 
(endogenous Eri1 levels) and Cre (Eri1-knockout is 
created). For the RIP assay anti-Eri1 monoclonal antibody 
was used. (a) Semiquantitative RT-PCR results for primers 
amplifying rRNA sequences along the 47S rRNA precursor 
are shown. (b) Simplified schematic depiction of the 47S 
rRNA precursor. ETS: external transcribed spacer, ITS: 
internal transcribed spacer. 
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GFP-Eri1 as well as the endogenous Eri1 co-immunoprecipitated sequences from 
the 5’ ETS, 18S rRNA, 5.8S rRNA, ITS-2 and 28S rRNA. This indicated Eri1 
association with the rRNA molecules present in the 45S rRNA precursor (Figure 
16a,b). Significant interaction of Eri1 with the 3’ ETS could not be detected. Within 
the Eri1 associated ribosomal RNAs, 5S rRNA could only be detected as a faint 
band, probably indicating the degree of unspecific background interaction. This 
provides support for the specificity of Eri1 binding to 5.8S rRNA and its precursor. 
3.1.4.3 The SAP domain and linker sequence of Eri1 support binding to 5.8S 
rRNA 
The analysis was extended to include the Eri1 mutations that had been published in 
the context of human Eri1 to impair histone mRNA binding (Yang et al., 2006). Two 
of the mutants, the SAP domain (R101A) mutant and the linker region (K107A 
K108A) mutant, had already been studied in the localization experiments in this 
thesis (section 3.1.3). The additional mutants were a truncated Eri1 protein with an 
amino terminal deletion spanning the SAP-domain (delta N-Eri1, aa107-345) and a 
catalytically inactive Eri1 bearing mutations that exchange two acidic amino acids in 
the exonuclease domain (D130G E132G), which are critical for coordinating a 
magnesium ion (Cheng and Patel, 2004). The two acidic amino acids, aspartic acid  
(D130) and glutamic acid (E132), were substituted with glycine (G), because of its 
conformational flexibility as the smallest amino acid.  
Binding of point mutants of the Eri1 protein to the 5.8S rRNA was tested under 
conditions of endogenous expression of Eri1 or overexpression. GFP-tagged proteins 
were typically expressed at substantially higher levels than myc-tagged proteins, the 
latter reached approximately endogenous Eri1 expression levels. This difference in 
expression levels, even when expressed from otherwise identical vectors, indicates a 
stabilization of Eri1 protein through aminoterminal fusion with GFP. 
 
First, RIP assays were performed on MEF cells that had been reconstituted with 
myc-tagged Eri1 proteins using the monoclonal anti-Eri1 antibody. The results 
showed that the catalytically inactive (D130G E132G) mutant still bound efficiently to 
the 5.8S rRNA, whereas the linker region (K107A K108A) mutant was reproducibly 
impaired in binding as compared to wildtype Eri1 (Figure 17a,b,d). The delta N 
mutant and the SAP domain (R101A) mutant of human Eri1 were also published not 
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to bind the histone stem-loop RNA in solution (Yang et al., 2006). However, these 
mutants could not be included in this experiment, because the monoclonal anti-Eri1 
antibody recognizes an epitope in the N-terminus that was absent in both mutants. 
The polymorphism A176D, which is found in the C57BL/6 mouse strain did not affect 
5.8S rRNA binding (Figure 17a,b,d). 
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Figure 17: The SAP domain and linker sequence of Eri1 support binding to 5.8S rRNA at 
endogenous expression levels. (a) A RIP assay for Eri1 was performed with anti-Eri1 monoclonal 
antibody. Wildtype and Eri1-knockout MEF cells were left untransduced or transduced with control 
retrovirus (pMSCV) or retroviruses encoding myc-tagged (WT) and the indicated Eri1 mutants. (b) 
Immunoblots using polyclonal anti-Eri1 and monoclonal anti-myc antibodies to detect Eri1 and myc-
Eri1 expression in MEF cells of the indicated genotypes that were used in the RIP assay. (c) RIP 
assay using anti-GFP polyclonal antibody. HEK293 cells were transiently transfected with pDEST12.2 
expression constructs for GFP-Eri1 (WT), the indicated mutants or GFP-expressing vector (control). 
Equal expression levels were judged by fluorescent microscopy. (d) Schematic depiction of the 
structure of Eri1 and the employed point and deletion mutants. 
Next, the association of 5.8S rRNA with Eri1 wildtype and mutant forms, including the 
delta N and R101A mutants, was tested in HEK293 cells. For these experiments, 
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GFP-tagged Eri1 proteins were overexpressed by transient transfection and RIP 
assays were performed with GFP-specific antibodies that immunoprecipitate all 
mutants with equal efficiency. Consistent with the results from RIP assays using 
endogenous Eri1 expression levels, the catalytically inactive (D130G E132G) mutant 
could still associate with 5.8S rRNA. Whereas at overexpression levels the 
sequences in the N-terminal SAP domain (deltaN and R101A mutants) and linker 
region (K107A K108A mutant) were no longer required for Eri1 interaction with 5.8S 
rRNA (Figure 17c,d). The reason for these differences may lie in the high expression 
levels attained in transfected HEK293 cells. The findings indicate that the N-terminal 
region of Eri1 supports rRNA binding but is not required for the interaction with 5.8S 
rRNA at least in an artificial system using high expression levels. 
3.1.4.4 In Eri1-deficient cells the 5.8S rRNA is extended at the 3’ end 
With the knowledge of mouse Eri1 binding to 5.8S rRNA as well as its precursor and 
Eri1 encoding for an exonuclease domain, Eri1’s function in 5.8S rRNA processing 
was analyzed. Therefore, 5.8S rRNA running behavior was tested on large 
denaturing acrylamide-urea gels. For this approach wildtype-MEF cells were either 
infected with retroviruses encoding an shRNA against Eri1 to create an Eri1 
knockdown, or with retroviruses encoding scrambled shRNAs as a control. During 
rRNA processing, alternative 5’ endonucleolytic cleavage sites generate the major 
short (S) as well as the less abundant long (L) forms of 5.8S rRNA. Both isoforms 
appeared on acrylamide-urea gels in Eri1-knockdown and wildtype MEF cell RNA 
extracts. Importantly, both showed similar retardation in migration after Eri1-
knockdown compared to wildtype (Figure 18a). 
The apparent increase in molecular weight is likely to reflect a change at the 3’ end of 
5.8S RNA. This was validated by an approach from K. Mark Ansel, in which 5.8S 
rRNA was isolated from the liver of wildtype and Eri1-knockout mice and 
subsequently sequenced (Ansel et al., 2008). The 5.8S rRNA 3’ end from wildtype 
cells uniformly terminated at the previously reported position. In contrast, the 5.8S 
rRNA 3’ end from Eri1-knockout cells was variable, and 15 out of 16 clones 
contained a 1- or 2- nucleotide 3’ end extension (Figure 18b). Thus Eri1 is crucial to 
ensure the fidelity of 5.8S rRNA maturation.  
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Figure 18: In Eri1-deficient cells the 5.8S rRNA 3’ end is extended. (a) Ethidium bromide-stained 
RNA from wildtype MEF cells infected with an shRNA against Eri1 or control shRNAs, respectively. 
5.8SS: short isoform of 5.8S rRNA, 5.8SL: long isoform of 5.8S rRNA. The according Western blot is 
shown in Figure 3-14g. (b) Histogram shows the frequency of sequences obtained from Eri1-wildtype 
(black bars; n=12) and Eri1-knockout (white bars; n=16) that correspond to the predicted 5.8S 
sequence or extended sequences as shown above. All sequence extensions matched the expected 
ITS2 sequences (+1, T; +2, TG), except for one +2 clone that contained a TT extension. (K. Mark 
Ansel) 
3.1.5 Reduced cell growth of primary Eri1-deficient MEF cells 
The growth rate of primary embryonic cells was observed for a possible connection 
between the defect in 5.8S rRNA processing in Eri1-deficient MEF cells (Figure 18) 
and the phenotype of a reduced body size observed in Eri1-deficient mice (Figure 
10). Primary MEF cells were generated from Eri1-knockout and control embryos 
(E13.5) and cell proliferation was measured using the Cellscreen (Innovatis). Pictures 
were taken of exactly the same cells and their progeny over a culture period of 24 h 
or 48 h, respectively. The percentages of the surface area covered with cells were 
determined by automated image analysis and used to calculate the doubling time of 
the primary MEF cell population. The data revealed that Eri1-knockout MEF cells 
grew significantly more slowly (P-value = 0.006) than cells obtained from their 
wildtype and heterozygous littermates (Figure 19). Ribosomes are among the most 
crucial factors for cell growth; hence the reduced cell growth might be caused by 
impaired ribosome synthesis in Eri1-deficient MEF cells.  
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Figure 19: Reduced growth of primary Eri1-knockout MEF cells. Mean (± s.d.) doubling times for 
three independent experiments using two measurements obtained between passages 6 and 9 of MEF 
cells derived from a total of six Eri1-knockout embryos and controls. At least eight replicates of each 
primary MEF cell culture were measured. 
3.1.6 Eri1 binds to histone mRNA and initates cell cycle-
dependent degradation 
3.1.6.1 Eri1 is associated with Hist2h4 mRNA in vivo 
Dominski and colleagues have published the binding of the human Eri1 to histone 
mRNA in vitro (Dominski et al., 2003). The interaction was confirmed in mouse cells. 
The RIP assay was used to show in vivo binding of histone mRNA, i.e. Hist2h4 
(histone cluster 2 histone H4), to the mouse Eri1 protein. Immunoprecipitation of 
endogenous Eri1 protein as well as the myc-tagged Eri1 protein revealed the 
association with Hist2h4 mRNA (Figure 20).  
 
Hist2h4 mRNA
Hist2h4 mRNA
RIP
Input
 W
T
 co
ntr
ol
K1
07A
 K1
08A
A1
76D
D1
30G
 E1
32G
WT
Reconstitution
Genotype KO KO KO KO KO
 
Figure 20: RNA-immunoprecipitation of Eri1 reveals association with Hist2h4 mRNA. A RIP 
assay for Eri1 was performed with anti-Eri1 monoclonal antibody. Wildtype and Eri1-knockout MEF 
cells left uninfected or reconstituted by transduction with pMSCV encoding myc-Eri1 (WT) and the 
indicated mutants. The according Western blot is shown in Figure 17b. 
It was proposed that 3’hExo interacts with histone mRNA in a sequence-specific 
manner through its SAP domain (Dominski et al., 2003; Yang et al., 2006). 
Consistent with the findings for 5.8S rRNA binding, the catalytically inactive mutant 
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(D130G E132G) and the C57BL/6 variant (A176D) could still bind to Hist2h4 mRNA, 
whereas the linker region mutant (K107A K108A) was impaired in binding at 
endogenous reconstitution levels (Figure 20, Figure 17b). These results provided 
support for a stem-loop specific histone mRNA substrate selection.  
3.1.6.2 Eri1 regulates replication-dependent histone mRNAs, which is 
supported by specific amino acids in the SAP domain and linker 
sequence  
The molecular basis for Eri1 substrate selection was analyzed further in the context 
of Eri1-dependent histone mRNA degradation at the end of S-phase by using the 
information from the crystal structure of human Eri1 bound to stem-loop RNA of the 
histone Hist2a (Y. Cheng and D. Patel, submitted to the Protein Data Bank). The 
crystal structure revealed two amino acids in the Eri1 SAP domain and linker 
sequence that located in close proximity and making physical contact with the 
conserved U13 nucleotide within the loop of the stem-loop structure of histone 
mRNAs (Figure 21). A new Eri1 SAP/linker sequence mutant was created by 
changing these critical two amino acids, asparagine (N69) and lysine (K107), into the 
non-polar amino acid alanine (A). Alanine was chosen to avoid protein misfolding of 
the Eri1 SAP domain by introduction of other charged amino acids. 
 
 
 
 
Figure 21: Contacts between histone stem loop RNA and 
Eri1. Intermolecular hydrogen bonding involving U13 of the 
histone RNA and K107 and N69 of the Eri1 protein is indicated 
by a dashed line. 
The N69A K107A mutant was first analyzed for its exonuclease function towards 
5.8S rRNA by testing the 5.8S rRNA running behavior on a large denaturing 
acrylamide-urea gel. Infection with retroviruses coding for wildtype Eri1 or mutant 
forms of Eri1 reconstituted Eri1-knockout MEF cells to about endogenous Eri1 levels 
(Figure 23g). As already seen for the RNA extracts from wildtype and Eri1-
knockdown cells (Figure 18), a major short (S) and a less abundant long (L) form of 
5.8S rRNA appeared on the gel and the Eri1-knockout cells revealed a 1-2 bp 
extension of both forms. Irrespective of its tag the Eri1 SAP/linker sequence (N69A 
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K107A) mutant was able to trim the 3' end of 5.8S rRNA, while the catalytically 
inactive (D130G E132G) mutant was impaired and the function of the delta N mutant 
seemed to be constricted (Figure 22). The result led to the conclusion that these both 
amino acids, N69 and K107, are not crucial for 5.8S rRNA processing. 
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Figure 22: The Eri1 SAP/linker (N69A K107A) sequence mutant  is not impaired in 5.8S rRNA 3’ 
end trimming. (a) Ethidium bromide-stained RNA from wildtype and Eri1-knockout MEF cells left 
untransduced or infected with the indicated mutants, respectively. 5.8SS: short isoform of 5.8S rRNA, 
5.8SL: long isoform of 5.8S rRNA. The according Western blot is shown in Figure 3-14g. (b) Schematic 
depiction of the structure of Eri1 and the employed point and deletion mutants. 
Our lab has shown that Eri1 is needed for the degradation of stem-loop containing 
histone mRNAs at the end of S-phase (Höfig et al., in preparation). In the 
experiments, cells were treated with hydroxyurea (HU), which is used to mimick end 
of S-phase to trigger degradation of histone mRNAs. To compare Eri1-knockout MEF 
cells and control-wildtype MEF cells in their ability to regulate replication-dependent 
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histone mRNAs, Hist2h4 mRNA was measured by qRT-PCR in cells before HU-
treatment, representing asynchronous growing cells, and in cells 45 min after 
addition of 5 mM hydroxyurea, representing the status in cells at the end of S-phase. 
The calculated ratio between these two time points represented the factor of 
degradation of Hist2h4 mRNA upon HU-treatment. This approach was extended 
comparing Hist2h4 mRNA degradation in wildtype MEF cells with or without Eri1 
knockdown as well as in Eri1-knockout MEF cells with or without Eri1 reconstitution. 
For the reconstitution, retroviruses were produced to express wildtype-Eri1, the 
delta N deletion mutant, the catalytically inactive (D130G E132G) mutant and the 
SAP/linker sequence (N69A K107A) mutant. The assumption in this experiment was 
that a direct association of Eri1 with histone mRNAs is crucial for degradation at the 
end of S-phase. Hence, the Eri1 SAP/linker sequence (N69A K107A) mutant should 
be impaired in binding and processing of Hist2h4 mRNA, if sequence specific binding 
mediated by these two amino acids is irreplaceable. 
 
In two independent experiments Hist2H4 mRNA levels have been measured by qRT-
PCR in asynchronously growing MEF cells. The expression of Hist2H4 mRNAs was 
normalized to HPRT mRNAs and are displayed in percentage of histone mRNA that 
was measured in the wildtype MEF cells (Figure 23a,b). Consistent effects on the 
overall level of histone mRNAs in asynchronously growing cells were seen: low 
Hist2h4 levels in Eri1-sufficient and two to five fold increased levels of Hist2h4 in 
Eri1-deficient cells. The level of Hist2h4 mRNA in MEF cells after reconstitution with 
the myc- or GFP-tagged mutants, N69A K107A, delta N, and D130G E132G, tended 
to resemble rather the knockout than the wildtype situation. The variance of histone 
mRNA expression levels may also be affected by clonal variation, growth condition, 
relative contribution of the cells in the different cell cycle phases and 
counterregulation. However, it could be concluded that already in asynchronously 
growing MEF cells Eri1 expression seems to decrease Hist2h4 mRNA levels.  
To investigate the impact of Eri1 in more detail, the change in histone mRNA levels in 
response to 45 min of HU-treatment was monitored (Figure 23c,d). The change in 
mRNA abundance was then expressed as x-fold decrease (Figure 23e,f). 
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Figure 23: Eri1 initiates Hist2h4 mRNA degradation after HU-treatment, this is supported by 
sequence-specific binding. (a, b) Two independent experiments measuring Hist2h4 mRNA levels in 
the indicated MEF cells after retroviral infection using the pSUPER-puro for knockdown of Eri1 and the 
pMSCV-puro for reconstitution with wildtype-Eri1 and mutants. Hist2h4 was detected by qRT-PCR and 
normalized to HPRT as well as a calibrator using the Light cycler 480 software (Roche). Then the 
Hist2H4 mRNA in wildtype MEF cells was set 100%. The normalized Target/Ref (Hist2h4/HPRT) 
value for wildtype MEF cells constituted 2.79 in the first experiment (a) and 2.72 in the second 
experiment (b). Duplicates were measured in the Light cycler to calculate error bars. (c, d) Hist2h4 
mRNA levels in the indicated MEF cells after 45 min HU-treatment. Again, values were normalized to 
HPRT and the calibrator. (e, f) Degradation of Hist2h4 mRNA during incubation with hydroxyurea. For 
this depiction the Hist2h4 mRNA value measured before HU-treatment was divided by the Hist2h4 
mRNA value measured after HU-treatment. The calculated result represents the factor of Hist2h4 
mRNA degradation during 45 min HU-treatment. (g, h) Immunoblots using monoclonal anti-Eri1 (5G8-
112), polyclonal anti-Eri1 (A28) and polyclonal anti-GFP antibodies to detect Eri1, myc-tagged Eri1 
and GFP-tagged Eri1 expression in the MEF cells that were examined in the acrylamide-urea gels and 
in the HU-experiments. The monoclonal anti-Eri1 antibody recognizes an epitope in the SAP domain, 
that is why the deletion and point mutants are not or less detected. 
Although the basal level of Hist2h4 mRNA was similar in the wildtype MEF cells of 
both experiments (calibrator-normalized Hist2h4/HPRT value: 2.79 in the first 
experiment and 2.72 in the second experiment, Figure 23a,b), the reduction upon 
HU-treatment differed. In the first experiment the Hist2h4 mRNA was reduced by a 
factor of 16.8 after HU-treatment (Figure 23e), whereas in the second experiment the 
Hist2h4 mRNA was only reduced by a factor of 9.5 (Figure 23f). Again, this could be 
due to the variability of the cell culture system. However, only a 2-fold reduction of 
Hist2h4 was measured in the Eri1-knockout cells in both experiments (Figure 23e,f), 
confirming that the Eri1 protein is an important factor for the degradation of 
replication-dependent histone mRNAs. The catalytically inactive (D130G E132G) 
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mutant as well as the N-terminal deletion mutant, were not able to initiate rapid 
Hist2h4 mRNA degradation (Figure 23e,f). Thus, catalytic activity as well as stable 
binding via the SAP domain to the histone mRNA target seemed to be crucial for Eri1 
to initiate histone mRNA degradation. Importantly, the new SAP/linker sequence 
(N69A K107A) mutant could not lead to rapid degradation of Hist2H4 mRNA in the 
first experiment, represented by a degradation factor of 4.4 for myc-tagged N69A 
K107A, and by a factor of 1.8 for GFP-tagged N69A K107A (Figure 23e). This 
experiment suggested that the two amino acids in close proximity to the U13 of stem-
loop histone mRNAs are indeed critical for the binding of histone mRNA. Conversely, 
in the second experiment the SAP/linker sequence (N69A K107A) mutant could 
decrease the levels of histone Hist2H4 mRNA with a degradation factor of 10.1 
(Figure 23f). No significant difference in the Eri1 expression levels could be detected 
by Western blotting (Figure 23g,h). Hence, the different outcome in the first and 
second experiment concerning the ability of the SAP/linker sequence (N96A K107A) 
mutant to initiate degradation of Hist2h4 mRNA may have been caused by altered 
cell conditions. It can be concluded from these two experiments that although the two 
amino acids, N69 and K107, support binding to histone mRNA they are not crucial for 
specific binding of Eri1 to histone mRNA.  
 
Thomas Mullen and William Marzluff have published that upon a 80-90% Eri1 
knockdown the degradation rate of cell cycle dependent histones in response to HU-
treatment did not change (Mullen and Marzluff, 2008). In contrast, quantitative RT-
PCR analysis of Hist2h4 mRNA levels in MEF cells before and after HU-treatment, 
showed that complete knockdown or knockout of Eri1 did indeed strongly impair the 
degradation of Hist2H4 mRNA (Figure 23e,g). Additionally, the level of Hist2h4 
mRNA in normal growing cell cultures was already increased in Eri1-knockout MEF 
cells or after Eri1 knockdown. These findings make Eri1 an important factor in the 
regulation of replication-dependent histone mRNA in growing MEF cells, initiating the 
degradation of histone mRNAs at the end of S-phase. 
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3.2 Dysmorphology phenotype of Eri1-knockout mice 
From the list of phenotypes that have been found in the systematic screen of Eri1-
deficient mice in the German Mouse Clinic (section 3.1.1.3), the skeletal anomalism 
was chosen for a detailed description (section 3.2.1) and for an investigation of its 
underlying molecular mechanism (section 3.2.2, 3.2.3, 3.2.4, 3.2.5). This has led to 
the analysis of the impact of Eri1 on miR-196a (section 3.2.6) and Eri1’s function on 
miRNA-mediated Hox mRNA silencing (section 3.2.7). 
3.2.1 Eri1-knockout mice show a homeotic transformation 
3.2.1.1 Additional rib pair in Eri1-knockout mice 
In the primary screen in the German Mouse Clinic 10 NMRI x C57BL/6 Eri1-knockout 
and wildtype control mice, females and males each, were subjected to dual-energy 
X-ray analysis. The obtained images revealed a dysmorphology phenotype: 80% of 
NMRI x C57BL/6 Eri1-knockout mice developed an additional 14th rib pair on vertebra 
#21 (Table 8). Heterozygous mice, analyzed during secondary screens, were 
identical to wildtype animals showing a normal number of 13 rib pairs and thoracic 
vertebrae. Interestingly, all female animals that developed the additional thoracic rib 
pair, also displayed an additional vertebra. Thus, the number of lumbar vertebrae, 
defined as those vertebrae without ribs that are posterior to the thorax and anterior to 
the vertebrae linked to the pelvic bones (sacral vertebrae), remained at the normal 
number of 6 in female mice. In contrast, male Eri1-knockout animals developed the 
additional 14th rib pair either in the presence or in the absence of an additional 
vertebra. Hence, in male Eri1-knockout mice the number of lumbar vertebrae varied 
between 6 and 5. 
To exclude that the developmental phenotype of Eri1-knockout mice depends on the 
mixed NMRI x C57BL/6 background, one of the rare surviving litters on a pure 
C57BL/6 background was analyzed. The Eri1-knockout phenotype could be 
confirmed to also occur in mice on inbred C57BL/6 background as shown on the X-
ray microtomography (µCT) pictures (Figure 24). Again, both the female and male 
Eri1-knockout mouse, showed an additional 14th rib pair, but only the female mouse 
also developed an additional vertebra. 
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Table 8: Skeletal dysmorphology in Eri1-knockout mice. The results from X-ray absorptiometry 
have been grouped according to the presence of a normal or an aberrant number of ribs, thoracic and 
lumbar vertebrae. wildtype, Eri1-heterozygous, and Eri1-knockout mice were analyzed from the F2 
generation of a mixed NMRI x C57BL/6 background. (Primary and secondary screen in the German 
Mouse Clinic.) 
Females Males 
Phenotype 
WT HET KO WT HET KO 
normal (26) 10 4 3 10 4 1 Number of 
ribs 
 aberrant (28) - - 7 - - 9 
normal (13) 10 4 3 10 4 1 Number of 
thoracic 
vertebrae* aberrant (14) - - 7 - - 9 
normal (6) 10 4 10 10 4 7 Number of 
lumbar 
vertebrae* aberrant (5) - - - - - 3 
Total number of mice 10 4 10 10 4 10 
 
* In this table, the rib bearing vertebrae were defined as thoracic vertebrae and vertebrae posterior to 
rib bearing vertebrae and anterior to the first sacral vertebra were defined as lumbar vertebrae. 
 
 
+/+ male -/- male -/- female 
 
Figure 24: Eri1-knockout mice show a skeletal dysmorphology phenotype. µCT pictures of one 
female and one male Eri1-knockout mouse with an aberrant 14th rib pair, compared to the normal 
number of 13 pairs of ribs in wildtype mice (C57BL/6). Additionally, the female Eri1-knockout mouse 
revealed an extra vertebra. (In collaboration with Wolfgang Hans.) 
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3.2.1.2 In Eri1-knockout mice 8 pairs of ribs are fused to the sternum 
In wildtype mice 7 of the 13 rib pairs are fused to the sternum. La Theta scans of 
Eri1-knockout mice revealed the fusion of an 8th pair of ribs to the sternum (Figure 
25a). For a more detailed investigation skeletal stains were performed on adult and 
newborn Eri1-knockout and control mouse skeletons. The method uses alcian blue to 
stain the cartilage and alizarin red to stain the bones. The skeletons confirmed the 
additional 14th rib pair in Eri1-knockout mice as well as the aberrant fusion of the 8th 
rib pair adjacent to the 7th rib pair at the sternum. Through this fusion a bony process 
at the last sternebra developed in several Eri1-knockout animals. In contrast, all 
wildtype animals showed the normal fusion of only the 6th and 7th rib pairs to that 
sternebra (Figure 25b).  
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r14
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+/+ -/- 
r7 
r8 
r13 
r14 
+/+ -/- 
(b) 
 
Figure 25: In Eri1-knockout mice an 8th rib pair is fused to the sternum. (a) The La Theta scanner 
was used to take pictures of the ribcage of Eri1-knockout mice. Representative picture of an Eri-
knockout male (NMRI x C57BL/6) showing an additional 8th pair of ribs attached to the sternum. (b) 
Skeletons stained with alcian blue (staining the cartilage) and alazin red (staining the bone). 
Representative pictures of one wildtype and one Eri1-knockout newborn (NMRI x C57BL/6). The 
wildtype newborn shows the normal number of 13 rib pairs and the fusion of the 6th and 7th pair of ribs 
to the last sternebra. The Eri1-knockout newborn reveals the aberrant number of 14 rib pairs and the 
fusion of the 6th, 7th and 8th pair of ribs to the same sternebra. (In collaboration with Christian Cohrs.) 
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3.2.1.3 Anteriorization of vertebrae in Eri1-knockout mice 
In depth analysis of the thoracic and lumbar vertebrae demonstrated that Eri1 
deficiency led to a full transformation of the 8th thoracic vertebra (T8) to a 7th thoracic 
vertebra (T7’) (Figure 26a). Consequently, the vertebrae T7 and T7’ looked identical 
in Eri1-knockout mice. This kind of homeotic transformation is called anteriorization.  
 
 
Figure 26: Anteriorization of thoracic, lumbar, and sacral vertebrae in Eri1-knockout mice. (a) 
Individual thoracic vertebrae from skeletal stains of wildtype and Eri-knockout newborns (NMRI x 
C57BL/6). (In collaboration with Christian Cohrs.) (b) Schematic representation of the skeletal 
phenotype of Eri1-knockout mice compared to wildtype control mice. 
Furthermore, the duplication of the 7th vertebra resulted in an extension of the 
anteriorization towards the sacral vertebrae and included the homeotic 
transformation of L1 to T13’ and S1 to L6’ (Figure 26a,b). This phenotype was 
observed in all female Eri1-knockout mice as well as in those male Eri1-knockout 
mice that developed the additional 14th rib pair in presence of an additional vertebra. 
In contrast, the male Eri1-knockout mice with 14 pairs of ribs with no additional 
vertebra, only showed a partial transformation (T8 to T7’). This partial transformation 
did only lead to anteriorization of the more posterior located vertebrae up to the 3rd 
lumbar (L3). Hence the lumbar vertebra L1 still adopted a T13’ phenotype, but the 
sacral vertebra S1 did not transform into L6 identity. Consequently, the number of 
thoracic vertebrae rose to a total of 14 vertebrae, but the number of lumbar vertebrae 
dropped to 5 (Table 8). These results argued for the development of an additional 
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true rib in the Eri1-knockout mice caused by a homeotic transformation into the 
anterior direction of each vertebra starting at the 8th thoracic (T8). 
3.2.2 High expression of Eri1 in the prevertebrae of embryos 
To investigate Eri1 expression in the embryo during development, Eri1 mRNA and 
Eri1 protein levels were measured by qRT-PCR and Western blot methods. Embryos 
at 12.5 dpc were sliced into 6 parts along their anterior-posterior axis and the 
abundance of Eri1 RNA or protein was examined in the individual tissue extracts 
(Figure 27a). Eri1 mRNA as well as Eri1 protein detection revealed that already at 
early embryonic developmental stages Eri1 is expressed allover the body (Figure 
27b,c). To show the distribution of Eri1 in the embryo in more detail 
immunohistochemistry stains using affinity-purified polyclonal anti-Eri1 antibodies 
was performed. Despite the fact that Eri1 was expressed in equal amount in the 
different sections of the embryo, there was higher Eri1 expression in the prevertebrae 
and in the brain, here especially in the cortex and in the plexus choroideus. The 
intensive stain of the liver might be due to a non-specific peroxidase activity in 
hepatocytes and abundant Eri1 protein in proliferating hematopoetic cells (Figure 
27d,e,f,g). The predominant expression of Eri1 protein in the prevertebrae of 
embryos gave a strong indication of Eri1 function in the development of vertebrae as 
well as ribs. 
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Figure 27: Eri1 expression pattern in the mouse embryo. (a) Mouse embryos (E12.5) were sliced 
into 6 parts along their anterior-posterior axis. (b) Eri1 mRNA levels in part 2-6 from a wildtype embryo 
(C57BL/6) was detected by qRT-PCR. Part 1 was not analyzed, but was used for genotyping. (c) The 
ubiquitous expression of Eri1 protein is shown by immunohistochemistry using a monoclonal anti-Eri1 
antibody. Tubulin was included as loading control. The Western blot of the wildtype embryo on BalB/c 
background is a representative out of eight BALB/c and two C57BL/6 embryos analyzed. (d-g) 
Immunohistochemistry stains using affinity-purified polyclonal anti-Eri1 antibody on an embryo at 
E12.5 (BALB/c). (d) Depiction of the whole embryo. (e) Blow-up of the prevertebrae. (f) Blow-up of the 
plexus choroideus. (g) Blow-up of the cortex. (In collaboration with Frauke Neff.) 
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3.2.3 Molecular phenotyping of Eri1-knockout embryos 
To investigate Eri1-knockout dysmorphology on the molecular basis, close to 
genome-wide microarrays were used for mRNA expression profiling of embryos 
(E12.5). Total RNA was isolated from the trunk, omitting the heads, of four Eri1-
knockout and four wildtype control animals (C57BL/6) and sent for a secondary 
screen analysis to the German Mouse Clinic. Table 9 summarizes the results of three 
chip hybridizations; the statistical analysis identified 34 significantly down-regulated 
mRNAs in the experiments of three animals (Eri1-knockout 2, 3 and 4). Interestingly, 
no up-regulated mRNAs were found. 
The expression pattern of Eri1-knockout 1 was different from the other three embryos 
(Table 10) and was therefore excluded from the statistical analysis. The calculated 
false discovery rate of 6.3% and the different brightness of the color in the heat plot 
(Table 10) indicated high biological variability of the expression patterns across the 
analyzed embryos. 
In Eri1-knockout 2, 3 and 4 the differential expression of Hba-a1 and Hba-a2 was 
confirmed by four independent probes on the array. These different probes for the 
identical gene showed similar regulation providing confidence for the expression 
profiling data. In order to analyze whether specific functional annotations were over-
represented among the regulated genes, 12 of the down-regulated genes were 
classified into two categories of Gene Ontology terms: molecular functions and 
biological processes (Table 11). Over-representation of four molecular functions was 
detected: transporter and catalytic activity as well as binding of adenyl nucleotides 
and metal ions. In the category of biological processes cell growth, metabolism of 
proteins and nucleotides as well as defense response, signal transduction and 
homeostasis were over-represented pathways. Only 2 of the 12 genes are 
associated with developmental processes: Afp (alpha feto protein) is a major plasma 
protein produced by the yolk sac and the liver during fetal life (Jin et al., 2009). Abr 
(active BCR-related gene) plays an important role during vestibular morphogenesis 
(Kaartinen et al., 2002).  
Finally, although smaller differences in the expression of several genes were found in 
this molecular phenotyping approach, the results did not reveal a candidate gene 
being a key player in skeletal patterning during embryogenesis. 
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Table 9: Heat plot of gene expression profiles from six DNA microarray experiments of 
Eri1-mutant versus control embryos. One dye-flip pair represents two experimental replicates of 
each analyzed animal. One Array TAG ID is the unique probe identifier from the Lion Bioscience clone 
set. Official gene symbols are given. The scale bar encodes the ratio of the fold induction (red is up-
regulation and green down-regulation in mutant mice). (In collaboration with Marion Horsch.) 
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Table 10: Heat plot of gene expression profiles from eight DNA microarray experiments of Eri1-
mutant versus control embryo. Eri1-knockout 1 shows a different expression pattern in the 
regulated genes. (In collaboration with Marion Horsch.) 
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Table 11: Functional classification of the regulated genes in Eri1-knockout embryos. In order to 
analyze whether specific functional annotations were over-represented among the regulated genes 
EASE (a module of the DAVID database) was used to classify the genes for two categories of Gene 
Ontology (GO) terms. (In collaboration with Marion Horsch.) 
Category GO term Gene symbol 
transporter activity 
AFP; ALB; NUP155; 
SLC4A1; TXNDC3 
catalytic activity 
GRIPAP1; MARK3; 
RAB5B; TXNDC3 
adenyl nucleotide binding MARK3; TXNDC3 
Molecular function 
transition metal ion binding AFP; RLF 
cell growth and/or 
maintenance 
AFP; ALB; FBXO32; 
NUP155; SLC4A1 
protein metabolism ERAF; MARK3 
nucleotide and nucleic acid 
metabolism 
RLF; TXNDC3 
defense response AFP; IL6ST 
signal transduction ABR; IL6ST 
Biological processes 
homeostasis ALB; SLC4A1 
 
3.2.4 Literature and database research to reveal Eri1 target 
candidates 
The MGI (Mouse Genome Informatics) database is a resource for information about 
the laboratory mouse, providing integrated genetic, genomic and biological data (The 
Jackson Laboratory, http://www.informatics.jax.org/). 
In order to find other laboratory mice displaying the same or a similar phenotype as 
the Eri1-knockout mice, the search term: increased rib number was used to obtain a 
list of 64 genotypes. Looking closer at these candidates, the development of an 
additional rib pair at the first lumbar vertebra in wildtype mice, vertebra #21, has been 
reported for mouse mutants with a single and combined deletion of the Hoxc8, 
Hoxa9, Hoxc9 and Hoxa10 gene (Chen and Capecchi, 1997; Fromental-Ramain et 
al., 1996a; Le Mouellic et al., 1992; Rijli et al., 1995; Satokata et al., 1995; Suemori, 
1995; van den Akker et al., 2001; Wellik and Capecchi, 2003). All gene deletion 
mutants showing an additional rib pair on vertebra #21 are summarized in Table 12.  
However, only Hoxc8 and Hoxc9-deficient animals also share the other prominent 
skeletal abnormality of the Eri1-deficient mice, which is the fusion of the 8th rib pair to 
the sternum (Le Mouellic et al., 1992; Suemori et al., 1995; van den Akker et al., 
2001). In the case of Hoxc9-deficient animals the 9th rib was found to partially fuse to 
Results 
 
 74 
the sternum as well (Suemori, 1995), indicating that Hoxc9 deficiency may result in a 
slightly different abnormality compared to Eri1-deficient mice.  
Finally, the perinatal lethality due to an unknown cause is shared between Eri1- and 
Hoxc8-deficient mice. Individuals of both genotypes die within a few days after birth, 
and in both cases mortality of knockout animals was partially rescued if they were 
generated on an outbred strain background (section 3.1.1.2) (Ansel et al., 2008; Le 
Mouellic et al., 1992; Tiret et al., 1998; van den Akker et al., 2001) 
Table 12: All published Hox gene(s) deletion mutants showing an additional rib pair on 
vertebra #21. 
Type of mutant Hox gene(s) Publication(s) 
Hoxc8 
Le Mouellic et al., 1992; van den Akker et 
al., 2001 
Hoxa9 Fromental-Ramain et al., 1996(a)  
Hoxc9 Suemori, 1995 
Single deletion mutants 
Hoxa10 Rijli et al., 1995; Satokata et al., 1995  
Hoxc8/d8 van den Akker et al., 2001 
Hoxa9/d9 Fromental-Ramain et al., 1996(a) Double deletion mutants 
Hoxa9/b9 Chen and Capecchi, 1997 
Hoxb8/c8/d8 van den Akker et al., 2001 
Hoxa9/b9/c9/d9 *1 Chen and Capecchi, 1997 
Deletion of all 
homologous genes from 
one cluster Hoxa10/c10/d10 *2 Wellik and Capecchi, 2003  
 
*1 Additional rib pair on vertebra #21, #22, #23 and #24.  
*2 Rib processes on all lumbar and sacral vertebrae. 
 
It seemed unlikely that the Eri1 protein directly upregulates Hoxc8 gene expression, 
because so far Eri1 has not been described in the context of transcription activation. 
However, the homologue of Eri1 in C. elegans was published to inhibit RNAi in 
neurons and it was suggested that Eri1 degrades siRNAs (Kennedy et al., 2004). 
SiRNAs and miRNAs show pronounced similarities in their biogenesis and silencing 
activity, and it has been shown that some proteins are active in several RNAi 
pathways (section 1.3.1). This made mouse Eri1 a promising candidate for miRNA 
regulation.  
The Targetscan database (Targetscan 5.1, http://www.targetscan.org/), which 
predicts mRNA targets of mammalian miRNAs and vice versa, was used to find 
promising miRNAs for Hoxc8 mRNA regulation. The database research revealed, 
that the Hoxc8 UTR exhibits 4 conserved and 1 non-conserved recognition motifs for 
miR-196a/b. This makes Hoxc8 the first hit on the list of predicted target proteins for 
miR-196a/b. The list is ranked due to the calculation of the total context score, which 
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is based on the type, the number and the context of miRNA-biding sites on the target 
mRNA (Grimson et al., 2007). Importantly miR-196a and miR-196b are expressed 
from Hox clusters as well, so that they are regulated by the same epigenetic temporal 
and spatial control mechanisms (Soshnikova and Duboule, 2009b). The Hoxc9 
mRNA is not on the list of predicted targets of miR-196a/b, suggesting that Hoxc9 is 
less likely to be affected by miRNA overexpression in the Eri1-deficient mice. Another 
published target of miR-196a/b is Hoxb8, which has a nearly perfect complementary 
sequence for miR-196a/b in its UTR. This makes Hoxb8 a pronounced target 
because its mRNA was rather degraded than translationally inhibited upon miR-196a 
expression (Hornstein et al., 2005; Mansfield et al., 2004; Yekta et al., 2004). Very 
recently, it has also been shown that during chick development knockdown of miR-
196 induces expansion of the anterior limit of Hoxb8 and thereby induces a cervical 
to thoracic homeotic transformation (McGlinn et al., 2009). Together, these findings 
gave a strong indication to investigate Hoxc8 and also Hoxb8 expression in Eri1-
deficient embryos.  
3.2.5 Shift of Hox gene expression in Eri1-knockout embryos 
3.2.5.1 Posterior shift of Hoxc8 expression in Eri1-knockout embryos 
Embryos were analyzed at 12.5 dpc, a time at which the anterior boundary of Hox 
expression has been established in embryonic development (Wellik, 2007). In section 
3.1.2 it was shown that Eri1 protein expression could be detected in all embryo parts 
along the anterioposterior axis and the detailed analysis in immunohistochemistry 
stains supported Eri1 function in prevertebrae by revealing enhanced Eri1 expression 
levels. Analyzing Hoxc8 expression in embryo sections by Western blot, high protein 
levels were found only in part 4 and 5, whereas a faint band was present in part 3 
and 6 and no Hoxc8 protein was determined in the most anterior parts 1 and 2 
(Figure 28a). 
Similar to the protein levels, Hoxc8 mRNA could not be detected at significant levels 
by qRT-PCR in the anterior part 2; with a mean Cp-value of 39.2 in wildtype embryos 
the detection border was reached. But Hoxc8 mRNA was measured at strongly 
increased levels in the posterior half of the embryo. Different from the protein level,  
the mRNA showed a steep increase of Hoxc8 expression that was already observed 
in part 3 of the wildtype embryo. And, in contrast to the rapidly declining Hoxc8 
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protein levels in the most posterior part 6, its mRNA expression declined much less 
(Figure 28a,b). A similar expression profile was determined in wildtype embryo parts 
for Hoxb8 mRNA levels (Figure 28c). 
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Figure 28: The anterior border of Hoxc8 and Hoxb8 expression is shifted posterior in Eri1-
knockout mice. (a) Mouse embryos were sliced into 6 parts along their anterior-posterior axis at 12.5 
dpc (Figure 3-18a). The position specific expression pattern of Hoxc8 protein is shown by 
immunohistochemistry using a monoclonal anti-Hoxc8 antibody. Tubulin was included as loading 
control. The Western blot of the wildtype embryo on BALB/c background is one representative out of 
eight BALB/c and two C57BL/6 embryos analyzed. (b, c) Hoxc8 and Hoxb8 mRNA levels were 
detected by qRT-PCR in three Eri1-knockout and wildtype embryos (C57BL/6) and normalized to the 
pbgd housekeeping gene. The mean Cp-value of the three wildtype embryos in part 2 was 39.2 
measuring Hoxc8 mRNA and 39.2 measuring Hoxb8 mRNA, compared to 26.4 measuring pbgd 
mRNA. The ΔCp Hoxc8/pbgd or Hoxb8/pbgd of wildtype part 2 was set 1 (log2 of 0). The expression 
of Hoxc8/Hoxb8 mRNA in the six embryo parts is shown on a logarithmic scale as multiples of the 
mRNA expression in part 2 of the wildtype embryos. (b) * Significantly less Hoxc8 mRNA in part 3 of 
Eri1-knockout embryos (T test, one-tailed, unpaired, P = 0.026). (c) * Significantly less Hoxb8 mRNA 
in part 3 of Eri1-knockout embryos (T test, unpaired, P = 0.008). (The single embryo measurements 
are shown in the supplementary.) 
Comparing Hoxc8 mRNA expression in Eri1-knockout and wildtype embryos, on 
average a ~16-fold decreased expression of Hoxc8 mRNA in part 3 of Eri1-knockout 
embryos was measured. A statistically significant ~4 fold decrease was also 
observed for the Hoxb8 mRNA in part 3 of Eri1-knockout embryos (Figure 28b,c). 
Both Hoxc8 and Hoxb8 mRNAs only displayed significant regulation by Eri1 in the 
embryo part 3, which, in the wildtype embryo, may include the first anterior segments 
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with high Hoxc8 and Hoxb8 expression. These findings suggest an exclusive 
regulation at the anterior boundary of Hoxc8 and Hoxb8 mRNA expression by Eri1 
and the posterior shifted expression of these mRNAs in the absence of Eri1. 
3.2.5.2 miR-196a expression pattern in wildtype and Eri1-knockout embryos 
The miRNAs miR-10 and miR-196 have been proposed to restrict expression of Hox 
target genes at their anterior boundaries (Mansfield et al., 2004; McGlinn et al., 2009; 
Yekta et al., 2004; Yekta et al., 2008). Importantly, the 3' UTR of the Hoxc8 mRNA 
has 4 highly conserved and one non-conserved binding site for miR-196a/b (section 
3.2.4). Analyzing the mature miR-196a expression in embryo parts 1-6 using qRT-
PCR miR-196a can already be detected in anterior regions (Figure 28a), but the 
steep increase to high expression of mature miR-196a was shifted into the posterior 
direction compared to Hoxc8 mRNA expression in the wildtype situation (Figure 28a, 
Figure 29a). This is consistent with the spatial and temporal colinearity of Hox cluster 
gene expression, because the loci encoding miRNAs of the miR-196 family are 
positioned 5’ to group 8 Hox cluster genes, so that they are predicted to be highly 
expressed more posterior and later during development (Figure 6). 
Although increased expression of miRNA-196a in part 3 was observed in two Eri1-
knockout embryos compared to their wildtype littermates, in the unmatched Eri1-
knockout and wildtype pair there was slightly more miR-169a in part 3 of the wildtype 
embryo (Supplementary Figure S-36). Hence, the difference was not statistically 
significant when comparing 3 wildtype and knockout counterparts (Figure 29a). Other 
predicted regulatory miRNAs for Hoxc8 are miR-181a/b/c/d with 2 conserved binding 
sites on the UTR. The qRT-PCR results for miR-181a showed neither an anterior-
posterior expression gradient nor a difference between Eri1 wildtype and knockout 
embryos (Figure 29b). 
Whole mount in situ hybridization for miR-196a revealed that in wildtype embryos at 
12.5 dpc miR-196a can be detected from vertebra #23 up to the tip of the tail (Figure 
29c). The in situ hybridization technique is probably less sensitive than qRT-PCR 
analysis. This would explain restricted detection of miR-196a in the posterior part of 
the embryos using a probe for in situ hybridization, while qRT-PCR amplified also low 
levels of miR-196a in more anterior regions (Figure 29a,c). In the discussion further 
experiments will be proposed how to analyze miR-196a levels in Eri1-knockout and 
wildtype embryos more precisely.  
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Figure 29: Expression of mature miR-196a in mouse embryos. (a, b) Mature miRNA levels for 
miR-196a, and miR-181a were detected by qRT-PCR in three Eri1-knockout and wildtype embryos 
(C57BL/6) and normalized to the U6 snRNA housekeeping gene. The mean Cp-value of the three 
wildtype embryos in part 2 was 37.1 measuring miR-196a and 25.8 measuring miR-181a, compared to 
29.1 or 29.8 measuring U6 snRNA. The ΔCp, mature miRNA/U6 mRNA, in wildtype part 2 was set 1 
(log2 of 0). The expression of mat-miR-196a and miR-181a in the six embryo parts is shown on a 
logarithmic scale as multiples of the miRNA expression in part 2 of the wildtype embryos. (The single 
embryo measurements are shown in the supplementary.) (c) In situ hybridization for miR-196a on an 
embryo at 12.5 dpc. (In collaboration with Bastian Hösel.) 
3.2.6 Eri1 reduces mature miR-196a levels in MEF cells 
To test the effect of Eri1 on miR-196a in fibroblasts, Eri1-knockout MEF cells were 
infected with adenoviruses coding for pri-miR-196a and Eri1 or pri-miR-196a and 
GFP control, respectively. For pri-miRNA infection a titration series was performed. 
The depicted MOI values of 250 and 10 represent overexpression and approximately 
endogenous miRNA expression levels. The pri-miR-196a and mat-miR-196a levels 
were analyzed by quantitative RT-PCR and normalized to pbgd or U6 snRNA, 
respectively (Figure 30). Slightly more pri-miR-196a was obtained in the Eri1 
reconstituted MEF cells. In contrast, decreased levels of mature miR-196a were 
detected in the very same cells. In Eri1-deficient cells the mature miR-196a level was 
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1.34-fold increased in the case of higher miR-196a expression (MOI 250) and even 
1.68-fold increased in the case of lower miR-196a expression (MOI 10). 
This result supported the notion that Eri1 has an impact of on the miRNA-mediated 
RNAi pathway in mammalian cells, either by negatively influencing the processing of 
precursor miRNAs to their mature form or by reducing the half-life of mature miRNAs. 
 
 
 
 
Figure 30: Eri1 reduces mature miR-196a 
levels in MEF cells. To analyse the impact of 
Eri1 on miRNAs, Eri1-knockout MEF cells 
were transduced with both an Eri1 or GFP 
expression plasmid (MOI 500), and a pri-miR-
196a expression plasmid (MOI 250 or 10). 
The levels of pri-miR-196a and mat-miR-196a 
were measured by qRT-PCR in a Light cycler 
480 and normalized to pbgd or U6 snRNA, 
respectively. 
3.2.7 The exonuclease activity of Eri1 inhibits miR-196-mediated 
silencing of Hoxc8 through its 3’ UTR 
3.2.7.1 Generation of a dual-luciferase reporter system for MEF cells 
A dual-luciferase reporter system was set up as a functional assay for testing the 
impact of Eri1 on miR-196a-dependent Hoxc8 mRNA regulation. The term ‘dual’ 
refers to the simultaneous expression and measurement of two individual reporter 
enzyme activities in the system. The experimental reporter (Renilla luciferase, Rluc) 
is linked to the specific conditions, while the activity of the second ‘control’ reporter 
(Firefly luciferase, Luc) provides an internal control that serves as a baseline for 
infection efficiency. The psiCHECK2 vector from Promega encodes for both reporter 
genes on the same plasmid. For the application of this project, psiCHECK2 was 
cloned into the context of an adenoviral backbone (pAd-Pl, Invitrogen) to produce 
reporter constructs suitable for the infection of MEF cells.  
In the following assays, a reporter construct was co-transduced with adenoviruses 
encoding pri-miR-196a and Eri1, or appropriate GFP controls. The infection was 
performed at constant multiplicities of infection (MOI). Importantly, the MOI values of 
the adenoviruses were determined according to their efficiency to infect A549 cells. 
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These cells are highly infectable with adenoviruses compared to the much lower 
infection efficiency of MEF cells. For example, Eri1-knockout MEF cell infections with 
pCAGAdDU + myc-tagged Eri1 adenoviruses at an MOI of 50 was barely 
reconstituting the cells with levels that matched endogenous Eri1 expression (Figure 
33).  
In a first experiment the repression of the Hoxc8 3’ UTR by miR-196a in MEF cells 
was tested. The activity of Rluc that was linked to the Hoxc8-3’UTR was strongly 
repressed upon co-expression of pri-miR-196a in wildtype MEF cells, whereas a 
control reporter was unaffected by miR-196a expression. The repression of the 
Hoxc8 3’ UTR was only observed in wildtype but not in a Dicer-deficient MEF cell 
clone (Figure 32a). These findings show that miR-196a-dependent repression of the 
Hoxc8 3’ UTR only occurred in cells with intact miRNA-biogenesis. Furthermore, the 
comparable activity of the Hoxc8 3’ UTR reporter in the absence of ectopic miR-196a 
expression in wildtype and Dicer knockout cells indicated that this 3’UTR is not 
repressed substantially through endogenous miRNAs in MEF cells (Figure 31). 
 
 
 
Figure 31: Repression of the Hoxc8 3’ UTR by 
miR-196a in MEF cells. The 3’ UTR of Hoxc8 was 
linked to RLuc and tested for repression by a pri-
miR-196a expression plasmid. Dicer-knockout and 
wildtype MEF cells were co-transduced with pri-miR-
196a expression plasmid or GFP (MOI 500) and 
with either the Hoxc8 3’ UTR reporter or a control 
reporter plasmid, without a 3’ UTR linked to Rluc. 
Luc is co-expressed from the luciferase reporter 
plasmid and used to normalize for the transduction 
efficiency. * Very significantly less Rluc light units 
after pri-miR-196a co-transduction (T test, one-
tailed, paired, P = 0.002). 
3.2.7.2 Eri1 inhibits miR-196a-mediated silencing of the Hoxc8 3’ UTR and 
interferes with the miRNA-mediated RNAi pathway 
In the following experiments Eri1 was titrated into Eri1-knockout MEF cells on a GFP 
background. The cells were co-transduced to express constant amounts of a reporter 
(the Hoxc8 3’ UTR reporter or the control reporter) and a miRNA (the pri-miR-196a or 
the pri-miR-150). 
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Increasing levels of Eri1 were indeed able to attenuate miR-196a-dependent Hoxc8 
3’ UTR repression, represented by the increase of Rluc light units. But Eri1 did not 
derepress the control reporter, which misses the 3’ UTR (Figure 32a). Consequently, 
adding Eri1 to a system in which miR-196a silences the Hoxc8 3’ UTR, Eri1 had a 
positive effect on Hoxc8 expression.  
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Figure 32: Eri1 inhibits miR-196a-mediated Hoxc8 3’ UTR silencing and Eri1 interferes with the 
RNAi pathway. (a) Eri1-knockout MEF cells were co-transduced with either of the luciferase reporter 
plasmids and the pri-miR-196a expression plasmid (MOI 500), while an expression plasmid for Eri1 
was titrated in on GFP background. For the diagram the expression of the Rluc reporter activity 
without Eri1 co-transduction was set 1. (b) Eri1-knockout MEF cells were transduced with a luciferase 
reporter plasmid, encoding either the intact Hoxc8 3’ UTR or a mutated Hoxc8 3’ UTR, in which all four 
conserved miR-196a binding sites have been disrupted. The pri-miR-196a expression plasmid (MOI 
500) and a titration series of the Eri1 expression plasmid on a GFP background were co-transduced. 
(c) Eri1-knockout MEF cells were co-transduced with the Hoxc8 3’ UTR reporter and the pri-miR-196a 
or pri-miR-150 expression plasmid (MOI 500), while an expression plasmid for Eri1 was titrated in on 
GFP background.  
It should further be investigated, if Eri1 inhibits the miR-196a-mediated Hoxc8 3’ UTR 
silencing using the RNAi pathway. Therefore all four conserved miR-196a binding 
site sequences were mutated (actaCCt>actaAAt) within the seed sequence to create 
a ‘mutated Hoxc8-UTR reporter construct’. The mutations of the miRNA-binding sites 
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for miR-196a abolished derepression of the Rluc-reporter by Eri1 (Figure 32b). Eri1-
dependent derepression of the Hoxc8 3’ UTR was also not observed when the Hoxc8 
3’ UTR reporter was co-expressed with pri-miR-150 (Figure 32c). MiR-150 has no 
predicted binding site in the Hoxc8 3’ UTR and could therefore serve as a negative 
control. Hence, these experiments provided proof that Eri1 affects the RNAi pathway 
and that Eri1 needs mat-miR-196a binding to the conserved binding sites on the 
Hoxc8-UTR sequence to show an effect. 
3.2.7.3 The exonuclease activity of Eri1 is required for its impact on miR-196a 
mediated silencing of the Hoxc8 3’ UTR  
An interesting question was whether the derepression of Hoxc8 3’ UTR requires the 
exonuclease activity of Eri1. Indeed, the catalytically inactive (D130G E132G) Eri1 
mutant was not effective compared to its wildtype form to increase the expression 
level of the Hoxc8 3’ UTR reporter (Figure 33a). Equal protein expression of the 
wildtype Eri1 protein and the catalytic inactive Eri1 protein was confirmed by 
immunoblotting (Figure 33b). This result supported the idea of Eri1 being a negative 
regulator of miRNAs using its exonuclease activity to reduce miRNA levels. 
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Figure 33: The exonuclease activity of Eri1 is required for its impact on miR-196a mediated 
Hoxc8 3’ UTR silencing. (a) Eri1-knockout MEF cells were co-transduced with the luciferase reporter 
plasmid and the pri-miR-196a expression plasmid (MOI 500), while an expression plasmid for Eri1 
wildtype or the catalytically inactive Eri1 D130G E132G mutant was titrated in on a GFP background. 
(b) The comparable titration series of Eri1 wildtype and Eri1 (D130G E132G) mutant are shown by 
immunoblotting using monoclonal anti-Eri1 antibody. For comparison to endogenous Eri1 expression 
levels wildtype MEF cell extract was loaded in the first lane. Tubulin was included as loading control.  
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4 Discussion 
In this work, the impact of Eri1 in mice has been investigated using an Eri1-knockout 
mouse model. Critical findings from the different areas of this investigation have 
contributed to the demonstration of several distinct molecular roles of Eri1. For 
example, it has been shown that the catalytic activity of Eri1 is essential for 5.8S 
rRNA 3’ end formation during ribosome biogenesis (Ansel et al., 2008) and for 
histone mRNA degradation at the end of S-phase (Höfig et al., in preparation). 
Further, it has been found that Eri1 limits cellular miR196a-abundance and it counter-
regulates miR-196a-dependent Hoxc8 3’ UTR silencing in MEF cells. Eri1 affects 
Hox gene expression in embryos and thereby controls skeletal patterning in mouse 
development (Rath et al., in preparation).  
4.1 Severe phenotypes in Eri1-knockout mice 
4.1.1 Growth defects, postnatal death and male sterility 
The Eri1-knockout mice were systematically analyzed for their phenotypes to get an 
impression of the function of murine Eri1. It was observed that Eri1-knockout mice 
show a reduced body size and weight throughout development and till adulthood 
(Figure 10). Consistent with this finding, it could be shown that primary MEF cell 
cultures from Eri1-knockout embryos have a prolonged doubling time (Figure 19). 
The cell screen analysis cannot distinguish between (1) prolonged duration between 
cell divisions of all cells in the culture or (2) some of the cells in the culture dividing 
normally while others become impaired to divide. Experiments to test cell apotosis 
were not performed in the frame of this thesis, so this cannot be excluded.  
The growth defects resemble those associated with Minute Drosophila mutants, Belly 
spot and tail (Bst) mouse mutants and Diamond-Blackfan anemia patients. All three 
of them have been linked to mutations in ribosomal genes (Draptchinskaia et al., 
1999; Lambertsson, 1998; Oliver et al., 2004). In this work it could be shown, that 
Eri1 binds to and processes 5.8S ribosomal RNA (section 3.1.4). Therefore a 
connection might be suggested between impaired ribosome biogenesis, a prolonged 
doubling time of primary Eri1-deficient MEF cells and decreased growth of Eri1-
knockout mice. 
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Mice of an inbred strain are genetically as alike as possible by being homozygous for 
virtually all alleles. This makes them favorable for knockout studies, because the 
phenotypic variability between individual animals is very small. On the other hand, 
inbred strain animals are more vulnerable to mutations, because they are less able to 
compensate for experimentally generated loss of function of specific gene products. 
In the case of Eri1 deletion, deficient mice on an inbred C57BL/6 stain background 
died soon after birth (Figure 11, Table 6). A strategy to combat this neonatal mortality 
was found by crossing in an outbred strain that had strongly increased allelic 
variability. Generating Eri1-knockout mice on an NMRI x C57BL/6 background could 
indeed largely rescue the phenotype (Table 6). These data suggest that Eri1 
deficiency in combination with one or many specific other alleles decreases survival, 
which can be overcome by compensatory mechanisms present in mixed strains.  
 
Tissue Western blotting revealed relatively high levels of Eri1 in the testes of mice 
(Figure 13). The deficiency of Eri1 led to the phenotype of male sterility, which was 
also reflected by an underdevelopment of the testes (Figure 12). It may be 
speculated that this phenotype is a consequence of Eri1’ s impact on cell cycle-
dependent histone mRNAs (Figure 23). A unique regulation of histones occurs in 
mammalian spermatogenesis. During meiosis, the replication-dependent histones 
are replaced with testis-specific variants and these themselves are then substituted 
by protamines in the mature sperm (Kimmins and Sassone-Corsi, 2005). Potentially, 
Eri1 could be involved in the exchange of replication-dependent histones to testis-
specific histones. If in the Eri1-deficient testis this crucial step is impaired one could 
imagine that spermatogenesis is arrested. 
4.1.2 Results from the screen in the German Mouse Clinic 
For a more detailed analysis of phenotypes in Eri1-deficient mice, Eri1-knockout, 
Eri1-heterozygous and wildtype littermates were sent to the German Mouse Clinic to 
test them in a number of standardized screens. Tests were performed in 14 different 
categories. In five categories no abnormalities were found: allergy, cardiovascular 
function, eye, lung function and nociception, but in nine categories Eri1-dependent 
phenotypes were discovered: behavior, clinical chemistry and hematology, 
dysmorphology, energy metabolism, immunology, molecular phenotyping, neurology, 
pathology, and steroid metabolism (Table 7). The diversity of categories exhibiting a 
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phenotype already suggests that Eri1 is a regulator in many different cell types either 
of the same cellular pathway or even of several different pathways. This work has 
provided support for the latter by showing that Eri1 is involved in such crucial 
processes as ribosome biogenesis, canonical histone mRNA regulation and RNAi.  
For example, in the clinical chemistry and hematology screen Eri1-deficient mice 
showed a macrocytic anemia phenotype. The cause of Diamond-Blackfan anemia 
has been described to be abnormal processing of ribosomal RNA due to mutations in 
the ribosomal protein S19, which leads to abnormalities in ribosomal function 
(Draptchinskaia et al., 1999). Consistent with this finding, the macrocytic anemia in 
Eri1-deficient mice might be connected to impaired ribosomal RNA processing as 
well (Figure 18). The behavior phenotype of increased anxiety in the Eri1-knockout 
mice could be due to loss of Eri1 function in neurons. Eri1 has been shown to be 
highly expressed in a subset of neurons in C. elegans (Kennedy et al., 2004). 
Further, in Eri1-deficient worms an increased RNAi sensitivity was reported. Testing 
the worms for siRNA-mediated silencing of a neuron-specific reporter gene, the Eri1-
knockout worms showed a 70% decrease in reporter gene expression upon feeding 
with dsRNA, while the dsRNA had no affect in wildtype animals (Kennedy et al., 
2004). These findings suggest that Eri1 might have an important function on miRNAs 
in the neurons of mice, but this has not been demonstrated yet. 
4.2 Limitations of molecular phenotyping of embryos 
Comparative genome-wide expression profiling is a powerful tool in the effort to 
annotate the mouse genome with biological function. The analysis of mRNA 
expression data of knockout mice may support the understanding of the molecular 
biology in the mutants. Within the German Mouse Clinic the efficiency of systematic 
genome-wide expression profiling for the detection of molecular phenotypes in 
organs of a mammalian model organism has been demonstrated (Horsch et al., 
2008). 
To address the question, which genes cause the phenotype of dysmorphology in the 
development of Eri1-deficient mice, the mRNA expression of whole embryos, 
excluding the head, was analyzed instead of singular organs. A number of mRNAs 
coding for hemoglobin have been found to be down-regulated in Eri1-knockout 
embryos (Table 9). This might be linked to the macrocytic anemia phenotype of adult 
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mice, which is often associated with an insufficient concentration of hemoglobin in 
the cells. However, only two developmentally regulated genes, Abr (active BCR-
related gene) and Afp (alpha feto protein), could be found in the pool of 13 diverse 
regulated genes (Table 11). Abr is important during the vestibular morphogenesis of 
the inner ear in mice. The vestibular system has important sensory functions and 
contributes to spatial orientation. Probably, the increased expression of Abr in Eri1-
knockout mice does not induce a noticeable phenotype, because in the screen of the 
German Mouse Clinic only small problems were noticed in behavior tests (Table 7). 
AFP is the main fetus serum glycoprotein, which is produced by the fetal yolk sac 
and the fetal liver. In pregnant women increased levels are indicative of open neural 
tube defects in the fetus (Leighton et al., 1975) and decreased levels are indicative of 
the Down syndrome (Cuckle et al., 1984). Contrary, it has been proposed that AFP is 
not required during mouse embryonic development. Furthermore, it has been shown 
that AFP null females are infertile whereas males are fertile (Gabant et al., 2002). 
However, it has not been solved in the framework of this thesis whether the 
increased level of Afp expression in Eri1-knockout embryos has an influence on any 
of the observed phenotypes. 
All down-regulated mRNAs show only about a 2-fold regulation (Table 9). Probably, 
the analyses of whole embryos were not precise enough to reveal greater differences 
between Eri1-knockout and wildtype embryos. Additionally, a high variability among 
the four Eri1-knockout embryos was discovered (Table 10). Biological variability in 
gene expression, oscillation of stress responsive genes and technical variability of 
the dissection or the blood content of the embryos might bear potential for anti-
correlation in the gene expression patterns between individuals of one genotype. In 
addition, several recent publications have provided evidence for biological variability 
of expression levels for particular genes (Churchill, 2002; Drobyshev et al., 2003; 
Oishi et al., 2003; Pritchard et al., 2001; Seltmann et al., 2005).  
Altogether, the molecular phenotyping approach did not reveal potential genes that 
are involved in the prominent Eri1-knockout phenotype of skeletal dysmorphology. 
4.3 Expression and intracellular localization of Eri1 
The EST (expressed sequence tags) profile of Eri1 in M. musculus is shown on the 
NCBI-Unigene webpage (http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi 
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?uglist=Mm.207534). The profile gives numbers for the Eri1 specific EST versus all 
EST in the pool of each organ analyzed. Relative high mRNA levels were found in 
the bladder, bone, dorsal root ganglion, spleen and thymus. The EST profile further 
shows Eri1 expression in various developmental stages. Eri1 mRNA is expressed as 
early as cleavage to the morula stage occurs. High mRNA expression was found in 
the developmental stages of gastrula, organogenesis, fetus neonate and juvenile. 
These data on Eri1 mRNA expression are largely consistent with the protein 
expression described in this thesis work. Analyzing Eri1 protein expression in adult 
mice, it was found to be expressed ubiquitously with especially high levels in tissue 
protein extracts from spleen, thymus and testis (Figure 13). High mRNA and protein 
levels in spleen and thymus indicate a possible, increased impact of Eri1 on blood 
cell maturation. Initial experiments have been performed to analyze the differentiation 
of bone marrow cells in vitro. Although changes in differentiation between the 
hematopoetic cells from Eri1-knockout and wildtype mice were observed, a high 
variability in both groups was determined and excluded to describe statistically 
significant changes (data not shown). However, the macrocytic anemia phenotype of 
Eri1-knockout mice indicates a function of Eri1 at least in the erythroid lineage (Table 
7). Immunohistochemistry stains of embryos at 12.5 dpc revealed Eri1 protein 
expression allover the embryo with higher Eri1 protein levels in the prevertebrae and 
in the brain (Figure 27). The elevated Eri1 protein abundance in prevertebrae and the 
higher mRNA levels in the bones of adult mice (NCBI-Unigene) are in line with the 
skeletal anomalism of Eri1-knockout mice. 
 
In previous studies intracellular localization of the human homolog of mouse Eri1, 
3’hExo, was investigated in HeLa cells. Human Eri1 linked to a C-terminal GFP tag 
accumulated in the cytoplasm and the nucleoli (Yang et al., 2006). In C. elegans, 
functional Eri1-GFP fusion proteins seemed to be strictly cytoplasmic, and Flag-
tagged Eri1 localized only to the cytoplasm in S. pombe (Bühler et al., 2006; Gabel 
and Ruvkun, 2008; Kennedy et al., 2004). 
Consistent with the observations for human Eri1 and in contrast to worm and fission 
yeast, analysis of the intracellular localization of GFP-tagged mouse Eri1 revealed 
localization to the cytoplasm and the nucleus (Figure 14). Inside the nucleus Eri1 was 
especially enriched in the nucleoli, the site of ribosomal RNA biogenesis. An 
extended analysis employing point mutants of Eri1 showed that this localization 
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depends on an intact SAP domain and linker sequence. Although the exchange of 
single amino acids did not impair the entry into the nucleus, no enrichment was seen 
in the nucleoli any more. Probably, the adherence of the Eri1 mutants to attach to the 
RNA or DNA in the nucleolar structures was reduced. This is supported by analysis 
of the mutants in RNA immunoprecipitation assays, which revealed that the very 
same amino acids support binding to 5.8S rRNA (Figure 17). 
4.4 The RNA target molecules of Eri1 
The Eri1 protein contains an amino-terminal SAP domain, a linker sequence and a 
carboxy-terminal exonuclease domain. A structure-based comparison with other 
known 3’ exonucleases of the DEDD family revealed that the human homolog of Eri1 
is more similar to DNA-specific exonucleases than to RNases (Cheng and Patel, 
2004). Nevertheless, in this work it could be shown that the exonuclease domain of 
mouse Eri1 is crucial for the regulation of at least three RNA target molecules: 
ribosomal RNA, canonical histone mRNA and miRNA.  
4.4.1 Ribosomal RNA processing 
The synthesis of ribosomes is among the most fundamental of biological processes 
in each cell. Yet our understanding of ribosome biogenesis remains incomplete. 
Gabel and Ruvkun have demonstrated that Eri1 is essential for the maturation of the 
3’ end of 5.8S rRNA in C. elegans and S. pombe (Gabel and Ruvkun, 2008). 
Together with the finding of mouse Eri1 being involved in 5.8S rRNA processing 
(Ansel et al., 2008), this leads to the conclusion that Eri1 has a conserved function in 
rRNA processing. 
In this work it was shown that Eri1 is directly associated with 5.8S rRNA in living cells 
and that the 5.8S rRNA 3’ end is extended in Eri1-deficient MEF cells (Figure 15, 
Figure 18). In an in vitro assay of 5.8S rRNA maturation, recombinant Eri1 was able 
to access and convert the 3’ end of the 5.8S rRNA of intact ribosomes from Eri1-
deficient liver extract to exactly the same size as mature wildtype 5.8S rRNA (Ansel 
et al., 2008). Taken together, these findings strongly support the conclusion that Eri1 
binds to and removes the unpaired nucleotides from the 3’ end of 5.8S rRNA in vitro 
and in vivo. 
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In the mature ribosome structure, the 3’ end of 5.8S rRNA forms a duplex with the 5’ 
end of 28S rRNA, leaving a 3’ overhang in Eri1-deficient cells (Ansel et al., 2008). 
This 5.8S-28S rRNA duplex resembles the structure of siRNA duplexes. Previous 
work on homologs of Eri1 have shown that a characteristic of Eri1 activity is its 
enhanced exonucleolytic function on free 3’ overhangs compared to single-stranded 
RNA or duplexes (Iida et al., 2006; Kennedy et al., 2004; Yang et al., 2006). Hence, it 
could be reasoned that the Eri1 protein recognizes duplex RNA structures. These 
duplex structures are also present in hairpins for which Eri1 would then be able to 
process the 3’ unpaired end. This feature is shared with the canonical histone 
mRNAs for which our group has demonstrated that Eri1 processes the 3’ end (Höfig 
et al., in preparation).  
RIP assays proved that Eri1 already interacts with the longer 45S rRNA precursor 
(Figure 16). No significant association could be detected with the 3’ ETS, which is the 
sequence that is transcribed last in the generation of the 47S rRNA precursor. One 
possible explanation would be, that Eri1 binds to the precursor at its 5’ part before 
the 47S rRNA has been fully transcribed. It has been shown for S. cerevisae, that co-
transcriptional cleavage takes place within the 3’ ETS (Henras et al., 2004). If this 
was true for mammalian cells as well, the 45S precursor, lacking the 3’ ETS 
sequence, would be the earliest detectable species that can be visualized by the 
applied method. Consequently, it cannot be excluded that Eri1 binds to the entire 
47S rRNA precursor as well. Interestingly, an impact of Eri1 on earlier processing 
steps could not be detected, because (1) Eri1-deficient and wildtype cells showed 
equal levels of 5.8S rRNA (Figure 15) and (2) pulse chase experiments in these cells 
to analyze rRNA precursor processing did not reveal a difference (Ansel et al., 2008). 
Hence the importance of the binding of Eri1 to the ribosomal RNA during early 
processing steps remains unclear. 
4.4.2 Histone mRNA degradation 
As cells approach the end of S-phase, the need for new canonical histone proteins 
vanishes and the levels of replication-dependent histone mRNAs decrease. Recently, 
it has been demonstrated in human cells that degradation of histone mRNAs requires 
SLBP, which is involved in recruiting the proteins necessary to add a short oligo(U) 
tail to the histone mRNA that is being translated (Mullen and Marzluff, 2008) (Figure 
2). The oligo(U) tail is an optimal binding site for the LSM1-7 complex, which binds to 
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oligo(U) tails as well as poly(A) tails. The binding leads to the degradation of the 
histone mRNA by pathways that are similar to those involved in the degradation of 
poly(A) mRNA after deadenylation induced shortening of the poly (A) tail towards an 
oligo(A) tail (Parker and Song, 2004; Tharun et al., 2000). SLBP itself is cell cycle-
regulated; but although the levels of SLBP and canonical histone mRNA parallel 
each other during cell cycle, the molecular signals that regulate these two factors are 
distinct (Marzluff et al., 2008). Hydroxyurea-induced inhibition of DNA replication in 
the middle of S-phase resulted in rapid degradation of replication-dependent histone 
mRNA, but there was no effect on SLBP levels (Whitfield et al., 2004). In addition, 
stabilizing SLBP did not prevent replication-dependent histone mRNA degradation at 
the end of S-phase (Zheng et al., 2003). Consequently, an additional protein has to 
trigger histone mRNA degradation. 
In this work mouse Eri1 has been shown to directly interact with the replication-
dependent Hist2h4 mRNA (Figure 20). Furthermore, it could be demonstrated that 
Eri1 initiates Hist2h4 mRNA degradation upon hydroxyurea-treatment simulating the 
end of S-phase (Figure 23). This finding disproved the current results from Mullen 
and Marzluff. In HeLa cells, they could not detect a contribution of Eri1 to the 
degradation of canonical histone mRNAs after hydroxyurea treatment (Mullen and 
Marzluff, 2008). One possible explanation for these contrary results could be that 
Mullen and Marzluff did only achieve an 80-90% knockdown in HeLa cells. In the 
experiment presented in this work, a knockdown with undetectable Eri1 levels on a 
Western blot was attained in MEF cells (Figure 23g). Furthermore, Mullen and 
Marzluff did only induce a short-term knockdown by the transfection of siRNAs, 
whereas retroviral infection of shRNAs, as performed in this thesis work, induces a 
longterm knockdown. These differences did probably lead to diverse starting 
conditions for the hydroxyurea experiments, which would explain the different 
outcome.  
Further, it could be demonstrated in this study that the exonuclease activity of Eri1 is 
crucial for the initiation of histone mRNA degradation (Figure 23). Consequently, not 
only the binding of Eri1 to canonical histone mRNA, probably in cooperation with a 
larger protein complex, but also the enzymatic activity of Eri1 is needed for histone 
mRNA degradation. Further experiments have been performed that reveal the effect 
of Eri1 on canonical histone mRNAs in T cells and that provide a detailed insight into 
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the mechanism how Eri1 cooperates in the canonical histone mRNA degradation 
pathway (Hoefig et al., in preparation). 
4.4.3 How does Eri1 recognize its target RNAs? 
The SAP (SAF-A/B, Acinus and PIAS) domain of Eri1 has been found to facilitate 
binding of proteins to double stranded DNA and RNA. The domain codes for a 
scaffold attachment factor (SAF)-box, which was shown to recognize AT-rich regions 
in the chromosomal DNA known as scaffold-attachment regions (Aravind and 
Koonin, 2000; Kipp et al., 2000). Furthermore, it had been claimed that the SAP 
domain and linker sequence of human Eri1 are essential for sequence-specific 
binding to the histone mRNA stem loop and its conserved 3’ terminal ACCCA 
sequence (Yang et al., 2006). 
In this work, binding of Eri1 to the histone mRNA could be confirmed in the mouse 
cell system in vivo (Figure 20). Furthermore, it was shown that Eri1 associates with 
the 5.8S rRNA and its precursor (Figure 15, Figure 16). The RNA 
immunoprecipitation assays did not reveal a direct contact to the 5S rRNA, which is 
also present in the 60S large ribosomal subunit. These findings supported the 
hypothesis that Eri1 selects its RNA substrates. Further evidence was given in 
experiments testing point mutations in the RNA-binding linker sequence of Eri1. 
These impaired direct binding to 5.8S rRNA and histone mRNA at low, endogenous 
expression levels (Figure 17a, Figure 20). Unfortunately, the function of the SAP 
domain could not be tested, because the monoclonal anti-Eri1 antibody recognizes 
an epitope in this domain. Generating monoclonal antibodies against the 
exonuclease domain, these were not specific enough for the use in RIP assays (data 
not shown). Therefore, GFP-tagged Eri1 wildtype and mutants were 
immunoprecipitated by a polyclonal anti-GFP antibody. Contrary to the earlier 
experiments, the SAP domain and the linker sequence were now functionally 
dispensable (Figure 17c). GFP-tagged proteins are often several fold higher 
expressed than the endogenous protein. Consequently, it has to be concluded that 
the here investigated residues in the SAP domain and the linker domain as well as 
the SAP domain itself are not required for 5.8S rRNA processing in cells under 
conditions at which a mutant of Eri1 is expressed at a significantly higher level than 
endogenous expression.  
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The analysis of an additional Eri1 SAP/linker sequence (N69A K107A) mutant was 
based on the crystal structure of human Eri1 bound to histone mRNA (Y. Cheng and 
D. Patel, submitted to the Protein Data Bank). The open question was, whether these 
two amino acids in the SAP domain and linker sequence are crucial for binding to the 
histone mRNA, but not to the 5.8S rRNA. In this thesis work, it could indeed be 
shown that the two amino acids, N69 and K107, are supportive for histone mRNA 
binding. While the mutant could reconstitute processing of the 3’ end of 5.8S rRNA in 
Eri1-knockout cells (Figure 22), the same cells were impaired to initiate degradation 
of Hist2h4 mRNA upon hydroxyurea-treatment (Figure 23e). Consequently, it can be 
proposed that different amino acids in the SAP domain or linker sequence support 
the binding of Eri1 to each of the RNA substrates. Nevertheless, in a second 
experiment the very same mutant could initiate histone mRNA degradation, probably 
because of slightly higher expression levels or varying cellular conditions or more 
efficient introduction of the mutant protein into endogenous complexes. This result is 
partly consistent with the findings on human Eri1 binding to histone mRNA in vitro. 
Inherent substrate specificity of Eri1 protein towards the histone loop was lost at high 
Eri1 concentrations, testing binding to histone mRNA loops comprising nucleotide 
replacements or truncations (Dominski et al., 2003; Yang et al., 2006). 
Together, the data suggest that single amino acids in the Eri1 protein support binding 
to specific RNA target molecules, but at higher expression levels they are 
dispensable. Hence, additional protein-protein contacts between Eri1 and ribosomal 
proteins or factors associated with histone mRNA degradation have to participate in 
the substrate selection of Eri1 RNA targets. 
4.5 Eri1 regulates skeletal patterning 
This work contributes new data concerning the genetic basis of skeletal patterning in 
mice. It is shown that (1) a homeotic transformation is present in Eri1-deficient mice,  
(2) the Hoxc8 expression border is shifted in Eri1-knockout embryos relative to 
wildtype and (3) Eri1 has an impact on miR-196a-mediated silencing of the Hoxc8 
3’ UTR. 
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4.5.1 Shared phenotypes of Eri1- and Hoxc8-knockout mice 
Homeotic transformations are characterized by the change of segment identity during 
development. This is induced by a mutation or misexpression of developmentally 
critical genes, for example the Hox genes in animals. Several Hox gene knockout 
mice show the phenotype of an additional rib pair at vertebrae #21. This has been 
reported for mouse mutants with a single or combined deletion of Hoxc8, Hoxa9, 
Hoxc9 and Hoxa10 (Chen and Capecchi, 1997; Fromental-Ramain et al., 1996a; Le 
Mouellic et al., 1992; Rijli et al., 1995; Satokata et al., 1995; Suemori, 1995; van den 
Akker et al., 2001; Wellik and Capecchi, 2003) (Table 12). Accordingly, an overlap of 
function between the gene products of these paralogues as well as non-paralogues 
Hox genes may be suggested. 
In Eri1-knockout mice a skeletal anomalism was detected with a high penetrance of 
80% (Table 8). A duplication of the 7th thoracic vertebra was observed resulting in a 
total number of 14 rib bearing vertebrae (Figure 24, Figure 26). Furthermore, Eri1-
deficient mice showed the fusion of an 8th rib pair to the sternum (Figure 25). This is 
a logic consequence of a duplication of exactly the 7th rib, which is the last rib 
attached to the sternum. This Eri1-knockout mouse phenotype is only shared with the 
Hoxc8- and Hoxc9-deficient mice (Le Mouellic et al., 1992; Suemori, 1995; van den 
Akker et al., 2001). Although, the phenotype of Hoxc9-deficient mice resembled 
closely that of Eri1- and Hoxc8-deficient mice, in some of the Hoxc9-knockout 
animals the anteriorization effect seemed to be even more prominent. The 9th rib was 
partially found to fuse to the sternum as well. The Hoxc9-knockout mouse phenotype 
might also develop due to an altered expression of Hoxc8 which was suggested to be 
regulated by Hoxc9 (Suemori, 1995).  
Hoxc8 expression is particularly high in the lower thoracic prevertebrae compared to 
levels of Hoxb8 and Hoxd8. Hence, it was this domain, in which the most penetrant 
phenotypes were found in Hoxc8-knockout mutants. Hoxb8-knockout mutants 
showed predominantly abnormalities in the upper rib cage. Hoxd8 was found to be 
expressed in the region of sacral vertebrae but only with low levels of gene 
expression. Hoxd8 deficiency rather increased the phenotype in double or triple 
mutants, than developing abnormalities as a single knockout (van den Akker et al., 
2001). 
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Interestingly, different from Hox-knockout mice in Eri1-knockout animals there was 
never a rudimentary rib or a one-sided additional rib observed on vertebra #21. The 
additional rib pair was always fully developed. It may be speculated that the Eri1 
deletion leads to a different outcome than Hox gene deletion, because Eri1 works on 
the secondary, post-transcriptional level. 
A detailed analysis of the vertebrae in Eri1 mutants revealed that the duplication of 
the 7th thoracic vertebra leads to an anteriorization of all following vertebrae down to 
the lumbar or sacral region (Figure 26). This anteriorization stopped in the lumbar 
domain in some of the male mice, while in the other male mice as well as in all 
female animals the anteriorization was extended to the sacral domain. Both cases 
have been seen occasionally in Hoxc8-, Hoxc8/d8- or Hoxb8/c8/d8-deficient mice as 
well (van den Akker et al., 2001). The diversity of the phenotypes probably results 
from partially incomplete homeotic transformation of thoracic, lumbar and sacral 
vertebrae. 
Altogether, it may be concluded that the Eri1-knockout dysmorphology phenotype 
resembles closely the Hoxc8 single and combined deletion mutants. Apart from the 
shared skeletal anormalisms the Hoxc8 mutant mouse line did show the phenotype 
of postnatal death as well. Most Hoxc8-deficient mice die shortly after birth from a still 
unknown cause (van den Akker et al., 2001). Another shared phenotype is the 
reduced fore-limb grip strength that was also observed in Hoxc8- knockout animals 
(Tiret et al., 1998).  
4.5.2 Hox expression pattern in embryos  
Hox genes have been shown to play important roles in the establishment of the body 
axis during development (Krumlauf, 1994). Hox genes are a particular subgroup of 
homeobox genes, which code for a group of transcription factors. Special of Hox 
genes is not only their organization in chromosomal clusters, but the striking 
phenomenon of spatial colinearity (McGinnis and Krumlauf, 1992). In vertebrates, 
also a temporal colinearity has been detected (Duboule, 1994; Kmita and Duboule, 
2003). 
Hox proteins have been proved to be difficult to stain in whole mount 
immunohistochemistry approaches. Reviewing the current literature, the sensitivity of 
the different methodical approaches resulted in diverse Hoxc8 gene expression 
borders (Juan et al., 2006; Kwon et al., 2005b; Le Mouellic et al., 1992; van den 
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Akker et al., 2001). Recently, researchers replaced the Hoxc8 allele with either a 
GFP or a LacZ reporter. It could be shown that already the introduction of a reporter 
may lead to differences in endogenous Hox gene expression (Blackburn et al., 2009). 
The embryonic stage also seems to play an important role because the expression 
domains are labile within larger domains till embryonic day 12.5 dpc (McIntyre et al., 
2007). In this study Hoxc8 expression in mouse embryos was analyzed using the 
Western blot method. The analysis of embryo parts revealed a specific protein 
expression in the posterior half of the embryo (Figure 28a).  
Comparing mRNA and protein levels of Hoxc8 in wildtype embryos at 12.5 dpc, 
Hoxc8 mRNA could be detected in a broader area, while high expression of protein 
was restricted to a smaller region in the center of the mRNA expression area (Figure 
28a,b). This difference in the mRNA and protein expression pattern do not exclude a 
regulation on the protein level, but strongly suggest a regulation on the post-
transcriptional level causing an absence of Hoxc8 protein at the anterior and 
posterior expression borders. MiRNAs have been shown to repress the translation of 
target genes as well as to reduce the target mRNA expression levels and they have 
been proposed to act as fine-tuners of developmental gene expression programs 
(Stark et al., 2005). Consequently, it may be assumed that miRNAs inhibit Hoxc8 
mRNA translation at sites of low expression.  
Hoxc8 and Hoxb8 mRNAs could be identified to be targets of Eri1 during embryonic 
development. The Hoxc8 and Hoxb8 mRNA expression levels showed distinct 
phenotypes in Eri1-knockout and wildtype littermates (Figure 28b,c, Figure S-35). In 
the mutants the anterior expression border of Hoxc8 as well as Hoxb8 was shifted 
into posterior direction on the A-P axis of the embryo. In the critical expression area 
(embryo part 3) a 16-fold change for Hoxc8 and a 4-fold change for Hoxb8 was 
measured. However, no significant impact of Eri1 was seen in the posterior region of 
high Hoxc8 and Hoxb8 expression. The shift of Hox gene expression into the 
posterior direction in Eri1-knockout mice may account for both Eri1-knockout mouse 
phenotypes, the attachment of an 8th rib pair to the sternum as well as the 
development of an additional rib pair at the first lumbar vertebra. The posterior 
dominance model predicts that the more posterior expressed Hox genes have a 
greater effect on the pattering information than the more anterior expressed genes 
(Duboule, 1994). It can therefore be proposed that the Hoxc8 and Hoxb8 prevalence 
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starts only in the more posterior situated lower thoracic region in the Eri1-knockout 
situation.  
 
Although the presented data cannot rule out a possible positive effect of Eri1 on the 
transcription rate of Hoxc8 and Hoxb8 mRNAs, there is compelling evidence for Eri1-
mediated derepression of posttranscriptional silencing of Hoxc8. In support of this 
proposed mechanism, a very recently published paper showed an anterior expansion 
of Hoxb8 gene expression as the consequence of antagomir-mediated neutralization 
of the Hox miR-196 in chicken embryos (McGlinn et al., 2009).  
The levels of mature miR-196a were measured in Eri1-knockout and wildtype 
animals. Although a tendency for a shift into the anterior direction was observed in 
Eri1-knockout mice, no significant difference could be detected comparing three Eri1-
knockout and wildtype pairs by quantitative reverse transcription PCRs (Figure 29a, 
Figure S-36). This might be due to various reasons: First, the analyses were 
performed at 12.5 dpc, a time point when the identity of the segments has already 
been established. And second, the analysis is imprecise by measuring whole slices 
including the limbs, which express miR-196 as well. Therefore follow-up experiments 
using microdissection are planned in which exclusively the somites will be examined 
for their mature miR-196a expression. Further, whole mount in situ hybridizations on 
embryos at 11.5 and 12.5 dpc have been performed (Figure 29c), but the protocol 
still has to be established for earlier developmental stages closer to the time period of 
vertebrae anlage. A problem for the Eri1-knockout and wildtype comparison by in 
situ-hybridization is that the locked nucleic acids probe recognizes mature miR-196a 
as well as its precursor molecules, pre-miR-196a and pri-miR-196a. Regulation of 
precursor miRNAs by Eri1 has not been demonstrated yet.  
4.5.3 Eri1 regulates mature miR-196a levels 
Although much is known about the synthesis of miRNAs, up to now, very little is 
known about the regulatory mechanisms controlling the spatiotemporal expression 
pattern of miRNAs and nothing is known about their downregulation. Eri1 has been 
suggested to regulate exogenous as well as endogenous siRNA pathways in C. 
elegans (Duchaine et al., 2006; Kennedy et al., 2004). Kennedy and colleagues 
proposed a direct impact of Eri1 on exogenous siRNAs by degrading the 3’ 
overhangs of siRNAs, whereas Duchaine and colleagues suggested that Eri1 affects 
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the exogenous RNAi pathway only indirectly through its role in endo-siRNA 
production. In this model, Eri1-dependent endo-siRNA pathways inhibit RNAi by 
competing for cellular factors involved in the production or activity of both endo- and 
exo-siRNAs.  
Data from Eri1-deficient mice have shown that in T cells all analyzed miRNAs were 
enriched with a factor of 1.25, while other noncoding RNAs, such as U6 snRNA were 
unaffected (Rath et al. in preparation, data from KM. Ansel). Mature miR-196a levels 
have been analyzed in MEF cells in this work. The data revealed that in Eri1-deficient 
cells a 1.34-fold to 1.68-fold increase of mature miR-196a levels could be measured 
comparing to Eri1-reconstituted cells (Figure 30). These results uncovered a 
consistent increase in mature miRNA abundance in Eri1-deficient cells. Further 
investigations have to reveal, if the biogenesis of mature miRNAs is impaired through 
Eri1-deficiency, or rather if the half-life of mature miRNAs is reduced.  
4.5.4 The impact of Eri1 on miR-196-mediated Hoxc8 silencing 
Reporter assays in HeLa cells have indicated that miR-196 limits or dampens Hoxc8, 
Hoxd8 and Hoxa7 expression using Hox 3’ UTR fragments. In the case of Hoxb8 
even degradation of the reporter RNA was initiated (Yekta et al., 2004). 
Luciferase assays on MEF cells using the complete 3’ UTR of Hoxc8 have confirmed 
negative regulation of Hoxc8 by miR-196a through its 3’ UTR (Figure 31). 
Importantly, it was shown that Eri1 could attenuate this suppression. Increasing the 
amount of Eri1 did lead to higher expression levels of the Hoxc8 3’ UTR reporter 
(Figure 32a). Further experiments, in which all four conserved miR-196 binding sites 
in the Hoxc8 3’ UTR had been mutated revealed that Eri1 affects indeed the RNAi 
pathway and it could be shown that the exonucleolytic activity of Eri1 is crucial for its 
impact on miR-196a-mediated Hoxc8 silencing (Figure 32b, Figure 33). Together 
with the finding that Eri1 reduces mature miR-196a levels in MEF cells (Figure 30), it 
may be proposed that Eri1 has a negative influence on the accumulation of mature 
miRNAs in the cell through its exonuclease domain. Thus, through the reduction of 
miR-196a levels, silencing of Hoxc8 mRNA will be released and more Hoxc8 protein 
is expressed in the wildtype situation. 
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4.5.5 Model depicting the role of Eri1 in skeletal patterning 
Analyzing the skeletal phenotype in Eri1-knockout mice, the data suggest the 
following model (Figure 34). In wildtype mice, Eri1 expression leads to a decreased 
level of mature miR-196a, especially at sites of low expression of miR-196a. This is 
the case at the anterior expression border in the embryo. Consequently, Eri1 
counteracts the silencing of Hoxc8 mRNA by miR-196a and Hoxc8 protein will be 
expressed. In Eri1-knockout mice higher levels of functionally active miR-196a are 
expressed in more anterior segments of the embryo. Accordingly, the RNAi pathway 
inhibits Hoxc8 mRNA and thus the Hoxc8 protein expression will be shifted into the 
posterior direction in the embryo. According to the posterior prevalence model this 
may lead to the anteriorization phenotype observed in Eri1-deficient mice due to a 
lack of Hoxc8 prevalence over the more anterior Hox genes in prevertebrae of the 
lower thoracic region of the embryo. 
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Figure 34: Model depicting the role of Eri1 in skeletal patterning. 
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4.6 Conclusion 
In this study the conserved exonuclease Eri1 could be shown to be involved in at 
least three RNA pathways: ribosomal RNA processing, histone mRNA degradation 
and miRNA-mediated RNAi. 
Eri1 was found to be enriched in nucleoli and to directly bind to and process 5.8S 
rRNA. Contrary to the proposed model of Mullen and Marzluff that excludes a 
contribution of Eri1 in histone mRNA degradation (Mullen and Marzluff, 2008), it 
could be demonstrated that the exonuclease activity of Eri1 initiates cell cycle-
dependent histone mRNA degradation. Furthermore, the findings on Eri1 binding to 
5.8S rRNA and Hist2h4 mRNA support the view that specific residues in the Eri1 
SAP domain and linker sequence facilitate binding to RNA duplex structures, as they 
are inherent in the ribosomal RNA or the histone mRNA stem loop. However, this 
binding acts in concert with one or more so far unknown cellular binding partners to 
determine substrate specificity. 
Eri1-knockout mice revealed a number of phenotypes, most prominently growth 
defects, postnatal death, male sterility and skeletal dysmorphology. Detailed 
analyses of the skeleton discovered high similarity to Hoxc8-knockout mice (van den 
Akker et al., 2001). Consistently, molecular analyses detected a shift of the anterior 
expression boundary of Hoxc8 in embryos. A negative regulatory function of Eri1 on 
mature miR-196a levels could be shown and Eri1 was demonstrated to inhibit miR-
196-mediated Hoxc8 3’ UTR silencing. These findings suggested a model, in which 
Eri1 defines the Hoxc8 expression pattern in the embryo and is consequently 
required for the correct patterning of the skeleton. 
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Figure S-35: Hoxc8 and Hoxb8 expression in three Eri1-knockout and wildtype embryos. Hoxc8 
and Hoxb8 mRNA levels were detected by qRT-PCR in three Eri1-knockout and wildtype embryos 
from two litters (litter one: knockout-A, wildtype-C, knockout-G and litter two: knockout-L, wildtype-M, 
wildtype-O; C57BL/6). The values were normalized to the pbgd housekeeping gene. The ΔCp 
Hoxc8/pbgd or Hoxb8/pbgd in wildtype part 2 was set 1 (log2 of 0). The expression of Hoxc8/Hoxb8 
mRNA in the six embryo parts is shown on a logarithmic scale as multiples of the mRNA expression in 
part 2 of the wildtype embryos. 
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Figure S-36: mat-miR-196a and miR-181a expression in three Eri1-knockout and wildtype 
embryos. Mature miRNA levels for miR-196a and miR-181a were detected by qRT-PCR in three Eri1-
knockout and wildtype embryos from two litters (litter one: knockout-A, wildtype-C, knockout-G and 
litter two: knockout-L, wildtype-M, wildtype-O; C57BL/6). The values were normalized to the U6 
snRNA housekeeping gene. The ΔCp, mature miRNA/U6 snRNA, in wildtype part 2 was set 1 (log2 of 
0). The expression of mat-miR-196a and miR-181a in the six embryo parts is shown on a logarithmic 
scale as multiples of the miRNA expression in part 2 of the wildtype embryos.  
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